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Abstract
S.cerevisiae mutants were isolated showing nuclear-coded resistance to the antibiotic 
venturicidin, a known F0ATPase binding antibiotic. Two types of mutant were 
identified, one of which had cross-resistance to a variety of antibiotics and appeared 
linked to the leux locus on chromosome VII, and one which was cross-resistant to 
chloramphenicol only and not linked to leux. The level of resistance to venturicidin was 
not increased in isolated mitochondria, therefore resistance shown in both groups is 
believed to be due to a decrease in plasma membrane permeability to these antibiotics.
The fluorescence properties of several organotin compounds, derivatives of the 
substituted flavones 3-hydroxyflavone (hof) and penta-hydroxyflavone (morin), were 
investigated on incubation with rat liver mitochondria. The compound Bu2SnBr(of) was 
found to show fluorescence enhancement when added to mitochondrial preparations, 
which could be lowered by addition of the non-fluorescent compound Bu3SnAc. 
Addition of Bu2SnBr(of) did not affect mitochondrial membrane potential, and 
conversely the energetic state of the mitochondrial inner membrane had no effect on 
Bu2SnBr(of) fluorescence. This compound was shown to be an inhibitor of 
mitochondrial ATPase, and is thought to have its binding site on the F0 moiety of that 
enzyme complex.
The nuclear gene causing respiratory deficiency in the complementation group G57 was 
cloned and sequenced. This gene (PETj7) encoded a protein of 36 Kdal which did not 
show significant homology with any known protein. The mutant strain was deficient in 
mitochondrial ATPase activity, but the major F, ATPase subunits were detected in 
mutant mitochondria, although in reduced amounts. Mutant Fi showed abnormal 
membrane binding and could not be isolated by standard methods. The protein encoded 
by the gene PETyj is transported into mitochondria and is thought to contribute to 
processing or assembly of one or more of the cytoplasmic subunits of the F,F0 ATPase 
complex.
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CHAPTER 1
INTRODUCTION
Aerobic organisms derive free energy from the oxidation of fuel molecules such as 
glucose and fatty acids. Intermediate in the transfer of electrons from these compounds 
are the carrier molecules nicotinamide adenine dinucleotide (NAD*) and flavin adenine 
dinucleotide (FAD), which accept electrons released by the degradation reactions of 
glycolysis and the citric acid cycle, converting them to their reduced forms NADH (and 
H*) and FADH2. Cells which can use molecular oxygen as the electron acceptor for the 
reoxidation of NADH and FADHj enormously increase their ability to generate ATP, 
compared with anaerobic cells, which transfer these electrons to an organic metabolite or 
inorganic oxidant. However, electron transfer from NADH and FADH2 releases enough 
free energy to drive the synthesis of several ATP molecules. To achieve release of this 
energy in a controlled, conservable fashion electrons are transferred stepwise through a 
series of reversible electron carriers, located in the mitochondrial inner membrane 
(Figure 1.1.a, b).
Mitochondria are centres for respiratory energy metabolism in eukaryotic cells. These 
organelles have two membrane systems (Figure 1.1.a): the outer membrane, which is 
freely permeable to small molecules and ions and has few enzymatic activities, and the 
inner membrane, which is extensively folded into ridges, termed cristae. and intrinsically 
impermeable (having a different phospholipid composition) with many associated 
enzyme activities. Hence the mitochondrion contains two compartments; the 
intermembrane space and the mitochondrial matrix which is totally enclosed by the inner 
membrane. The matrix houses the soluble enzymes of the citric acid cycle and those for 
fatty acid oxidation. The complex respiratory assemblies responsible for electron 
transfer and ATP synthesis span the mitochondrial inner membrane, together with 
transport systems to carry specific ions and metabolites across the impermeable
1


membrane bilayer (Tzagoloff, 1982).
The subject of this thesis is the complex multisubunit enzyme which catalyses ATP 
synthesis, the F jFq ATP synthase (ATPase) common to all respiring organisms. Both 
genetics and biochemistry of this enzyme can be studied conveniently in the yeast 
S.cerevisiae. Initially we discuss possible mechanisms coupling electron transport to 
ATP synthesis in the mitochondrial inner membrane, followed by an examination of the 
respective contributions of the nucleus and the mitochondrial genome to mitochondrial 
biogenesis. Mechanisms of transport of nuclear-coded proteins to their correct location 
in the organelle will be considered. A detailed description of the mitochondrial ATPase 
derived from both biochemical and  molecular genetic analysis of a number of species 
with reference to S.cerevisiae is a lso included.
1.1. Oxidative Phosphorylation
The electrons from NADH and FADH2 have a high transfer potential, releasing a large 
amount of energy during passage through the mitochondrial electron carriers to 
molecular oxygen. The mitochondrial electron carriers are arranged in four distinct 
respiratory assemblies (complex I to IV), each assembly containing numerous centres 
capable of reversibly accepting electrons. Flavin, iron-sulphur, quinone and heme groups 
are all utilised to transfer electrons in the direction of increasingly positive redox 
potential. The tendency of a membrane-bound electron carrier to donate or accept 
reducing equivalents is usually expressed as its midpoint potential, which is determined 
with reference to a standard electrode. These carriers can be divided into isopotential 
pools based on their midpoint potentials (Figure 1.1.c). Transfer of electrons between 
any of these pools represents a large fall in potential, resulting in a release of energy. At 
three steps during the transfer o f electrons from NADH (two steps for FADH2) the 
energy released is sufficient to drive the synthesis of ATP. The topology of the 
respiratory complexes and sites o f ATP synthesis are summarised in Figure 1.1.b, c.
4
The coupling of these energy releasing electron transfer reactions to the energy requiring 
synthesis of ATP has puzzled biochemists fo r many decades, and has not yet been 
resolved (reviewed in Slater, 1987). As passage o f electrons through the inner membrane 
carriers does not directly allow ATP synthesis, a “ high energy" mediating factor is 
necessary. A number of concepts for a coupling mechanism have been proposed, all 
differing in the nature of this high energy intermediate:
The chemical hypothesis (Slater, 1953) was based on the theory that oxidative 
phosphorylation had the same basic mechanism as substrate-level phosphorylation, in 
which energy is conserved in a high energy molecule where inorganic phosphate (P4) is 
bound to a carrier molecule. From experimental data, however, it was evident that a 
non-phosphorylated intermediate was involved as respiration could occur in the complete 
absence of inorganic phosphate. The simplified reaction proposed for this mechanism is 
shown below:
a h 2 + b + c  ^  a - c  + b h 2
A - C  + ADP + P, ^  A + C -fA T P
where -  is a bond in the high energy molecule, A and B represent redox carriers and C is 
an unknown ligand.
Uncouplers were proposed to act by hydrolysing the A -  C bond thus dissipating the 
stored energy. However, compounds causing uncoupling have a diversity in structure 
which is not consistent with this mode of action. Also, concerted investigation to isolate 
this chemical intermediate failed to identify the mediating compound, and it is now 
considered untenable in the form proposed.
The conformational hypothesis (Boyer, 1965), which proposed that the high energy 
intermediate was a specific conformation o f a respiratory carrier. This is a great 
simplification of the chemical hypothesis as it no  longer requires ligand C for formation 
of the high energy intermediate, thus:
5
AHj + B ^  A - + BH2 
A -  + ADP + Pj *  A ♦ ATP
The chemiosmotic hypothesis (Mitchell, 1961, 1966, Nicholls, 1982), which has as the 
intermediate a proton gradient and transmembrane potential (ApH+) formed across the 
mitochondrial inner membrane. Thus the equation for this hypothesis does not associate 
— with any of the redox carriers;
AH2 ♦ B ^  A ♦ BH2 +  -  
-  + ADP + P, ^  ATP
The theory envisages electron transfer through the energy conserving sites resulting in 
transmitted conformational changes which eject protons from the matrix to the 
cytoplasmic side of the membrane without compensating movement of counter charges. 
The circuit is completed by proton transport back into the matrix through the ATP 
synthase, resulting in synthesis of ATP. This theory proposed that uncouplers catalysed 
proton translocation across the energy transducing membrane thus dissipating ApH4.. 
Much experimental evidence has been accumulated to support this theory:
1. Translocation of protons from matrix to cytoplasm does take place when electrons 
are transferred through the respiratory carriers, or when ATP is hydrolysed by 
mitochondrial ATPase (Mitchell and Moyle, 1965).
2. ApH+ can be artificially induced across the inner mitochondrial membrane by a 
number of different methods, and can drive the synthesis of ATP (Jagendorf and 
Uribe, 1966, Racker and Stoeckenius, 1974). ATP synthesis by this method can 
take place as fast, or faster than ATP synthesis driven by respiration (Thayer and 
Hinkle. 1975).
The mode of action of uncouplers could also be explained by this theory. Known 
uncouplers are weak acids/bases. and are thought to prevent ATP synthesis by picking up
6
protons in regions of high proton concentration and releasing them where the proton 
concentration is low, thus dissipadng the proton gradient across the inner mitochondrial 
membrane.
However the chemiosmotic hypothesis has not been accepted in its entirity, and 
refinements in the original theory have been made in an attempt to incorporate further 
experimental evidence. There are discrepancies in the kinetics of this mechanism; from 
double inhibitor titrations it was evident that the respiratory complexes are not 
completely isolated from each other, but "direct cross-talk”  between them occurs, which 
is not consistent with having delocalised protons as a pool intermediate (Westerhof et al, 
1984). Circumstances also exist in which there is no obvious connection between ApH+ 
and oxidative phosphorylation; some alkophilic (Krulwich and Guffanti, 1983) and 
halophilic bacteria (Helgerson, 1983) have negligible membrane potential but still 
synthesise ATP.
Some of these discrepancies between predicted and experimental results can be explained 
by making non-fundamental changes in the chemiosmotic hypothesis, but it is perhaps 
more fruitful to base investigations on hypotheses which do not need extensive 
adjustment.
The localised proton hypothesis (Williams, 1961), which differs from the chemiosmotic 
hypothesis in that it postulates that the protons produced by electron transfer are directly 
delivered to the ATP synthase, effectively remaining associated with the membrane. To 
account for generation of the transmembrane potential a second pathway for protons is 
proposed where a proportion are allowed to leave the membrane.
The collision hypothesis (Boyer, 1984, Slater et al, 1985), which combines some aspects 
of previous theories in proposing energy transfer by random collision of redox complexes 
with the ATP synthase. The large respiratory complexes are randomly distributed within 
the plane of the inner mitochondrial membrane, and are free to diffuse in this plane. The 
frequency of collisions between redox complexes and the ATP synthase is 3 to 5 times 
the rate of ATP synthesis, and Slater proposes that these collisions are not abortive.
7
At present none of these hypotheses can be accepted in their entirity and experimentation 
can only identify areas in which each is correct. The role of proton translocation as a 
critical factor in the coupling o f oxidation and phosphorylation is well established, and 
experimentadon has shown that membrane potential can be used to drive ATP synthesis. 
However, the generation of membrane potential may be of secondary importance, as 
evidence suggests a more direct route for protons in normal ATP synthesis.
1.2. The Mitochondrial Genom e
Mitochondria and chloroplasts are unique among eukaryodc organelles as they contain 
their own genome encoding a small proportion of their own proteins. Also encoded in 
the mitochondrial genome are a complete complement of ribosomal RNA (rRNA) and 
transfer RNA (tRNA) to enable the mitochondrion to translate these proteins using its 
own protein synthedc apparatus. In most organisms, including S.cerevisiae, 
mitochondrial DNA (mtDNA) exists as a circular superhelix which is not associated with 
nucleosomes. In S.cerevisiae its length ranges from 70-76 Kbp, giving short and long 
forms due to an increase in non-coding DNA (Prunell et ai, 1977, Morimoto and 
Rabinowitz, 1979). Thus the mitochondrion has a degree of autonomy, which can best 
be defined by describing the proteins for which it codes (for reviews see Grivell, 1983, 
Tzagoloff and Myers, 1986).
Over 90% of mitochondrial protein is encoded by the nucleus, synthesised on the cyto- 
ribosomes and post-translationally imported into the organelle. The mitochondrial 
genome contributes to 4 enzyme complexes:
1. Coenzyme QH 2-cytochrome c reductase: one of the 8 subunits (cytochrome b) is
encoded by mitochondrial DNA in S.cerevisiae (Weiss and Zigante, 1974, Katan et 
ai, 1976).
2. Cytochrome oxidase: three o f the 7 subunits are mitochondrially-coded in S.cerevisiae
(Tzagoloff et ai, 1975d, Eytan. 1975), with all coding regions interrupted by introns.
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Some of these introns have been found to code for maturases, whose sole function is 
to catalyse excision of the intron on which they are encoded (Carignani et al, 1983, 
Hensgens et al, 1984).
3. F XF 0 ATPase: the number of mitochondrially coded subunits varies with the
organism as summarised in Table 1.1. In S.cerevisiae subunits 6, 8 and 9 of 
mitochondrial ATPase F0 are encoded on mitochondrial DNA.
4. Mitochondrial ribosomes: the varl protein of the small ribosomal subunit is
mitochondrially coded in S.cerevisiae, but its site of synthesis varies in different 
organisms.
The respiratory complex polypeptides encoded in S.cerevisiae mitochondrial DNA are all 
highly hydrophobic, and thus have much of their amino acid sequence integrated into the 
membrane.
Chloroplast Mitochondrion
Sector Subunit Site Subunit Maize S.cerevisiae N.crassa Bovine
a O a O C C C
p O p C c c c
F, Y c Y c c c c
5 c 5 c c c c
£ o e c c c c
OSCP c c
I o 6 o o o
F„ II c 8 o o o
QI o 9 o o c c
Inhibitor c c
Table 1.1 Site of synthesis o f subunits for F jF 0 ATPase in a range of organisms. 
Subunits encoded in organelle DNA (O) and nuclear DNA (C) are indicated.
Mitochondria also possess a complete biosynthetic system for translation of these 
proteins. Most of the subunits of the mitoribosomes are imported from the cytoplasm,
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but, to date, the dogma that there is no RNA molecule exchange between mitochondrion 
and cytoplasm still holds true. The rRNA and tRNA required for mitochondrial protein 
synthesis are coded on mitochondrial DNA. Mitochondrial ribosomes bear a superficial 
similarity to bacterial ribosomes, but differ substantially on closer examination, having 
no SS rRNA and differing numbers of proteins. However, mitochondrial ribosomes are 
inhibited by chloramphenicol and erythromycin, which inhibit bacterial protein synthesis, 
but are not affected by cycloheximide and emetine, which inhibit eukaryotic 
cytoribosomes. This has enabled the two eukaryotic protein synthesis systems to be 
studied in isolation by selective use of these inhibitors, and was the initial method used 
for identifying mitochondrially-coded proteins. The mitochondrial genetic code also 
differs from the universal code (three codons are different in S.cerevisiae mitochondria), 
and is read by a more restricted number of tRNAs (Grivell, 1983).
S.cerevisiae mitochondrial DNA appears to code for 2 rRNAs, 25 tRNAs, 6 known inner 
membrane proteins and more than 10 reading frames which code for proteins of unknown 
function (termed unassigned reading frames or URFs). Although the yeast mitochondrial 
genome does not contain significantly more information than the human genome it is 
more than 5 times longer (Figure 1.2). Yeast mtDNA coding sequences are separated by 
long, non-coding regions rich in the bases A and T, and a number of coding regions are 
interrupted by introns (often encoding maturases). Transcription of the coding regions 
results in rRNAs with both upstream and downstream sequences which are not translated. 
In contrast human mtDNA is organised extremely efficiently (Anderson et al, 1981), with 
few if any non-coding nucleotides. Thus there are no signal sequences in non-coding 
DNA to initiate transcription, so an alternate method of regulation has been suggested by 
Attaidi and colleagues (Montoya et al, 1981, Ojala et al, 1981) in which one major 
promoter on each strand is responsible for a full length RNA which is subsequently 
cleaved. Two o f the bovine ATPase genes actually overlap by 40 bases: the ATPase 6 
gene is initiated in the coding region of the A6L gene (Feamley and Walker, 1986).
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Yeast Mitochondrial ONA
Figure 1 2  Comparison of human and yeast mitochondria] genomes, showing essentially the same set of 
genes but with different orgamsauon. Both strands of each double helix are shown, but the yeast 
DNA molecule is approximately 6ve times longer than the human DNA, so the scale used is dif­
ferent for each. Coloured regions show genes coding for known proteins in green, yellow and red. 
for tibosomal RNA in light blue, for transfer RNA in dark blue and for unassigned reading frames in 
brown (based on GriveU. 1983). Some of the human unassigned reading frames have since been 
shown to be subunits of NADH dehydrogenase.
Maintaining the mitochondrial genome is a very expensive process in biochemical terms. 
The nucleus codes for the vast majority of mitochondrial proteins, but also for all the 
enzymes required for maintenance and replication of mitochondrial DNA, and a number 
of polypeptides which, together with the mitochondrially-coded rRNAs, tRNAs and 1 
ribosomal protein, coordinate to enable the mitochondrial protein synthesis system to 
function. That the mitochondrial genetic system exists at all suggests that this organelle 
differs in its origin from that o f other organelles. The endosymbiont theory proposes that 
these organelles have evolved from an ancestral respiring bacterium which was engulfed 
by a larger primitive eukaryotic cell deriving its energy from the considerably less 
efficient method of fermentation. However the mitochondrial genome bears little 
relation to eukaryotic or prokaryotic genetic systems, so the organism from which 
mitochondria evolved may be no more related to present day prokaryotes than to 
eukaryotes. However, this can be partially explained by anticipating different 
evolutionary pressures acting on an endosymbiont.
Initially it was proposed that the mitochondrial genome had been conserved because it 
encoded hydrophobic inner mitochondrial membrane proteins which needed to be 
synthesised inside the mitochondrion for their correct integration and assembly. This has 
been disproved after study of mitochondrial genetic material from a number of 
organisms:
1. Subunit 9 of mitochondrial ATPase F0 is mitochondrially-coded in S.cerevisiae but 
nuclear coded in N.crassa and higher organisms
2. Most chloroplast ATPase F, subunits are synthesised in the organelle
3. One ATPase Ft subunit is organelle-coded in maize mitochondria
The patterns of gene distribution in different organisms are thought to be due to alternate 
pathways for “ escape" events of genes from the ancestral endosymbiont to the nucleus.
12
This is consistent with the transitional stage of dual representation of the same gene in 
nucleus and organelle as demonstrated for subunit 9 of ATPase in N.crassa (van den 
Boogaart et al, 1982) and A.nidulans (Scazzocchio et al, 1983), and the identification of 
non-functional mitochondrial DNA sequences in the nuclear DNA due to abortive gene 
translocation (Farrelly and Butow, 1983). Alternative evolutionary pathways by which 
endosymbiont genes have been transferred to the nucleus are thought to give rise to the 
organelle genome diversity evident today.
1.3. Mitochondrial Genetics o f S.cerevisiae
Saccharomyces cerevisiae is an ideal organism on which to base a study of the energy 
transducing membrane of eukaryotes. Apart from its already well defined genetics, 
respiratory deficient mutants can be stably propagated on fermentable substrates. 
However, it is by no means typical as it can survive anaerobically and strains used today 
have been extensively manipulated and thus differ from those occurring naturally. 
Consequently the S.cerevisiae inner mitochondrial membrane is one of the best 
characterised membrane systems to date.
Mutations in S.cerevisiae mitochondrial DNA are inherited in a non-Mendelian fashion, 
and can be divided into 4 broad categories:
1. Petite mutations were the first cytoplasmic mutations to be associated with 
mitochondrial DNA. A petite can lose all of the wild-type (or grande) 
mitochondrial genome (p°), or retain part of its mitochondrial DNA (p~), which is 
amplified so that the total amount of DNA approaches that present in normal 
mitochondria. This provides a small sequence in large quantities useful for 
analysis, and can be used to locate mutations in other mitochondrial mutants (petite 
deletion mapping). This mutation leads to a non-revertable respiratory deficient 
phenotype.
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2. miC mutants, like petites, cannot grow on non-feimentable carbon sources such as 
glycerol or ethanol, but, in contrast to petites, can still conduct mitochondrial 
protein synthesis. Because mit~ mutations are point mutations or small deletions or 
insertions, they can often revert to wild-type.
3. syn~ mutants are specifically deficient in mitochondrial protein synthesis. These 
mutations are located in either the rRNA or tRNA genes.
4. Antibiotic or inhibitor resistant mutations confer the ability to grow on non- 
fermentable substrates in the presence o f that antibiotic or inhibitor.
Nuclear-coded genes required for the formation of respiratory-competent mitochondria 
are grouped under the general category of PET genes (Sherman, 1963). Mutations in 
these genes, pet mutations, encompass mutations in genes for structural proteins, or 
mitochondrial function can be affected because the nucleus encodes enzymes needed for 
replication and expression of mitochondrial DNA. This effect is usually expressed by 
pleiotropic deficiency in a number of mitochondrial enzyme activities. Antibiotic 
resistance can also be mapped to nuclear DNA, where the polypeptides interacting to 
give the antibiotic binding site are nuclear-coded.
Nuclear Control o f Mitochondrial Biogenesis
The involvement o f nuclear gene products in regulation of mitochondria has been 
demonstrated at a number of levels; firstly in the transcription of S.cerevisiae 
mitochondrial DNA, in the processing of the precursor RNA and in the translation of 
mitochondrial messages. Mutation in the regulatory genes cause respiratory deficiency, 
and are classified as pet mutations. By analysing the phenotype of pet mutants, those 
which carry mutations in genes fulfilling regulatory functions can be tentatively 
identified. Pet mutations analysed fall into three categories when assayed for 
mitochondrial protein synthesis (Michaelis e ta l, 1982):
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1. Complementation groups which have no detectable effect on mitochondrial protein 
synthesis
2. Groups which block mitochondrial protein synthesis completely
3. Groups which cause absence or alteration of a specific or a restricted number of 
mitochondrial translation products.
The latter group are of interest as these are candidates for regulation of mitochondrial 
gene expression by the nucleus. All mutations of this type studied to date have been 
shown to exert their effects post-transcriptionally (reviewed by Fox, 1986), either by 
mRNA processing (Dieckmann et al, 1984, McGraw and Tzagoloff, 1983, Pillar et al, 
1983), enhancing translation (at the 5’ end) (Roedel, 1986, Fox, 1986) or post 
translational modification (Pratje etal, 1983).
Some nuclear suppressors have been identified which act on specific mit~ loci (NAM 
mutations or nuclear accommodation of mitochondria) (Dujardin et al, 1980). These 
mutations are thought to affect the mitoribosome, causing ambiguity of translation thus 
allowing pseudoreversion of the mit~ mutations they suppress (Zagorski et al, 1987). 
Most of the suppressed mutations are premature ochre terminators in introns or exons of 
mitochondrial genes, although they also suppresses frame-shift or missense mutations 
because of their lack of translation fidelity.
Mitochondrial Effect on Nuclear Function
The protein composition of p" mitochondria is essentially identical to that of respiratory 
competent mitochondria, with the obvious exception of mitochondrially-coded proteins 
(Schau et al, 1972). The synthesis of PET proteins occurs in the absence of an intact 
mitochondrial genome, and this argues against any regulation o f nuclear mRNA by 
mitochondrial gene products. However, a number of altered cell surface characteristics 
can be observed in S.cerevisiae cells convened to p", including differing permeability to
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a number of metabolites, flocculation behaviour, and degree of partition in a biphasic 
system (Wilkie and Evans, 1982), but this could be attributed to changes in the cellular 
balance of the ions and compounds under mitochondrial regulation (Ca2+ and ATP for 
example. Wilkie. 1983).
1.4. Transport
The majority of the mitochondrion’s polypeptides are encoded on nuclear DNA and 
synthesised on cytoribosomes. These proteins must be imported and targeted to their 
correct subcellular compartment. The mechanism substantiated by recent data involves 
synthesis of a precursor peptide in the cytoplasm, which is post-translationally targeted to 
its specific sub-mitochondrial location (reviewed by Reid, 1985). This involves:
1. Recognition of the precursor by a receptor on the mitochondrial outer membrane 
surface (Henning and Neupert, 1981, Riezman et al, 1983).
2. Transfer of the polypeptide into or across one or both mitochondrial membranes.
3. Conversion o f the precursor to mature protein (by proteolytic cleavage, 
conformational change or addition of a prosthetic group for example)
4. Assembly into an active protein complex.
Mechanisms for the growth of mitochondria are based on addition of mitochondrial 
proteins to an existing mitochondrial template. They take as a premise that receptors for 
transport are already present and correctly orientated in the membrane (Gillespie, 1987). 
Receptors in the outer mitochondrial membrane are thought to recognise the subset of 
cellular proteins destined for mitochondria, and this recognition step is protease- 
sensitive. Ribosomes associated with the mitochondrial membrane preferentially 
synthesise mitochondrial proteins (Suissa et al, 1984), but their transport is not coupled 
to synthesis in the manner of endoplasmic reticulum secretary proteins. Some mRNAs 
fractionate with free ribosomes (Suissa and Schau, 1982), and recognition by the
16
membrane receptors can occur at different stages of polypeptide chain completion. Most 
inner membrane and matrix proteins are synthesised with amino-terminal extensions 
20-50 amino acids long (Neupert and Schatz, 1981, Maccecchini et al, 1979). These 
leader sequences tend to have a net positive charge, with the notable exception of 
coenzyme QH2-cytochrome c reductase which has a highly acidic N-terminal. The 
recognition signal can also occur in the secondary or tertiary structure in the absence of a 
leader sequence, which is generally the rule for proteins in the outer membrane or the 
inter-membrane space. However, exceptions exist to both of these generalisations about 
presequences.
Transport across or into the outer mitochondrial membrane occurs in an energy- 
independent manner, but matrix or inner mitochondrial membrane proteins require an 
energised inner mitochondrial membrane for transport to occur (Gasser et al, 1982, 
Schleyer et al, 1982). It is possible that both mitochondrial membranes are traversed in a 
single step (Nelson and Schatz, 1979). Once the polypepdde has entered the 
mitochondrion, a matrix protease then cleaves it to its mature size (Bohni et al, 1980, 
Yaffe et al, 1985), with some precursors requiring more than one proteolytic cleavage 
(for example cytochrome C |) (Ohashi et al, 1982).
Proteins encoded in mitochondrial DNA tend to be hydrophobic integral membrane 
proteins, but it is evident that in the process of evolution a number of these genes have 
been transferred to the nucleus. The gene for subunit 9 of mitochondrial ATPase is 
mitochondrially-coded in S.cerevisiae but nuclear-coded in N.crassa. This brings into 
question how this subunit can be integrated into a functional complex from either side of 
the membrane. However, evidence suggests that transport mechanisms have evolved 
purely to transfer proteins destined for mitochondria across the two membranes, at which 
point another process is employed to give the correct topological integration into the 
membrane. Yeast mitochondrial ribosomes are tightly bound to the inner mitochondrial 
membrane, and integration of these mainly hydrophobic proteins into this membrane is
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thought to occur co-translationally.
1.5. Mitochondrial ATP synthase (ATPase)
The enzyme that catalyses oligomycin sensitive ATP synthesis was first isolated by 
Kagawa and Racker (1966). Mitochondrial ATPase is a multi-subunit enzyme of dual 
genetic origin, having two functionally distinct domains (Figure 1.3):
1. F, is a water soluble, oligomycin insensitive ATPase comprised of 5 subunits, a ,  P. 
y, 8 and e. which associate to give a stoichiometry of 3a:3p:ly:l8:le (Futai and 
Kanazawa. 1980). F] houses the active site of ATP synthase, but. when isolated, 
will only hydrolyse ATP. All 5 subunits are encoded by the nucleus, synthesised on 
the cytoribosomes, and finally transported into the mitochondrion (Bennet and 
Butow, 1974).
2. F0 is membrane-associated and forms a channel across the hydrophobic inner 
membrane, allowing proton flow through the enzyme back into the matrix. It has 
the binding sites for oligomycin, tri-ethyl tin, venturicidin etc. (Walter et al, 1967, 
Griffiths and Houghton. 1974, Lardy et al, 1975) and confers sensitivity to these 
compounds on the F,FoATPase.
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Tabic 1.2 Subunit equivalence of F tF 0 ATPases
This enzyme can be seen in its simplest form in E.coli (reviewed in Senior, 1985), which 
has the five F, subunits and an additional three F0 subunits, but it increases in complexity 
in eukaryotes. Increasing subunit number in organisms higher on the evolutionary scale 
is a common motif among respiratory enzymes. The most complex version yet identified 
is bovine ATP synthase, which has 13 subunits, a number of which have no equivalent in 
E.coli. Homologous subunits and their site of synthesis are summarised in Table 1.2. All 
eight subunits o f  the bacterial ATP synthase complex are encoded on a single operon 
(Walker et al, 1984) which has been completely sequenced. This is termed the unc 
operon as the genes were originally identified by investigation of uncoupled mutants. 
Genes for the five F! subunits are clustered, as are the F0 subunit genes. The mechanism 
by which the transcription and translation of these genes from one operon gives the 
observed stoichiometry of 3a:3|3:1 y: 15: le is unknown.
F i - The Catalytic Unit o f ATP Synthase
The enzymadc activity of ATP synthase is located in its F, moiety, which can be 
removed intact from the membrane giving a soluble homogeneous enzyme preparation 
capable of high levels of ATP hydrolytic activity. E.coli F| is easily displaced with
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additions of low concentrations o f EDTA; equally the complex can be reconstituted by 
addition of Mg2+ ions. S.cerevisiae requires more stringent measures to displace F,. The 
isolated Fj presents fewer experimental problems than study of the FiF0 complex, and its 
mechanism of ATP hydrolysis has been investigated with the assumption that it would 
provide insights into membrane bound ATP synthesis. The applicability of this 
assumption is discussed by Gautheron et al (1984). Isolated F, has three enzymatic 
activities:
1. ATP hydrolysis
2. Exchange between the Y’Phosphoryl oxygen of ATP and that of H20  during 
hydrolysis of low concentrations of ATP thought to be due to reversals of hydrolysis 
(Choate et al, 1979)
3. Synthesis of [32y ATP] from ADP and 32P (Sakamoto and Tonomura, 1983)
The sites of ATP hydrolysis in F, are located on the p subunits, giving three catalytic 
sites per F,. with the a  subunits possibly contributing to binding of the adenosine moiety. 
The antibiotic aurovertin binds to the three active sites with different affinities suggesting 
that these sites are non-identical (Issartel et al, 1983). A further ATP binding site occurs 
on the a  subunit, but this is a non-exchangeable site to which ATP binds tightly, and its 
role is thought to be regulatory in nature. Current experimental approaches suggest that 
ATP synthesis requires no direct energy input, but that the reaction is driven by the 
binding of product ATP to a high affinity catalytic site. Energy input is required, 
however, to displace ATP from this binding site. Cooperativity between the major Fj 
subunits is vital for its normal catalytic activity (Ackerman et al, 1987). Binding of 
substrate ADP is thought to result in the release o f product ATP from an alternative 
catalytic site. E.coli mutants have been isolated where single base changes in the a  
subunit result in an F, with very low ATPase activity due to loss of oc-P intersubunit 
conformational interaction (Futai and Kanazawa, 1984). A point mutation in the a
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subunit can also prevent binding of F, to the mitochondrial inner membrane (Maggio et 
al, 1988).
The genes for the a  and P subunits have been sequenced in S.cerevisiae (Saltzgaber- 
Muller et al, 1983) and also isolated in the yeast S.pombe (Boutry et al, 1984). The P 
subunit from S.cerevisiae can be integrated into S.pombe F, resulting in a hybrid 
complex (Boutry and Douglas, 1983). This indicates that these evolutionary divergent 
yeasts have a common import and assembly mechanism for cytoplasmically-synthesised 
mitochondrial proteins.
Structure and Assembly o f F 0 (reviewed in Nag ley, 1988)
Fj is a distinct functional unit with a well-defined subunit composition. Thus any 
subunits not identical with any of the 5 F, subunits are usually assigned to F0 by default, 
but this does not necessarily mean that they are integral membrane proteins. The 
mitochondrially-coded subunits all have membrane-spanning helices intimately involved 
in proton transduction, but the nuclear coded F0 subunits (sometimes called FA - 
associated factors) are thought to be more involved in the coupling of proton 
translocation and ATP synthesis.
In the yeast S.cerevisiae subunits 6, 8 and 9 are all encoded in mitochondrial DNA 
(Tzagoloff and Meagher, 1972). These subunits are not thought to undergo post- 
translational cleavage, and are delivered directly to the matrix side of the inner 
mitochondrial membrane by the mitoribosomes. In contrast, subunit 9  is nuclear-coded 
in N.crassa and bovine cells. Bovine subunit 9 is expressed in a tissue-specific manner 
as two different species differing in their leader sequences. The N.crassa subunit is 
translated with a positively charged 66 amino acid leader sequence which is cleaved by 
its matrix protease. Yeast mitochondria with energised membranes can import and 
correctly process N.crassa subunit 9 to its mature form in vitro (Schmidt et al, 1983). 
This implies that the import mechanism is not specific for individual mitochondrial
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precursors and that these precursors have common signals (Schmidt et al, 1983).
Genetic Studies o f Oxidative Phosphorylation
Research investigating the interaction of antibiotics which block the proton channel of 
mitochondrial ATPase has been very productive in locating the genes for the ATPase F0 
subunits. Initially interest was focused on resistant mutants showing cytoplasmic 
inheritance, with the aim of identifying mitochondrial genes.
Mutants resistant to antibiotics such as oligomycin (Avner and Griffiths, 1973a, b), 
venturicidin (Griffiths et al, 1973, Lancashire and Griffiths, 1973b, Lancashire et al, 
1974) and triethyl tin (Lancashire and Griffiths. 1975a) were sub-divided into two classes 
according to their cross-resistance spectrum. Class I mutants showed, in addition to the 
selective antibiotic, cross-resistance to unrelated inhibitors, uncouplers and/or inhibitors 
of mitochondrial protein synthesis. Mendelian inheritance was generally the case for this 
group. These mutations are thought to be due to membrane permeability or some other 
non-specific effect (Marahiel et al, 1977, Rank and Robertson, 1978). Class n  mutants 
were so classified because they possess specific resistance to their selective antibiotic, 
and are only cross-resistant to related antibiotics (Avner and Griffiths, 1973). Class II 
mutations expressed oligomycin resistance at mitochondrial and sub-mitochondrial 
panicle level, providing evidence that resistance was due to a specific modification of an 
inhibitor site in the mitochondrial inner membrane (Griffiths and Houghton, 1974).
Study o f Class II mutations enabled identification and mapping of a number of 
mitochondrial loci. They were inherited mitotically and could be deleted by treatment 
with ethidium bromide. Initially two unlinked loci were identified with oligomycin 
resistance markers OLI and OLII, which on later investigation have been found to 
correspond to mitochondrial ATPase subunits 9 and 6 respectively. A further locus 
O Lin was mapped, linked to OLI (the gene OUI), and identifiable by its cross resistance 
to venturicidin, and later OLIV, showing weak oligomycin resistance, was found to be
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linked to OLII (the gene Oli2).
In addition to these mitochondrial loci, a number of other loci were identified which 
showed apparent cytoplasmic inheritance, but were not located on mitochondrial DNA. 
This includes mutants resistant to venturicidin (Griffiths et al, 1975, Lancashire and 
Griffiths, 1975b) and triethyl tin (Lancashire and Griffiths. 1975a), and these markers 
have not yet been mapped.
From cross-resistance analysis a certain amount of information can be deduced about the 
binding sites for these antibiotics. Results suggested that oligomycin and triethyl tin bind 
to completely separate sites, but both of these overlap with the binding site for 
venturicidin. It also suggests that the oligomycin binding domain is made up of solely 
mitochondrially-coded polypeptides, whereas that for triethyl tin comprises non- 
mitochondrial polypeptides.
The genes for the F0 subunits encoded in mitochondrial DNA, identified in antibiotic 
mapping studies, have now been cloned and sequenced in S.cerevisiae and some other 
species. From analysis o f the protein translation of olil, oli2 and aapl (subunits 9, 6 and 
8 respectively) information concerning the secondary and tertiary structure of the 
mitochondrial F0 proteins has been deduced (Figure 1.4). Subunit 9 is a protein 76 amino 
acids long (Macino and Tzagoloff, 1979), having two transmembrane helices joined by a 
hydrophilic loop which projects into the matrix. It has conserved regions in its glycine- 
rich N-terminus, its hydrophilic loop region and its C terminal helix, which always has an 
acidic residue to which DCCD covalently binds. Analysis of mutations mapped in this 
gene can provide information about functional domains and topology of the protein 
(Figure 1.5). The antibiotic oligomycin binds to F0 and prevents proton conduction thus 
inhibiting ATP synthesis. Point mutations causing resistance to this antibiotic have been 
located on both helices of subunit 9, the sites on h2 forming a major domain for 
oligomycin binding (Ooi et al, 1985). Resistant mutations to venturicidin, a functionally
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Figure 1.4 The mitochondrially-coded subunits of yeast mitochondrial ATPase F0. showing their orienta- 
tion in the mitochondrial inner membrane. Three of the membrane-spanning helices of subunit 6 are 
not shown, but these are not thought to contribute to the F0 proton channel. The residues at either 
end o f each iransmembrane helix is indicated, as are the amino (N) and carboxy (C) termini o f each 
protein.

similar antibiotic, can also be mapped both on h, and h2 of subunit 9 implying that its 
two transmembrane stems are directly involved in the proton translocation mechanism 
(Nagley et al, 1986). This is confirmed by analysis of a mit~ mutation gly^—»asp located 
on the h] helix, which appears to have a defective proton channel.
A mit~ mutation in the hydrophilic loop connecting the two helices of subunit 9 has a 
contrasting phenotype. Mutants where arg39—»met are not correctly coupled to F]. 
When revertants to this mutation were analysed one was found to be a recessive nuclear- 
coded suppressor. It is possible that this suppressor mutation could be located in one of 
the complex’s subunits also involved in F1F0 interaction.
Subunit 6 has at least 5 transmembrane spans (some sources propose 7, Ray et al, 1988), 
and even in the absence of strong amino acid homology its general structure is conserved 
between species. Its carboxy-terminal helices h4 and h5 are thought to form part of the 
proton channel, in concert with h| and h2 of subunit 9. Residues involved in oligomycin 
binding occur in both h4 and hs, but no resistance mutants to venturicidin are located in 
this protein. These a  helices are amphiphilic, with their charged residues lying along one 
face of the helix. The charged amino acids are thought to point inwards to form the 
proton channel, and to play a vital role in the conduction of protons. The N-terminal 
region of the protein is needed for the assembly of the complex and docs not appear to be 
directly involved in proton translocation.
Subunit 8 is a proteolipid 48 amino acids in length which is encoded by the 
mitochondrial aapl gene (Velours et al, 1984). It has only one transmembrane stem 
located towards its N-terminal, with a C-terminal charged hydrophilic domain of basic 
residues involved in F,F0 interaction.
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S u b ™ Phenotype Locus Domain Functional Deficiency Reference
9<olil) o"vR Gly0 —»Ala hi (1)
oRvR G lyu-iC ys h, [2]
o*vR Gly2j—»Ser h, (2]
o*vs Lcu,j-»Phe Ih [1.3]
oRvR A la«—*Thr hi [21
o*vR Phe«—»Leu hi [1.21
mill" G iy a—»Asp h, Defective proton channel? [41
mit," Arg j*—»Met loop Defective coupling to F, [41
mitf Gly,»—»Asp h, No assembly o f 9.8.6 [41
mitf SerM—»stop hi No assembly of 9.8,6 [41
mitf frameshift (4)* all No assembly of 9,8,6 [41
6<oli2) o*v* Ser17J-»Cys 1»4 [51
o"v* llel7,-»Phe h4 [61
o"v* Leujjj—»Phe h. [51
Oss*V* Asp2j4-»Asn h5 [61
mitf TIum , —*Lys h. Defective coupling to F| [7]
mit] Ser »a—»stop C-terminus Assembly o f 8,9, truncated 6 [71
mitf frameshift (34)* Assembly o f 8,9, not truncated 6 [71
8(aapl) mitf frameshift (2)* Assembly o f 9, not truncated 8 or 6 [8.91
Notes (n)* - all but the first n residues are deleted by the frameshift
mitj" - non-functional ATPase but F0 assembly not grossly impaired 
mit2 - non-functional ATPase with abnormal F0 assembly
[1] Ooi eta l, 1985
[2] Nagley et al, 1986
(3J Macino and Tzagoloff. 1979
[4] Nagley and Linnane, 1987
[5] John and Nagley, 1987
[6] Ray eta l. 1988
[7] John et al, 1986
[8] Linnane et al, 1985
[9] Macreadie etal, 1983
Table 1.3 Location of n u t  and antibiotic resistance mutations in mitochondrially-coded 
ATPase subunits o f S cerevisiae (Based on Nagley, 1988).
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Only one of the nuclear-coded F0 subunits has been sequenced (Velours et al, 1988). 
ATP subunit 4 is a polypeptide 209 amino acids long, which in its nascent form has a 
hydrophilic, positively charged leader sequence of 35 amino acids. This protein has a 
high predicted a  helix content, having two distinct domains. The N-terminal domain A 
is hydrophobic and has few charged amino acids possibly acting as an anchor to the 
membrane although not long enough to span it, whereas domain B contains a relatively 
large number of charged residues.
1.6. Objectives of Current Research
The initial aim of this project was to identify nuclear-coded subunits of mitochondrial 
ATPase Fq, to complement the work on the mitochondrially-coded subunits already in 
progress. The method chosen was to isolate mutants of the yeast S.cerevisiae resistant to 
antibiotics known to have their active site located within the mitochondrial ATPase F0 
domain, with a view to identifying nuclear-coded resistant mutations. Mutants found to 
be nuclear-coded would then be subjected to a second selection procedure, which 
involves determining the degree of resistance to the selective antibiotic at mitochondrial 
level. Resistant mutations resulting from a structural change in a mitochondrial 
component could be identified by this strategy.
The antibiotic venturicidin was to be used for selection of resistant mutations, as it was 
thought to have the greatest potential for generating nuclear mutations showing 
resistance at mitochondrial level. However, novel ATPase inhibitors were also 
investigated to determine their usefulness in studies of this nature.
An alternative approach to isolating a nuclear-coded F0 subunit was undertaken in 
addition. A pet mutant had been isolated by Prof. A. Tzagoloff which was specifically 
deficient in mitochondrial ATPase activity. This mutant was analysed immunologically 
and was found to have the major F, subunits (this study) so was selected for investigation 
as a potential F0 mutant.
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CHAPTER 2
INVESTIGATION OF NUCLEAR ANTIBIOTIC RESISTANCE IN S. CEREVISIAE
2.1. INTRODUCTION
Oligomycin and other antibiotics which block the proton channel in ATPase F0 have 
been useful tools in the study of the energy-transducing membrane. The antibiotics have 
been employed to elucidate the pathway of oxidative phosphorylation, and drug resistant 
loci have been vital in mapping mitochondrial DNA and identifying the genes specifying 
ATPase subunits. By sequencing these mitochondrial genes the location of oligomycin 
and venturicidin resistance mutations have been pinpointed, and from this aspects of the 
complex’s tertiary structure can be deduced: the polypeptide chain residues which make 
up the antibiotic binding site can be tentatively identified as being proximal to each other 
and this can give information about folding of subunits and their spatial organisation with 
respect to each other. These amino acids are expected to be at or near the proton 
translocation site of F0, or cause an allosteric change in that area.
The contribution that the nucleus makes to the F0 binding site of these antibiotics, if any, 
has not yet been determined. Nuclear-coded resistance mutants isolated to date have 
shown complex phenotypic properties. A wide range of cross-resistance to related and 
unrelated antibiotics has been described (Rank et al, 1975, Saunders and Rank, 1982), 
and cytoplasmic factors causing changes in phenotype further confuse analysis (Cohen 
and Eaton, 1979, Simmons and Breen, 1983). Nuclear resistance to these antibiotics 
could conceivably occur at a number of different levels
1. Resistance at the plasma membrane level, preventing the antibiotic from entering 
the cell.
2. Degradation of the antibiotic by modified enzymes in the cytoplasm.
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3. Resistance at the mitochondrial membrane level.
4. Degradation of the antibiotic within the mitochondrion.
5. Resistance due to a structural change in the enzyme binding site.
A nuclear contribution to the venturicidin binding site is evident, as demonstrated by 
Nagley (Nagley et al, 1986). The nuclear background in which a particular 
mitochondrial mutation PheM to Leu was resident was found to be the determining factor 
in the expression of venturicidin resistance/sensitivity.
This chapter describes the generation and analysis of nuclear mutations resulting in the 
expression of venturicidin resistance.
2.2. MATERIALS AND METHODS
Bacteriological peptone, yeast extract, bacto-agar and yeast nitrogen base were 
purchased from Difco Laboratories, Detroit, Michigan, USA. Adenine sulphate was 
purchased from BDH Chemicals, Poole, Dorset. Trizmabase, ATP and oligomycin were 
purchased from Sigma Chemical Co., Poole, Dorset. Venturicidin was a gift from Glaxo 
UK and Ossamycin a gift from the Bristol-Myers Corporation. All other reagents were 
of ‘AnalaR' grade purity.
Growth Media for Yeast
Two types of medium are used routinely. YPD is used to support growth of respiratory 
deficient strains and YPG is used to differentiate between respiratory deficient and 
respiratory competent cells, and for antibiotic containing media.
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YPD YPG
1 %(w/v) Yeast extract 1 %(w/v) Yeast extract
2%(w/v) Bactopeptone 2%(w/v) Bactopeptone
2%(w/v) Glucose 3 %(v/v) Glycerol
2%(w/v) Agar (for plates) 2%(w/v) Agar (for plates)
Glucose is autoclaved separately to prevent caramélisation. The media referred to as NO 
and N3 are YPD and YPG respectively, buffered with 50mM Na/K buffer pH 6.25 
(lOmM Na2HPOV40mM KH2P04)
WO
0.67%(w/v) Bacto Yeast Nitrogen base 
without amino acids 
2%(w/v) Agar (for plates)
If amino acid supplements were required they were added as specified by Sherman et al,
1983.
S (sporulation medium)
0.4%(w/v) NaAc 
2%(w/v) Agar
Addition of antibiotics
Andbiotics were added to N3 medium in ethanolic solution, with the exception of 
chloramphenicol which is water soluble. The standard concentrations used for 
antibiotic-containing media are shown in Table 2.2.1, concentrations differing from these 
are referred to in the text.
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Antibiotic Media Concentration
Venturicidin N3 2.5pgml_I
Oligomycin N3 0.5pgml_1
Ossamycin N3 2pgml_1
Leucinostatin N3 2pgml-1
Chloramphenicol N3 2mgml-1
Erythromycin N3 5mgml_1
Table 2.2.1 Concentration of antibiotics routinely used in S.cerevisiae growth media 
Preservation of Strains
Yeast strains were routinely subcultured every 3 months by streaking onto NO solid 
medium in bijou bottles, growing up overnight, and storing at 4°C.
Isolation o f Mutants: (JV Mutagenesis
D273-10B/A1 was grown up overnight in liquid YPD. After spinning down in a bench 
centrifuge at 5K rpm for 5 mins, cells were re-suspended to a titre of lx  108 cells ml' -‘ in 
phosphate buffer (Sorensons buffer). Aliquots of this suspension were plated onto 
N3/N3V to check the viability/sensitivity of the strain.
Mutagenesis was carried out under UV set at 1 Jm"2s_l. Cells placed in an uncovered 
Petri dish were irradiated for a total of 2 mins 20 secs with frequent agitation. 
Mutagenised cells were plated on N3V, YPD and N3 at 5x 103 cells per plate.
Treatm ent with EtBr (Slonimski etal, 1968)
Haploid S.cerevisiae mutants were convened to p~ or p° by treatment with the DNA 
intercalating agent ethidium bromide (EtBr). This compound is highly carcinogenic and 
was handled with gloves at all times. EtBr was added to YPD to a final concentration of 
50 pgm T1 and colonies replicated onto these plates were incubated for three days at 
30°C in darkness. After further replication onto a fresh EtBr plate and incubation for 
three days these haploids were tested for complete conversion to p" by replicating onto
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N3. If no growth was observed after three days the culture was assumed to consist of p" 
cells
Growth Rate Analysis (Avner and Griffiths, 1973a)
A standard inoculum of 1% stationary phase yeast was introduced into various liquid 
media, and grown at 30°C in an orbital shaker. Turbidity of the cultures was measured 
using an EEL colorimeter (607nm filter).
Cross Resistance Testing
To test several mutants simultaneously two methods were used :-
1. Replica-plating: This well established technique involves taking an impression from a
master plate on velveteen cloth and printing onto selective media.
2. Drop out analysis: Wells of a microtitre tray were partially filled with 200pl aliquots
of sterile distilled water, and each was inoculated with a single mutant strain. Using 
an aluminium stamper, sterilised by flaming in methanol, a discrete impression from 
each well could be made on antibiotic media.
Genetic Techniques (Sherman etal, 1983)
Mating o f  strains
Haploid strains of opposite mating types and differing metabolic deficiencies were mixed 
in equal quantities on an NO plate and grown overnight at 30°C. Cells were transferred to 
WO plates (with amino acid additions if necessary), and incubated at 30°C for 1-2 days.
Complementation Analysis
Diploid colonies were grown on WO medium at approximately 100 cells per plate, and 
these master plates were replicated onto the appropriate antibiotic-containing media.
34
Random Spore Analysis
Diploid cells were incubated on S medium for a minimum o f 3 days at 30°C. Optical 
microscope examination was used to determine whether a sufficient number of tetrads 
had been formed. When the tetrad count reached approximately 80% cells were scraped 
off the plate with a sterile loop and incubated in (1%) glusulase solution at 30°C for 30- 
60 minutes. Cells/spores were then counted, diluted with sterile distilled water, and 
spread on NO to give 100-200 colonies per plate. Colonies were identified as certain 
spores if they had inherited one of the metabolic deficiencies of the parent strains. This 
was determined by replicating onto W0 medium and picking colonies which did not 
grow up on W0 to a master plate (NO) for use in further analysis.
Preparation of mitochondria (Connerton, 1986)
A l%(v/v) inoculum of stationary phase yeast was added to 300ml of YPG liquid 
medium in a 21 Erlenmyer flask. The culture was harvested at late log. stage in a Sorvall 
GSA rotor at 2K rpm for 10 mins. The cell pellet was washed once in cold breaking 
buffer, and resuspended in the same buffer, adding 0.3ml o f buffer per gramme wet 
weight of cells.
Breaking buffer
0.5M Sorbitol 
lOrnM Tris/Cl pH 7.5 
ImM EDTA
0.1% BSA (fatty acid free)
The following operations were carried out at 0-4°C. The resuspended yeast cells were 
transferred to a 230ml screw-capped bottle, together with V4 vol ballotini (0.45-0.5mm 
diameter, washed in cold TE-sorbitol). Cells were then broken by Lang’s hand-shaking 
method, in three 2 min cycles with 1 min intervals on ice. The cell suspension was then 
decanted into two 60ml polycarbonate tubes, the beads washed through with 3vols of 
breaking buffer and the suspensions pooled. The cell debris was pelleted by spinning the
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homogenate at 2K rpm for 15 mins in a Sorvall SS34 rotor. The supernatant was re- 
centrifuged until no pellet was produced (usually twice). The mitochondrial fraction 
could then be isolated from the supernatant by spinning at 12K rpm for 15 mins. After 
washing and re-suspending the mitochondrial pellet in TE-Sorbitol the mitochondria 
were used immediately for ATPase assays or stored at -70°C
Protein Determination
Mitochondrial protein was estimated by the method of Gomall et al (1949). Protein was 
solubilised with an equal volume of 5% deoxycholate for a minimum of 5 minutes before 
adding Biuret reagent. After a further 20 minutes at room temperature samples were read 
at 540nm in an SP1800 spectrophotometer against a reagent blank and protein 
concentration determined from a standard curve (using bovine serum albumin, BSA, as 
the standard protein) produced under similar conditions.
ATP hydrolysis
Assays were carried out in a volume of 1ml containing approximately O.lmg of 
mitochondrial protein, 50mM Tris/Cl pH 8.0, 2mM MgCl2 and 5mM ATP. 
Mitochondria were pre-incubated in reaction buffer on ice with inhibitors and the 
reaction initiated by the addition of ATP. Tubes were incubated for 10 mins at 30°C, and 
the reaction stopped by adding 1ml of 10% TCA. Protein was removed by centrifugation 
in a bench centrifuge.
Inorganic Phosphate Determination (Heinonen and Lahti, 1981)
This method measures the yellow chromophore of phosphomolybdate when dissolved in 
acetone to monitor phosphate concentrations.
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AAM Solution
lOmM Ammonium Molybdate 1 vol
5M H2S04 1 vol
Acetone 2 vols
AAM solution (4ml) was added to 0.5ml of inorganic phosphate (P4) in H20  and the 
solution vortexed. Citric acid (0.4ml of 1M) was added and after vortexing the optical 
density of the solution was read immediately against a reagent blank at 355nm with an 
SP1800 spectrophotometer. The inorganic phosphate present was obtained from a 
standard curve produced under similar conditions.
2.3. RESULTS
Genotypes of the strains used in this chapter are tabulated below:
Strain Nuclear Genotype Mitochondrial Genotype Source
D273-10B/A1 a.met~ p * A.Tzagoloff
CD76 a leu~ p+ o» I.F. Connerton
D22 a ade~ p‘ D.Wilkie
D22/A21 a ade~ p'O* Avner and Griffiths, 1973
114-3
152-2
VUV1-280 am et~ p* This study
Tabic 23.1 Nuclear and mitochondrial genotypes of strains used in this chapter
The aim of the research covered in this chapter was to isolate and identify nuclear-coded 
components of mitochondrial ATPase F0. The proposed strategy was to generate mutants 
of S.cerevisiae resistant to antibiotics binding to ATPase F0, which were thought to have 
a nuclear component. These mutants could then be tested for inheritance and nuclear 
mutations selected. The nuclear resistant mutants could then be assayed to assess the 
biochemical resistance of their ATPase to the antibiotic (expressed in terms of pijo
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values) with the aim of isolating a mutant resistant in one of the structural components of 
ATPase. By this resistance marker the gene for this component could then be cloned and 
its DNA sequence determined.
The criteria for selection of a possible mutation causing an alteration in structure of the 
ATPase are listed below:-
1. The mutation should show clear nuclear inheritance.
2. The mutation should cause resistance to the selective antibiotic only, or if any 
cross-resistance is shown it is only to functionally related antibiotics, which could 
possibly share the same binding site.
3. The mutation should cause some change in the biochemistry of mitochondrial 
ATPase itself, ideally an increase in the in vitro resistance to the selective antibiotic 
or, failing that, a change in the specific activity of mitochondrial ATPase.
Venturicidin Resistance
Initially mutagenesis was carried out by UV-irradiating cells, as this method has been 
shown to preferentially produce nuclear-coded mutations. A number of chemical 
mutagens can also be used which favour nuclear mutations, among then N-methyl N- 
nitro nitrosoguanidine (see section 4.3) and ethyl methane sulphonace. Alternatively the 
mutagens ethidium bromide and manganese are used when production of a significant 
proportion of mitochondrial mutations is desirable, or when it is necessary to delete the 
mitochondrial genome (conversion to p°). From the initial mutagenesis of D273-10B/A1 
a number of venturicidin-resistant mutants were isolated. VUV1-127 were subcultured 
from medium containing 2.5ngml-1 venturicidin and VUV130-280 were isolated on 
1.23pgml-1 venturicidin. Clones were subcultured twice onto venturicidin-containing 
medium (the selection concentration), and then stored on NO slopes pending further 
analysis.
38
The venturicidin-rcsistant mutants were tested for their degree of tolerance to this 
antibiotic by drop-out analysis on venturicidin-containing medium, with the venturicidin 
concentration varied up to lOOngml-1. All of the mutants isolated were resistant even to 
the highest concentrations of venturicidin, and all clones tested actually grew better on 
the higher concentrations of the antibiotic (this also applies to the wild-type D273- 
10B/A1). The explanation for this unusual effect is unknown, but it may be produced by 
reversal of inhibition due to binding at a low affinity site on mitochondrial ATPase at 
high concentrations of antibiotic. The V-resistant mutants were also tested for cross­
resistance to a variety of functionally related antibiotics, for example oligomycin and 
ossamycin, but also to the mitochondrial protein synthesis inhibitors erythromycin and 
chloramphenicol.
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Strain
Antibiotic
N3V N301 N30s N3CAP N3ERY N3L
VUV37 >10 <0.5 1 2 4 1
VUV58 >10 <0.5 1 2 4 1
VUV78 >10 <0.5 1 2 4 1
VUV84 >10 <0.5 1 2 4 1
VUV86 >10 <0.5 1 2 4 1
VUV99 >10 <0.5 1 2 4 1
VUV107 >10 <0.5 1 2 4 1
VUV17 >10 2 1 2 4 1
VUV29 >10 2 1 2 4 1
VUV44 >10 2 1 2 4 1
VUV45 >10 2 1 2 4 1
VUV112 >10 2 1 2 4 1
114-3 >10 <0.5 1 1 4 1
152-2 >10 <0.5 1 1 4 1
D273/10B-A1 0.25 0.25 1 1 4 1
Table 2.3.2 Cross resisiance of venturicidin-resisiant mutants to related and unrelated anti­
biotics. Haploid strains were replicated onto plates containing various concentrations o f anti­
biotic and growth was scored after three days incubation at 30°C. Concentration of the inhi­
bitors venuiricidin (V), oligotnycin (Ol). ossamycin (Os) and leucinostatin (L) are given in 
|!g m l-1 . Concentrations of chloramphenicol (CAP) and erythromycin (ERY) are given in 
m g m T 1. All plates containing inhibitors were of buffered glycerol (N3) medium.
Two different patterns of resistance were evident, a group which were resistant to 
venturicidin and chloramphenicol only, and a group that showed cross resistance to 
oligomycin (and sometimes ossamycin) in addition to these two antibiotics (Table 2.3.2).
To determine whether these mutants were located in nuclear or mitochondrial DNA both 
mitotic and meiotic segregation criteria were used. When two haploid strains are mated 
the diploid resulting from this cross contains a mixed population of mitochondria. 
However, during subsequent divisions of this diploid cell one type of mitochondria will 
be progressively eliminated. Thus if a mitochondrial drug resistant marker was present
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in one of the haploids, it would be inherited by some, but not all, of the diploid progeny 
(mitotic segregation). A mutation in nuclear DNA would be stably inherited in all 
diploid progeny. On sporulation of a single diploid, the haploid spores would show a 2:2 
ratio of resistance to sensitivity for a nuclear mutation (i.e. Mendelian inheritance). 
However, if the diploid sporulated contained a mitochondrial marker it would be 
inherited by all haploid spores.
Firstly a number of mutants selected from each cross-resistance group were mated to a 
standard strain (CD76 or D22). Strain CD76 carries a mitochondrial oligomycin resistant 
marker, but D22 is a completely sensitive strain. Random diploids were tested for their 
degree of resistance to concentrations of antibiotics which have been shown to inhibit the 
sensitive parent strain (Table 2.3.3). Diploids from both groups showed a degree of 
resistance intermediate between that o f the parent sensitive strain and that of the resistant 
haploids.
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Strain V* Vs o« 0 s
VUV17 76 0 28 48
VUV29 76 0 28 48
VUV37 76 0 32 44
VUV44 76 0 21 55
VUV45 76 0 26 50
VUV58 76 0 16 60
VUV78 76 0 26 50
UVU84 76 0 25 51
VUV86 76 0 13 65
VUV99 76 0 18 58
VUV107 76 0 19 57
VUV112 76 0 40 36
114-3 100 0 44 56
152-2 77 0 33 44
D273/10B-A1 0 76 27 49
Tabic 2.3.3 Segregation of random diploids from venturicidin-resistant parent strains. Each 
venturicidin-resistant isolate was independently crossed to strain CD76, which has a mito­
chondrial oligomycin-resistant marker, and random diploids were replicated onto venlurici- 
din and oligomycin-containing media. Growth was scored after three days incubation at 
30°C. Individual diploid clones were scored as venuiricidin or oligomycin resistant (VR or 
O *  respectively) if growth was observed on plates containing 2.5 J lg m T 1 venturicidin (V) 
or 0.5 |Ig m l-1 oligomycin. If no growth was observed colonies were scored as sensitive to 
that inhibitor (V s or 0 s). Figures tabulated represent the number of individual diploid 
clones tested from one cross. The stock inhibitor solutions were added to buffered glycerol 
medium (N3).
The observed partial dominance is typical of the nuclear resistant mutations to these 
antibiotics isolated to date. Currently all mitochondrial antibiotic resistant mutations that 
have been isolated are dominant as they are present as single copies. The pattern of 
resistance of a typical mitochondrial mutation is demonstrated in the previously 
characterised O* mutant CD76. This gives a heterogeneous population of diploids, some 
completely resistant and some completely sensitive depending on whether they had 
inherited the O* or Os mitochondria from the haploid parent strains.
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A single diploid resulting from each of the crosses between the VR resistant mutations 
and the standard strains was sporulated by the method outlined in section 2.2, and spores 
analysed for their resistance to the antibiotics. Between 50 and 100 spores were isolated 
from each cross and the results are shown in Table 2.3.4. The two groups show 
Mendelian inheritance, giving an equal number of resistant and sensitive haploid 
offspring. In contrast, the mitochondrial VR strain produces offspring 100% resistant or 
100% sensitive depending on the phenotype of the diploid sporulated, as it is 
cytoplasmically inherited.
All of the venturicidin resistant mutations produced in this study were in a D273/10B-A1 
background, so they all have the metabolic deficiency met~, a requirement for the amino 
acid methionine. Complementation of the metabolic deficiencies of haploid strains was 
used to isolate diploids from mating crosses, the strain CD76 having the leux marker. On 
examining the spores from these diploids it was found that group II (cross resistant to 
oligomycin) does not segregate with the metabolic deficiency marker leux, as the 
resistant spores isolated from this cross will only cany the marker met~. This suggests 
that the mutation is on chromosome VII and tightly linked to leu ,, which indicates it is a 
member of the pleiotropic drug resistant (pdr) linkage group described by Cohen and 
Eaton (Cohen and Eaton, 1979, Cohen, 1977) as this maps close to the centromere of 
chromosome VII adjacent to this leu marker. Its phenotype shows many of the 
characteristics exhibited by this linkage group, including the papilladon of diploid 
colonies thought to be due to gene conversion. Group I mutations segregate 
independently of the metabolic deficiency markers.
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Strain VR V1 oR 0 s
VUV17 27 30 11 46
VUV29 30 31 61 0
VUV37 21 29 47 3
VUV44 10 12 22 0
VUV45 37 24 48 3
VUV58 24 21 2 43
VUV78 21 17 1 37
VUV84 25 18 12 31
VUV86 24 22 40 6
VUV99 34 40 16 58
VUV107 28 26 0 52
VUV112 70 86 34 122
D273/10B-A1 4 60 2 62
Table 2.3.4 Random spore analysis of progeny from the venturicidin-resistant parent 
strains. Venturicidin-resistant isolates were crossed to strain CD76 and a  single diploid from 
each cross was transferred to sporulation medium. After incubation at 30°C for a  minimum 
of 3 days, spores were separated by treatment with glusulase and plated onto NO medium at 
a title of 100 cells per plate. Certain spores were identified by replicating this plate onto WO 
medium and transferring colonies which did not grow to an NO master plate which was then 
used for antibiotic resistance testing. Antibiotic plates were scored after three days incuba­
tion at 30°C. Spores which grew up on plates containing 2.5 H gm l-1 venturicidin (V) or 0.5 
H g m T 1 oligomycin (0) were classified as resistant to that inhibitor (V R or 0 R respective­
ly). Spores which showed no growth were classified as sensitive (V s or O s respectively). 
Figures tabulated represent the number of spores produced from a single diploid tested. Inhi­
bitor plates were made up in buffered glycerol medium (N3).
Resistant spores of different mating types generated by this sporulation were crossed to 
each other to determine complementation groups. This was uninformative, with 
seemingly no correlation between the cross and the degree of resistance shown in the 
diploids. A single diploid taken from each of a number of crosses was sporulated, and 
the spores analysed to determine whether Group I and Group II were different linkage 
groups. Results are shown in Table 2.3.5, and this gives further evidence that Group I 
and Group II are unlinked, inter-group crosses showing 4:0 VR:VS ratios, intra-group 
crosses being approximately 2:1 VR:VS. The latter ratio differs from that expected (3:1),
and this may occur because the doubly-resistant genotype is lethal.
Cross VR Vs
Gil x Gil
VUV99 x 78 50 0
VUV58 x 99 51 0
VUV78 x 84 63 1
VUV58 x 84 41 0
VUV100 x 37 61 0
Gl x Gil
VUV86 x 44 114 52
VUV86 x 45 33 18
VUV107 x 29 48 29
VUV99 x 112 48 27
VUV107 x 112 56 30
VUV17 x 78 30 8
Gl x Gl
VUV17x 112 67 0
Table 2J.5 Random Spore analysis of crosses between venturicidin resistant mutants. Mu­
tants are classified as members of Group I if they are linked to leuj. A single diploid from 
each cross was sporulated by standard methods as outlined previously, and certain spores 
tested for their degree of resistance to O.S pgmT1 oligomycin (O) and 2.S pgml-1 venturi­
cidin after three days incubation at 30°C. Spores were classified as resistant (0 R or VR) if 
they grew on medium containing that inhibitor and sensitive (0 S or Vs) if they showed no 
growth. Figures tabulated represent the number of spores tested from a single diploid pro­
duced from one cross. Inhibitor stock solutions were added to buffered glycerol medium 
(N3).
A number of mutants from each group were analysed biochemically to assess their 
ATPase activity, together with the degree of resistance in vitro of the ATP synthase to a 
variety of antibiotics. Mitochondria from each mutant were prepared as described in 
section 2.2, and incubated with a range of antibiotic concentrations. The Pj produced by 
hydrolysis of ATP present in the assay was measured colorimetrically. Resistance 
mutations located in the mitochondrial genes coding for ATP synthase subunits confer an 
increased resistance to the enzyme in vitro. This indicates that the change causing 
resistance is located in one of the structural units of the enzyme, and is not due to
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transport or degradation factors. The percentage of residual activity (compared with a 
control without antibiotic) was plotted against antibiotic concentration allowing the pljo 
values for that antibiotic to be determined (the concentration of antibiotic needed to 
cause 50% inhibition of enzyme activity). The pl50 of both VR groups and of wild type 
mitochondria lies in the region of 0.16 pg of antibiotic per mg of mitochondrial protein. 
No changes in venturicidin pljo is apparent in the VR groups compared to the wild type, 
and this also applies to oligomycin pl50 for those strains cross-resistant to that antibiotic. 
A comparison between both groups of mutant and the wild-type D273/10B-A1 is shown 
in Figure 2.3.1, and includes an assay on the mitochondrially-coded oligomycin resistant 
mutation in the strain D22/A21 to indicate the effect of a structural change in the 
antibiotic binding site on the pI$o value. The PI50 for oligomycin in this strain is 10.5 
pgmg-1 compared with 3.6 pgmg-1 for wild-type mitochondria.
Thus these two groups of venturicidin resistant mutations do not fulfill the required 
criteria for a possible ATPase structural mutation, and any attempt to clone either would 
be hampered by their partial dominant phenotype. A number of further attempts were 
made to isolate venturicidin resistant mutants and one was successful in isolating a 
venturicidin resistant mutant which was not cross-resistant to any of the antibiotics in the 
study. This mutant was isolated by plating unmutagenised cells on venturicidin medium 
at a titre of 107 cells per plate. Resistant colonies were subcultured and analysed as 
previously described. Diploids produced from this strain were partially dominant and 
showed a 2:2 ratio of resistance to sensitivity when sporulated. However, on analysis of 
its mitochondrial ATPase pl30 no difference from the wild-type pl50 was observed.
2.4. CONCLUSIONS
Resistant mutants of S.cerevisiae have been generated to a number of ATPase inhibiting 
antibiotics (see Appendix I of this thesis). The best definition of phenotype was observed 
in venturicidin resistant mutants, and these were investigated in the greatest detail.
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?. 2.3.1a Mitochondrial ATPase resistance to the antibiotic venturicidin in wild type (D273/10B-A1) 
and venturicidin resistant (114-3) strains.
Concentration |ig/mg
Fig. 23 .1b  Mitochondrial ATPase resistance to the antibiotic oligomycin in wild type (D22) and 
mitochondrially-coded oligomycin resistant strain (D22/A21).
Methods for ATPase assay, phosphate determination and protein assay are described in section 2.2. 
Inhibitor concentration is given in SmuSg of inhibitor per mg o f mitochondrial protein.
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Although numerous attempts to produce mutants were undertaken using a variety of 
nuclear or mitochondrial DNA specific mutagens, none of the mutants analysed fulfilled 
all three criteria selected to identify ATPase structural mutations. Two groups of non­
allelic mutations were identified, one of which appeared to be a member of the pdr 
linkage group described by Saunders and Rank (1982).
It appears that structural mutations in the nuclear components of ATPase F0 resulting in 
VR are rare, or may not even occur, and by far the most frequent mutant type generated 
lowers membrane permeability to these antibiotics in a non-specific manner.
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CHAPTER 3
BIOCHEMISTRY O F ORGANOTIN DERIVATIVES OF 
3-HYDROXYFLAVONE AND MORIN
3.1. INTRODUCTION
Trialkyl tin compounds are known to inhibit oxidative phosphorylation (Aldridge. 1958, 
Aldridge and Street, 1964), showing different modes of action depending on 
concentration. At lower concentrations trialkyl tins bind to mitochondrial ATPase, 
causing loss of both ATP hydrolytic and ATP synthetic activities in an “ oligomycin- 
like”  manner. Its binding site has been located on F0 of ATPase (Sone and Hagihara. 
1964, Cain, 1976), and it has been shown to cause inhibition of proton conduction (Cain 
etal, 1977, Cain and Griffiths, 1977).
At higher concentrations these compounds have an uncoupling activity whose mode of 
action was attributed to a chloride/hydroxyl exchange across the inner mitochondrial 
membrane (Selwyn et al, 1970, Dawson and Selwyn, 1974). However, research 
performed in this laboratory, has shown that this depolarisation o f the mitochondrial 
membrane potential takes place in minimal halide media, and that addition of exogenous 
chloride has little or no effect on the rate or steady-state estimates of depolarisation 
(Connerton, 1986). The third activity of trialkyl tins is that they cause gross swelling of 
mitochondria when suspended in potassium chloride or isothionite media.
Trialkyl tin binding studies have given complex binding curves which have been 
interpreted as follows: there are at least two classes of binding site, a high affinity 
component which corresponds to the inhibition of ATPase activity (Rose and Aldridge. 
1972, Cain and Griffiths, 1977), and a low affinity binding site whose function is as yet 
undetermined. The ATPase binding site is proposed to involve histidine and thiol/dithiol 
groups, as mono and dithiols can specifically reverse trialkyl tin-mediated ATPase
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inhibition.
The spectrum of activity shown by trialkyl tins in rat liver mitochondria ranges between 
trimethyl tin chloride, which is a poor inhibitor of mitochondrial ATPase (pl3o>100) but 
an effective uncoupler, to tributyl tin chloride which has a lesser effect on mitochondrial 
membrane potential but with a pljo of 2.0, makes it a good inhibitor of ATPase 
(Connerton, 1986). However, by far the most effective tin compounds developed to date 
with respect to their inhibition of ATPase are penta-coordinate compounds, whose tin 
moiety is internally coordinated to nitrogen (van Koten et al, 1975). These compounds 
have no demonstratable effect on mitochondrial membrane potential.
This chapter describes some properties o f a group of recently synthesised tin compounds, 
including their effects on mitochondrial ATPase and mitochondrial membrane potential. 
A description of their fluorescence properties is also included with the aim of 
determining their possible use as a fluorescent probe for mitochondrial ATPase F„.
3.2. MATERIALS AND METHODS
3- hydroxyflavone was purchased from Aldridge Chemicals and penta-hydroxyflavone 
(morin) from the Sigma Chemical Co., Poole, Dorset. CCCP was purchased from Sigma 
and DSMP* from Gallard-Schlessinger Inc. Organotin derivatives were synthesised in 
this laboratory by Dr. D. E. Griffiths and Mr. K. Allsop. All other reagents were of 
standard ‘AnalaR’ grade purity.
Preparation of Rat Liver mitochondria
Livers were excised from adult male Wistrar rats (200-300g), finely chopped at 4°C and 
washed in ice-cold homogenisation buffer (250mM sucrose, lOmM Hepes pH 7.5, ImM 
EDTA) to remove any blood. The liver was homogenised in homogenisation buffer with
4- 5 passes in a glass homogeniser with a teflon pestle. The homogenate was centrifuged
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at 2.5K rpm for 10 mins in a Sorvall SS34 rotor, the supernatant decanted and 
recentrifuged. The supernatant from the second spin was centrifuged at 12K rpm for IS 
mins which produced a mitochondrial pellet. This pellet was washed and then 
resuspended in a minimum volume of mitochondrial resuspension buffer (250mM 
sucrose, lOmM Hepes pH 7.5).
A similar method was used for the preparation o f rat heart mitochondria.
Preparation of submitochondrial particles
Rat liver submitochondrial particles were prepared by sonicating a suspension of rat liver 
mitochondria in suspension buffer for four 15 second periods with 1 min intervals on ice 
to cool. The sonication tube was immersed in wet ice to prevent overheating. The sonic 
suspension was centrifuged at 10K rpm in a Sorvall SS34 rotor for 10 mins at 4°C, the 
supernatant decanted and centrifuged for 30 mins at 35K rpm in a Beckman 50Ti rotor at 
4°C. This produced submitochondrial particles (smps) as an orange translucent pellet, 
which was resuspended in mitochondrial resuspension buffer (250mM sucrose, lOmM 
Hepes pH7.5).
ATPase Assays
Estimation of protein, assay for ATP hydrolytic activity and determination of inorganic 
phosphate was performed as in section 2.2.
Fluorimetric Assays
Using DSMP*
The lipophylic dye DSMP* was used as an indicator of mitochondrial membrane 
potential in preparations of rat liver mitochondria, essentially as described by Mewes and 
Rafael (1981). A Perkin Elmer fluorimeter was used with both the excitation and 
emission slits set at 10mm. DSMP* (2 ill of a 1 mM solution in ethanol) was added with
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stirring to a four-sided 4 ml plastic cuvette containing mitochondria and buffer. An 
appropriate volume of mitochondria to give a total of 1 mg protein was added to 
mitochondrial resuspension buffer (250 mM sucrose, 10 mM HEPES, pH 7.5) to a total 
volume of 3 ml. Excitation and emission wavelengths were set at 479 and 589nm 
respectively, and, after addition of DSMP*, the fluorescence was allowed to achieve a 
maximum value before further additions. Compounds to be tested for their uncoupling 
activity were added in ethanolic solution (Mewes and Rafael, 1981, Connerton, 1986), 
ensuring that the ethanol concentration did not exceed 1% of the total volume.
Using Sn derivatives
A Perkin-Elmer fluorimeter was used with slit widths set as described previously. 
Initially compounds were investigated to identify where excitation and emission 
wavelengths combined to give a maximum value for fluorescence. A total of 3 ml 
containing 1 mg of mitochondrial protein in mitochondrial resuspension buffer was 
added to a four sided, 4 ml plastic cuvette, to which 2 ^1 of a 10 mM solution of one of 
the Sn compounds was added. Initially the emission wavelength was set at an arbitrary 
value (usually 500 nm) and the excitation wavelength was scanned. This was then set to 
any maxima observed in turn, and used to determine the wavelength required for 
maximum emission o f fluorescence.
In later experiments using Bu2SnBr(of). excitation and emission wavelengths were set as 
in Table 3.3.1, using 2 ill of a 1 mM ethanolic solution of the Sn compound per mg of 
liver mitochondrial protein. Less rat heart and submitochondrial protein was added as it 
gave a greater enhancement of fluorescence per unit protein, but this will be outlined in 
the text.
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3.3. RESULTS
A series of organotin derivatives of 3-hydroxyflavone (Hof) and penta-hydroxyflavone 
(morin) (structures shown in Figure 3.3.1a and b respectively) were synthesised by an 
addition reaction following the method of Blunden and Smith (Blunden and Smith, 
1982). Equimolar quantities of the tin di-halide structure of the product is shown in 
Figure 3.3.1c (after Blunden and Smith, 1982). These compounds are thought to have a 
penta-coordinated Sn moiety, which is internally coordinated to oxygen on one of the 
rings of hydroxyflavone.
The di- and tri-phenyl (of) compounds were crystallised by evaporating the solvent. On 
dissolving these two compounds in ethanol they lost their yellow colour so they were 
subsequently dissolved in DMF or acetone for use in assays. Other compounds were not 
recrystallised but used as an ethanolic solution of the oil left after evaporation of solvent, 
with the molarity calculated assuming the reactions had gone to completion. On 
attempting to recrystallise Bu2SnCl(of). white crystals were produced which redissolved 
in ethanol to give a yellow solution. However, this solution proved inactive when used in 
fluorescence assays, as it was not displaced by Bu3SnAc and it was therefore discarded.
A total of eight compounds were tested for their fluorescent properties when bound to 
mitochondria. Five 3-hydroxyflavone derivatives were produced, and their bound 
fluorescence is summarised in Table 3.3.1, with the exception of the Ph3 compound (this 
immediately lost its colour on addition to the cuvette). These derivative compounds 
were all yellow in colour. Three morin derivatives were also tested, and generally gave 
poor results showing a minimal increase in fluorescence on binding to mitochondria 
which could not be reduced on adding the non-fluorescent Bu3SnAc. These compounds 
were green/orange in colour. All assays were carried out using lmg mitochondria per 
cuvette and 2ill of a lmM solution of each of the analogues. A typical recorded trace is 
shown in Figure 3.3.2.
33
Figure 33.1  (a) The chemical structure of 3-hydroxyflavone and (b) Morin, (c) The penta-coor 
organotin derivative o f 3-hydroxyflavone where R can be either a methyl, ethyl or butyl group.
Figure 3 .3 2  Fluorescence traces from mitochondria with additions of the butyl derivatives of 3- 
hydroxyflavone and monn. Mitochondrial resuspension buffer (3 ml) was added to a four-sided 
fluorescence cuvette in a Perkin Elmer fluonmeter Excitation and emission wavelengths are given 
in Table 3.3.1. The fluorescent organoun derivative was added (2 til o f a 1 mM solution in ethanol), 
followed by a volume o f rat liver mitochondria containing I mg of mitochondrial protei 
fluorescent BuySnAc was added (2 p i o f 1 mM  in ethanol) after a maximum value far 
had been reached.
The non-
Compound Excitation Emission
Fluorescence
Enhancement +BuSnAc
Me2SnBr(oO 392 455 ++ to baseline
Et2SnCl(of) 390 450 to baseline
Bu2SnBr(of) 400 470 +++ to baseline
Ph2SnCl(of) 393 473 to baseline
Et2SnClMorin 400 510 ♦ no effect
Bu3SnBrMorin 402 497 no effect
PhjMorin 393 456 ♦ no effect
T abic 3 J .1  Fluorescence properties of organotin derivatives o f  3-hydroxyflavone and mo- 
rin. Excitation and emission wavelengths are those which g ive a maximum value for the 
fluorescence of each compound when incubated with rat liver mitochondria in mitochondrial 
resuspension buffer.
The fluorescence properties of these compounds are proposed to be due to their binding 
on the F0 domain of mitochondrial ATPase, at the site where previously analysed Sn 
compounds have been found to bind. This premise was used as a direction for further 
research. Enhancement of fluorescence occurs on binding to its site in mitochondria, but 
the fluorescent compound can be displaced by a non-fluorescent Sn compound which 
binds the same site with corresponding loss of fluorescence, supporting this theory. This 
is not the case for morin derivatives (Figure 3.3.2).
Tri-alkyl tin compounds have been found to be potent inhibitors of the mitochondrial 
ATPase. The newly-synthesised compounds were thus assayed to determine their 
effectiveness in an ATPase assay (Figure 3.3.3). The morin analogues showed very poor 
inhibition, their 150 being relatively large (Figure 3.3.3c). In contrast, the 
3-hydroxyflavone derivatives Bu2SnBr(of) and Et2SnCl(of) are good inhibitors, their 150 
in the range of BujSnAc (Figure 3.3.3a, b). The results are not presented in numerical 
form for a number of reasons. Firstly, the molarity of the solutions used was estimated 
assuming that the synthesis reactions had gone to completion, but this may not have been 
the case. This assumption does not consider the possibility of incomplete or side
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reactions and degree o f solubility in ethanol or in water. 150 values can be obtained from 
Figure 3.3.3, but these inhibition curves are only useful for comparison, and results are 
assumed to be very crude.
3-hydroxyflavone is known to be a weak inhibitor of mitochondrial ATPase when 
binding to F|. To eliminate this as a possible site for ATPase inhibition, 
3-hydroxyflavone compounds were investigated to determine whether F! was inhibited. 
Fj was prepared from rat liver mitochondria by the chloroform extraction method of 
Beechey (Beechey et al, 1975 and described in section 5.2), and lOp.1 of a lOmM solution 
of inhibitor was used in an ATPase assay (far exceeding the range in which the inhibitors 
are effective in a mitochondrial preparation). No inhibition of the rate o f  ATPase 
hydrolysis was observed.
The mitochondrial ATPase assay results correspond well with the data from the earlier 
fluorescence experiments, as the degree of fluorescence enhancement appears to correlate 
with the compound's effectiveness as an ATPase inhibitor. Further experiments were 
performed using one o f these compounds as representative of the group to  provide a 
detailed analysis of their properties. The compound Bu2SnBr(of) was selected for further 
study because it was a good inhibitor of mitochondrial ATPase, it showed a large 
fluorescence enhancement on adding to mitochondria, and it was displaced by addition of 
Bu3SnAc. The compounds synthesised with morin as starting material were not studied 
further as they did not show the most promising properties.
Previously studied compounds of this type showed diverse properties. At low 
concentrations they selectively inhibit mitochondrial ATPase in an oligomycin-like 
fashion, but at higher concentrations they cause dissipation of the membrane potential. 
DSMP* is a fluorescent probe which is an accurate indicator of membrane potential 
(Mewes and Raphael, 1981). Its fluorescence is enhanced on adding to energised 
mitochondria due to its import into the relatively lipophilic environment of the
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Fig.3.3.3a Resistance of mitochondrial ATPase to the antibiotics BujSnAc and Bu2SnBr(of). Rat liver 
mitochondria were prepared by differential centrifugation of homogenised liver tissue as described in 
section 3.2. ATPase activity, estimation of inorganic phosphate and protein determination are 
described in section 2.2. Concentration is given in nM inhibitor per mg of mitochondrial protein.
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Fig.3 .3 .3b  Resistance of mitochondrial ATPase to organotin derivatives of 3-hydroxyflavone. Rat liver 
mitochondria were prepared as described in section 3.2, and methods for ATPase assay, inorganic 
phosphate and protein determination are covered in section 2.2. Concentration of inhibitor is given 
in nM per mg of mitochondrial protein.
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Fig.3.3.3c Resistance o f mitochondrial ATPase to organotin derivatives or morin (pen ta-hydroxy (la vonc) 
Rat liver mitochondria were assayed for ATPase activity in the presence o f varying concentrations of 
antibiotic as described in section 2.2. Concentration o f inhibitor is given in nM  per mg of mitochon­
drial protein.
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mitochondrial matrix. On adding an uncoupler, for example CCCP, a sharp decrease in 
fluorescence is produced (Figure 3.3.4).
This assay was used to determine whether Bu2SnBr(of) caused uncoupling of the inner 
mitochondrial membrane. Recorder traces of this compound, compared with Bu3SnAc, 
are shown in Figure 3.3.4. Bu3SnAc causes uncoupling to take place, but Bu2SnBr(of) 
does not significantly affect the mitochondrial membrane potential. As the excitation and 
emission wavelengths of DSMP* are 479 and 589 nm respectively, no interference was 
anticipated due to the fluorescence of Bu2SnBr(of) (ex.400 em.470 nm). Because of its 
penta-coordinated Sn, Bu2SnBr(of) is of the same general structure as the Ve series of 
compounds described by Aldridge (Aldridge, 1978, Aldridge et al, 1981, Emanuel et al, 
1984), and this is reflected in the properties thus demonstrated. It inhibits mitochondrial 
ATPase, although it is not as efficient an inhibitor as Ve 2283 (ply) 0.15nmoles 
mg_1protein) or Ve 2281 (ply) O.lOnmoles mg-1 protein). However like the Ve 
compounds it does not affect mitochondrial membrane potential (Connerton, 1986).
To determine whether the energetic state of the inner mitochondrial membrane affected 
the fluorescence of bound Bu2SnBr(of) the uncoupler CCCP was used. Bu2SnBr(of) was 
added to rat liver mitochondria and its fluorescence allowed to reach steady-state, after 
which 2|0l of CCCP was added. The recorder trace is shown in Figure 3.3.5, and from 
this it can be seen that the fluorescence enhancement is unchanged when the 
mitochondrial membrane is uncoupled.
The non-fluorescent alkyl tin compound Bu3SnAc can be used to lower the fluorescence 
of Bu2SnBr(of) to its baseline in a titratable fashion (Figure 3.3.6). Other ATPase 
inhibitors can also be titrated against the fluorescence (Figure 3.3.7). The ATPase 
inhibitor venturicidin causes the greatest fluorescence decrease, followed by 
leucinostatin. Oligomycin has negligible affect on the fluorescence. This effect is more 
evident when mitochondria are preincubated with the inhibitors venturicidin and
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Figure 3 J . 4  The compound Bu,SnBr(of) does not affect mitochondrial membrane potential. Rat liver 
mitochondria were incubated with the fluorescent probe DSMP* (2 til o f a  1 mM solution). After 
reaching maximum fluorescence 2 id of a 10mM solution of BujSnBrfof) was added. The uncoupler 
CCCP (1 pi of a ImM solution) was used to demonstrate the effect that lowenng mitochondrial
membrane potential has on the fluorescence of DSMP*.
(Arb)
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oligomycin prior to addition of Bu2SnBr(of)- This provides further evidence that 
venturicidin and oligomycin have differing binding sites, and supports research done by 
other authors (Cain, 1976, Kiehl and Hated, 1980).
On adding Bu2SnBr(of) to smps fluorescence enhancement is observed, which is 
titratable with Bu3SnAc. The increase in fluorescence is greater (per mg protein) in smp 
preparations and is presumed to be due to the increase in the ATP synthase per unit 
protein in the smp preparation (which consists only of mitochondrial inner membrane 
protein, Figure 3.3.8). An increase in fluorescence enhancement per mg o f mitochondria 
can also be demonstrated in rat heart preparations, in comparison with rat liver 
mitochondria. Heart mitochondria are enriched in ATPase because of the increased 
requirement for ATP in that tissue.
3.4. CONCLUSIONS
Derivatives of 3-hydroxyflavone and morin have been investigated to determine their 
possible use as extrinsic fluorescent probes for the mitochondrial inner membrane protein 
ATP synthase. The Sn compounds derived from reaction with 3-hydroxyflavone were 
generally found to give a greater fluorescence enhancement and be more effective as 
ATPase inhibitors than the corresponding morin derivatives. Thus a 3-hydroxyflavone 
derivative was chosen for further study (Bu2SnBr(of)). This compound reflected the 
properties of the previously studied group of penta-coordinate Sn compounds (Aldridge, 
1978, Aldridge et al, 1981, Emanuel et al, 1984), although it was less effective as an 
ATPase inhibitor. When added to energised mitochondria Bu2SnBr(oD did not affect the 
membrane potential, and conversely uncoupling agents had no effect on its fluorescence. 
Enhancement of fluorescence was observed in submitochondrial particle preparations 
which were produced with no membrane potential. The enhancement of fluorescence has 
been ascribed to a binding and not a transport phenomenon.
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Figurt 3 J .8  The fluorescence enhancement of Bu^SnEMof) is greater (per mg o f protein) in submitochon- 
drial panicles than in mitochondrial preparations. BujSnBrfoO (2 n l o f a 10 mM soluuon) was incu­
bated in mitochondrial resuspension buffer with 0.2 mg of protein from submitochondnal panicles
:• |A
rb I
The binding site of these compounds has been tentatively identified as identical with the 
tri-alkyl tin binding site on the ATP synthase F0 domain as a result of the following 
evidence:
1. The fluorescence enhancement observed is due to binding of the compound to a  site 
or sites within the mitochondrion, and not to a transport mechanism as for DSMP*.
2. The fluorescence enhancement increases per mg protein with increasing proportions 
of the ATP synthase enzyme (and other inner membrane proteins) in the sample (rat 
heart and smp preparations).
3. Mitochondrial ATPase is inhibited by these compounds but ATPase F, is not 
affected.
4. The fluorescence of the compound is lowered by, and can be titrated against, 
additions of a non-fluorcscent tri-alkyl tin solution, which is consistent with the 
compounds competing for the same site.
The binding site is also competed for by venturicidin and to a lesser extent leucinostatin, 
but not by oligomycin, providing further evidence that the venturicidin and oligomycin 
sites are non identical.
The possible use of these compounds as fluorescent probes for mitochondrial ATPase F0 
is discussed in Chapter 6 .
68
CHAPTER 4
ISOLATION AND SEQUENCE ANALYSIS OF THE GENE PET51
4.1. INTRODUCTION
As S.cerevisiae is a facultative anaerobe it can stably propagate mutations on fermentable 
media which cause respiratory-deficient mitochondria. Nuclear-coded mutations 
conferring this phenotype are termed pet mutations. The nuclear-coded gene products 
are fundamentally important in the biogenesis of mitochondria, being both directly and 
indirectly involved in mitochondrial respiration/oxidative phosphorylation. The genetic 
material required for assembly of such a complex organelle must comprise a significant 
proportion of the cell’s genetic information.
Pet mutants can be produced both as conditional and non-conditional mutants. 
Anticipating that some PET products may be shared by the rest of the cell, conditional 
mutants have been generated (Michaelis et al, 1982, Edwards et al, 1983). However this 
method has the disadvantage that the mutant phenotype in not always well differentiated 
under selective conditions. Although a more limited assortment of non-conditional 
mutants can be generated, they are considerably easier to clone by complementation with 
a wild-type recombinant plasmid library (Dieckmann and Tzagoloff, 1983).
All o f  the mutants produced by A. Tzagoloff et al (1975a) were of the non-conditional 
type, selected for their inability to grow on glycerol, a non-fermentable substrate. 
Initially five phenotypic classes were defined depending on which of three mitochondrial 
enzyme activities were affected.
This chapter describes the cloning and sequencing of one of these mutants, which was 
deficient in ATP hydrolytic activity.
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4.2. MATERIALS AND METHODS
The following reagents were purchased from Sigma: DTT. (3-mercaptoethanol, RNAase 
A, Ampicillin, BSA. Glusulase was purchased from DuPont and dialysis tubing from 
Spectropore. All o ther reagents were of Anal-R grade purity, with the exception of those 
used for culture media.
Media (supplementary)
In addition to YPD and YPG, Galactose containing medium was also used, primarily in 
growing yeast for mitochondrial preparation.
YPGal_______________
1% (w/v) Yeast extract 
2% (w/v) Bactopeptone 
2% (w/v) Galactose 
2% (w/v) Agar for plates
Transformation of S.cerevisiae (Beggs, 1978)
Transformation medium
This medium is used for growing cells from spheroplasts. hence it has an inclusion of 
1.2M sorbitol to prevent lysis of spheroplasts.
T_________________________
1.2M Sorbitol
0.67% N-base w/o amino acids 
2% (w/v) Glucose
2% (w/v) Agar for plates
TGly______________________
1.2M Sorbitol
0.67% N-base w/o amino acids 
0.05% (w/v) Glucose 
3% (v/v) Glycerol 
2% (w/v) Agar for plates
All operations were sterile, and at room temperature unless stated. An overnight 
inoculum in 10ml YPGal was grown to early stationary phase (approx. 10* cells). The 
culture was centrifuged for 5 mins at 2K rpm, and the cell pellet washed with 5ml dH2Q.
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Cells were re-suspended in 3ml D TT solution and shaken for 10 mins at 30°C. They 
were then centrifuged for 5 mins at 2K rpm and washed twice with 1.2M sorbitol.
DTT solution Glusulase solution
1.2M sorbitol 
25mM EDTA pH 7.5 
7.7 m gmr'DTT
1.2M sorbitol 
lOOmM Na citrate pH 6.0 
lOmM EDTA
2% glusulase
Both solutions were sterilised by filtration
Cells were re-suspended in 1ml glusulase solution and shaken at 30°C for 30 mins. 1.2M 
sorbitol (5ml) was added and the suspension was centrifuged and washed once with 1.2M 
sorbitol, and once with 1.2M sorbitol. lOmM CaCl2.
After re-suspending in 0.1ml 1.2M sorbitol, lOmM CaCl2. cells were transferred to an 
Eppendorf tube. DNA (5-10nl) was added, and the cells incubated at 30°C for 15 mins. 
To this 0.9ml of 20% PEG. lOmM Tris pH 8. lOmM CaCl2 was added, mixed by 
inversion, and incubated for 10 m ins at room temperature. The tube was then centrifuged 
for 5 mins at 2K rpm and the supernatant removed with a sterile pasteur pipette.
Cells were re-suspended in 150^ x1 o f  1.2M sorbitol, lOmM CaCl2, plus 50^ x1 YPD in 1.2M 
sorbitol and shaken at 30°C for 20  mins, then plated on selective medium containing 
1.2M sorbitol (TGly plates) and non-selective medium to check the efficiency of 
transformation (T plates). Transformant colonies could be seen under magnification after 
two days incubation at 30°C.
Transformation of E.coli (Cohen e ta l,  1972)
E.coli RR1 was inoculated into 50ml L-broth and grown at 37°C to 100 Klett units. All 
further steps were carried out between 0-4°C unless stated. Cells were centrifuged in a 
Sorvall centrifuge with SS34 rotor at 3.5K rpm for 10 mins, washed with 10ml lOmM 
CaClj and re-suspended in 10ml 50mM CaCl2. After 30 mins on ice cells were
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centrifuged and re-suspended in 5ml 50mM CaC l2, and 200pl aliquots transferred to 
sterile Eppendorfs.
DNA (5-lOp.l) was added to competent cells, which were incubated on ice for 30 mins. 
Cells were heat shocked at 42°C for two minutes and added to 3ml of L-broth. After 
shaking at 37°C for 43 mins, 0.2ml was spread on a selective plate (containing 
ampicillin, amp). Remaining cells were spun down, re-suspended in a small volume, and 
spread on a second plate.
After growing at 37°C overnight transformant colonies were picked and patched out for 
DNA minipreps.
E.coli plasmid preparation
Large scale
An overnight culture grown up in 300ml L-broth plus ampicillin was spun down in an 
International centrifuge at 8K rpm for 10 mins. C ells were washed with 100ml lOmM 
tris/Cl pH 7.5 and re-suspended in 25ml lysozyme mix.
L y s o z y m e  m ix
50pl RNase (lOmgmT1 stock)
4mg lysozyme 
50mM glucose 
lOmMTris 
ImMEDTA 
dH20  to 100ml
After incubation on ice for 45 mins, 50ml 0.2N NaOH, 0.1% SDS was added and the 
suspension was stirred gently. 7M NaOAc (36ml) was added with thorough mixing, 
followed by centrifugation in a Sorvall centrifuge at 12K rpm for 15 mins.
To the supernatant from this spin three volumes o f  100% ethanol was added, the 
suspension spun at 4K rpm for 10 mins and the supernatant discarded. The pellet was
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dissolved in 10ml NH4OAC, re-precipitated with ethanol and re-dissolved in 10ml TE 
buffer. This solution was pipetted into dialysis tubing and dialysed twice against 21 of 
TE to remove any ethanol.
A caesium chloride gradient was made up by adding 6.5g CsCl p e r 6g DNA solution. 
Ethidium bromide (S m gm r1, 130(1.1) was added per tube, which were centrifuged in a 
Beckman ultracentrifuge 50Ti rotor at 39K rpm for 40hrs (at 20°C). The plasmid band 
runs lower than the nuclear DNA band and was taken from the gradient using a bent 
syringe. It was then extracted three times with isoamyl alcohol to remove EtBr and twice 
with ether. The DNA was dialysed twice against 21 of lOmM Tris/Cl pH 7.3, 0.1 mM 
EDTA to remove CsCl, dispensed into Eppendorfs, and stored at —70°C.
Medium Scale (Triton Procedure)
Cells were scraped with a sterile spatula from a confluent E.coli p late spread the previous 
day. These were transferred to 0.5ml 5% sucrose, 20mM Tris/Cl pH  8.0 and vortexed 
until well suspended. Lysozyme solution (0.8ml) was added and cells incubated on ice 
for 30 mins.
Lysis solution (0.8ml) was added, the suspension was mixed by inversion and centrifuged 
at 40K rpm in a Beckman ultracentrifuge 50Ti rotor for 15 mins at 4°C. The supernatant 
from this spin was transferred to a 15ml corex tube, followed by an equal volume of 
H20-saturated phenol. After mixing the phases were separated at 7K  rpm for 10 mins in 
a Sorvall centrifuge (SS34 rotor), and the upper phase washed three times with ether. 
The DNA was then precipitated by making 0.3M NaCl, adding three volumes of 100% 
ethanol and spinning down at 7K rpm for 10 mins. The oily layer left by this
L y s o z y m e  s o lu t io n L y s is  s o lu t io n
2ml lysozyme (5mgml_1 stock) 
lml of 0.125M EDTA 
in Tris/Cl pH 8.0 
0.1ml RNase A (lOrngml-1 stock)
3ml of 10% Triton X-100 
75 ml of 250mM EDTA 
15ml of 1M Tris/Cl pH 8.0 
dH20  to 100 ml
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precipitation contains DNA together with some Triton. The oil was dissolved in 2M 
NH4OAC and the DNA reprecipitated with 3ml of ethanol. After one further 
reprecipitation the DNA was washed with 80% ethanol and dried in a speed-vac. The 
pellet was dissolved in 200-500pl H20 , and stored at -70°C.
Small Scale (Birnbaum Preparation, Mini-prep)
Cells were taken with sterile toothpicks from patches grown up overnight, and suspended 
in lysozyme mix (100pl). After a 5 min incubation on ice lOOpl 2N NaOH, 0.1M  SDS 
was added with mixing, followed by 75pl 7M NaOAc. The eppendorf tubes were 
centrifuged for 5 mins in a microfuge and the supernatant transferred to new Eppendorf 
tubes.
DNA was precipitated with 100% ethanol, re-dissolved in 200pl of 2M NH4OA c. 0.2M 
EDTA, re-precipitated, washed and dried in a speedvac. The DNA was then dissolved in 
30pl H20 , and 5pl was used in restriction enzyme digests.
S.cerevisiae plasmid preparation
Transformed S.cerevisiae was grown up overnight in 10ml of WO with am ino acid 
supplements to allow growth. Cells were spun down at 2K rpm for 5 mins, re-suspended 
in 1ml 1.2M sorbitol, and transferred to an Eppendorf tube. After centrifuging, cells 
were re-suspended in zymolase mix, and incubated at 30° for 1 hour.
lml HjO
The spheroplasts thus produced were completely re suspended in lOOpl RNase solution 
and 200pl 0.2N NaOH, 1% SDS was added immediately. The suspension was m ixed by
Zymolase mix RNase Solution
3ml of 2M sorbitol 
0.5ml o f 1M Na citrate pH 7.0 
0.6ml o f 0.5M EDTA 
50pl (3-mercaptoethanol 
25mg zymolase 20000
0.5ml of 0.5M glucose 
0.125ml of 1M Tris/Cl pH 8.0 
0.1ml of 0.5M EDTA 
0.125ml of lOmgml"1 RNase A 
4.1ml HjO
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inversion and incubated on ice for 30 mins. Tubes were centrifuged in a microfuge for 
two minutes, the supernatant collected and transferred to a fresh Eppendorf tube. The 
DNA was precipitated with 100% ethanol twice, washed in 80% ethanol, and dried in a 
speed vac.
The DNA pellet was then dissolved in lOOpl of sterile lOmM Tris/Cl pH 7.3, 30mM 
CaCl2 and used to transform E.coli.
DNA manipulation
Restriction Enzyme Digestion and Gel Electrophoresis
Standard procedures were used for restriction endonuclease digestion, according to 
manufacturer’s instructions. An appropriate volume of Ficol stop mix (FSM) was added 
to the digest, which could then be loaded on 1% vertical agarose gels made with TBE 
buffer. Gels were run at 100mA for lh r with TBE buffer in both upper and lower tanks, 
stained with EtBr and photographed using a transilluminator.
For large-scale preparation of DNA fragments a flat bed gel was used, with EtBr added to 
both gel and running buffer at l|xl to 10 ml (from 5mgml_1 stock).
Treatm ent with CIP
Calf intestinal phosphatase (CIP) is used to remove the 5' phosphate from DNA to 
prevent self-ligation. When restriction enzyme digests were carried out at 37°C, CIP was 
added before starting the incubation. If digests required incubation at a higher 
temperature, CIP was added after the digest incubation, and the DNA incubated a further 
30 minutes at 37°C.
Preparative Isolation of DNA
DNA was isolated preparatively by electroelution. Bands were sliced from agarose gels
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and inserted into dialysis tubing containing 1/10 TBE buffer. The tubing was clipped at 
both ends after removing any bubbles and excess buffer. It was placed in an 
electroelution tank containing 1/10 TBE buffer, and left for 5-10 mins at 600V.
The agarose slice was removed after checking that the DNA had eluted out of the agarose 
on a transilluminator. After agitating the remaining liquid in the dialysis tubing to 
displace DNA from the membrane, the liquid was transferred to an Eppendorf tube. This 
was extracted once with phenol, three times with ether, ethanol precipitated, ethanol 
washed, and dried. The pellet was dissolved in H20  and 1 pi run on a check analytical 
gel.
Ligation of DNA
Vector DNA used in ligation reactions was treated with calf intestinal phosphatase (CIP) 
to prevent self-ligation. Two volumes of ligase buffer were made up using equal 
proportions of the following solutions, mixed in the stated order.
2x ligase buffer
0.4M Tris/Cl pH 7.5
0.1MM gCl2 
lOmM ATP
0.1M DTT
0.5mg ml-1 BSA
DNA fragments to be ligated were added in equal proportions established by comparison 
on an analytical gel. The ligation was set up as follows :-
2x ligase buffer lOpl
HzO + DNA(s) lOpl
T4 DNA ligase lpl
Incubations were carried out either at 37°C for 2-3hrs or at room temperature overnight.
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Treatment with Klenow
DNAs were treated with Klenow (DNA polymerase I, large fragment) in a reaction mix 
made up as follows
nick translation buffer 10|ii
each dNTP (0.8M) 10*11
Klenow fragment 1 (SU)
H20  + DNA to 100*11
The reaction was incubated at room temperature for 30 mins and stopped by the addition 
of 4*il 0.5M EDTA.
DNA Sequencing (Maxam and Gilbert, 1977)
DNA was cut to lengths ranging between 100-600 bases with a restriction endonuclease. 
The fragments generated were treated with CIP to remove S' phosphates. When the 
digestion had gone to completion the reaction mix was extracted with phenol (once) and 
ether (three times), and the DNA ethanol precipitated, washed and dried.
5' End Labelling
The DNA precipitate was dissolved in 20*il H20  in an Eppendorf tube, and heated at 
90°C for 5 mins to separate the two DNA strands. The Eppendorf was cooled 
immediately on wet ice to prevent the DNA strands from re-annealing. The following 
reagents were added in stated order to the side of the tube
kinase buffer 3(U
spermidine (0.1M) l(U
yI!p -a t p 2*1
polynucleotide kinase 2*1
The reagents were mixed and incubated at 37°C for lhr. 2M NH4OAc, 0.2mM EDTA 
(70*ll) was then added and the DNA ethanol precipitated, washed and dried.
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The DNA was then dissolved in 30*tl DMSO dye mix, heated at 90°C for 7 mins and 
quickly cooled on wet ice. It was then loaded on a thick 6% polyacrylamide gel (strand 
separation gel) and run at 250V overnight.
DMSO dye mix
30% DMSO, ImM EDTA 100**!
xylene cyanol/bromophenol blue 5*il
Gel Elution
The strand separation gel was removed from the gel tank, one glass plate removed and 
the gel covered with saran wrap. The gel was then exposed to X-ray film without an 
intensifying screen, usually for one minute (but dependent on the radioactivity of the 
gel), and the position of the gel very carefully marked onto the X-ray film.
The position of each DNA strand was determined by carefully aligning gel and 
developed film. Bands were cut from the gel with a sharp scalpel blade and counted for 
radioactivity. Each separate excised band was inserted into a 1000*11 pipette tip sealed at 
its point with a haemostat and plugged with glass wool.
The gel slices were ground to a gritty consistency with a metal rod, and 0.4ml elution 
buffer added. Each pipette tip was covered tightly with parafilm, placed in a 5ml glass 
tube, and incubated at 45°C for lhr. After incubation the sealed ends were cut open, 
parafilm removed, and the liquid drained into the glass tubes. To extract the remaining 
liquid the pipette tips and tubes were spun at 2K rpm for 5 mins. Carrier RNA (10*il) 
was added to each glass tube, followed by 1ml 100% ethanol. The suspension was 
transferred to etched Eppendorf tubes, frozen on dry ice for 5 mins and the DNA spun 
down in a microfuge. DNA was re-suspended in 300*11 of 2M NH4OAC, 0.2mM EDTA. 
0.02N HAc, re-precipitated, washed, dried and counted for radioactivity.
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Sequencing Reactions
Depending on the radioactivity of the pellet, the DNA was dissolved in >40|il (minimum) 
H20 . The solution was distributed between four etched Eppendorf tubes (marked with 
the number of the strand and G, A, T, C) for each of the sequencing reactions (6pl for G 
and C, 10pl for A and T). Reaction times depended on the length of the DNA fragment 
(larger fragments have more reaction sites) as follows :-
Reaction
No. of bases
600-400 400-300 300-200 <200
G 30 sec 30 sec 30 sec 30 sec
A 6 min 8 min 10 min 12-15 min
T 4-5 min 7 min 8-9 min lOmin
C 4-5 min 7 min 8-9 min 10 min
Tabic 4.2.1 Incubation time for sequencing reactions
Samples were re-suspended in a volume of formamide loading buffer based on their 
radioactivity after the piperidine wash. The minimum volume used was 12-13^1, to give 
enough solution to enable two or more gels to be run.
Formamide loading buffer 
formamide lOOpl
xylene cyanol and bromophenol blue lOpi
0.5M EDTA l*d
Samples were heated at 90°C for 5 mins, cooled quickly on wet ice, and loaded on a 
sequencing gel. These gels were thin polyacrylamide/urea slabs, 7% polyacrylamide 
used for 1st and 2nd channels, 6% for 3rd channels and 20% used to determine the order 
of bases proximal to the 3' label.
Gels were exposed overnight to Kodak X-omat film with a Lightning intensifying screen 
at -70^0.
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G A T C
DNA 6pl DNA lOpl DNA lOpl DNAfipl
add 200pl G-buffer add 8pl citrate pH 4.0 add 20pl ddHjO add 24pl SM NaCl
lp l DMS, mix, spin mix, spin mix, spin mix, spin
(•) secs at r.L (•) mins at 80°C 30pl hydrazine 30pl hydrazine
30|Xl DMS-stop to stop put on ice mix, spin mix, spin
then 5pl ctRNA. mix add300pl (•) mins at r.L (•) mins at r.L
1ml 100% EtOH, mix 
freeze 3', efuge 5' 
rinse lx  w/ 80% ElOH 
add 300pl 2M NH«OAc/ 
EDTA/HOAc
2M NH4OAc/EDTA/HO Ac 
then 5pi ctRNA, mix 
0.9ml 100% EtOH, mix 
freeze 5', efuge 5' 
wash 2x 80% ElOH/EDTA
add 300pl 2M NH^O Ac/EDT A/HO Ac
5pi carrier tRNA, mix
0.9ml 100% EtOH. mix
freeze 3', efuge 5'
rinse lx  with 80% EtOH
mix
0.9ml 100% EtOH 
freeze 5’, efuge 5' 
wash
2x 80% EtOH/EDTA 
1x80%  EtOH 
dry
lx  80% EtOH 
dry
add 300pl 2M NH4O  Ac/EDT A/HO Ac, mix 
0.9ml 100% EtOH. mix 
Freeze 3', efuge 5' 
wash
2x 80% EtOH/EDTA 
lx  80% EtOH 
dry
Piperidine wash: •  for times see tabic
add 40pl 1.5% piperidine ( ISOpJ piperidine:850pl cold HjO) 4.2.1
mix, spin
incubate 30 mins at 90°C. cover
immediately into spccdvac for 30 mins
wash 2x with 12pl hot H20  (ddHjO at 90°O
20  mins for each wash while centrifuging in the speedvac
dry
Table 4.2.2 Max am and Gilbert DNA sequencing reactions
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Miscellaneous
Nkk Translation
The reaction mix was as follows, incubation was at 30°C for lhr.
DNA
lOx nick translation buffer 
3x cold NTPs 
lx  labelled NTP (TTP) 
DNase (O.Olmg ml-1) 
DNA polymerase
3x 3pl
4 (il
2nl
3pl
im
During the incubation a G50 column was prepared. A 1ml syringe (with plunger 
removed) was packed to capacity with G50 swollen in TE. This was placed in a test tube 
and aligned so that it drained into an Eppendorf tube. The column was spun at 2K rpm 
for 4 mins and washed through with two volumes o f lOOpJ of STE.
STE
lOOmMNaCl 
lOmM Tris/Cl pH7.5 
ImM EDTA
The reaction was stopped with 80(il of 50mM EDTA, and loaded onto the column (total 
100|il). The column was centrifuged at 2K rpm for 4 mins and drained into a thick- 
walled Eppendorf. This solution was used as a probe in hybridisation proceedures.
Colony Hybridisation
An ampicillin plate of E.coli transformant colonies was grown up overnight and 
replicated onto a second ampicillin plate. This replica was left at 37°C for 4hrs and 
stored at 4°C. A sterile Whatman #40 filter paper, notched for orientation, was carefully 
lowered onto the master plate ensuring no air bubbles were trapped between plate and 
filter. The top o f the filter was labelled with pencil - label side up is colony side down. 
The plates were turned over and left for 13 mins at room temperature. The filter was
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removed with tweezers and floated colony side down in a tray of 0.5M NaOH (250ml) 
for 15 mins. After three 300ml washes in neutralising solution, the filters were placed 
colony side up on a piece of Whatman #3 paper and dried at 80°C for lhr.
Neutralising solution 20x SSC
1M Tris/Cl pH 8.0 3M NaCI
3M NaCl 0.3M Na citrate
Filters were rinsed in 6x SSC and bagged colony side out, 2 Alters per bag. Probe DNA 
(lOpl from nick translation) was added to 0.5ml cDNA, heated at 90°C for 5 mins and 
cooled rapidly on wet ice. Bags were Ailed with 5ml hybridisation buffer and injected 
with the probe. Sealed bags were incubated at 65°C overnight.
Hybridisation buffer 
6x SSC 
1% SLS
The Alters were washed twice for 15 mins in 300ml of 2x SSC, 0.1% SDS, then four 
times for 5 mins in 250ml of 5mM Tris/Cl pH 8.0. After drying on a paper towel colony 
side up. Alters were exposed for 5hrs or overnight depending on their radioactivity.
S.cerevisiae Chromosomal DNA Preparation
A 1% inocculum into 500ml of YPD was grown up overnight and harvested at 5K 
for 10 mins in a Sorvall GSA rotor. Cells were pooled and washed in 1.2M sorbitol, 
pellet was re-suspended in 3ml zymolase mix per gram wet weight of cells, 
incubated at 37°C for lhr. After optical microscope examination to ensure spheroplast 
formation had occurred, 100ml of 1.2M sorbitol was added and the spheroplasts were 
pelleted at 5K rpm for 5 mins. After 1 further wash in 1.2M sorbitol, cells were re­
suspended in 3ml of lysis solution per gram of cells.
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1 
i
Lysis solution PCI
1.5% SDS 
20mM Tris pH 7.5
250ml CHC1,
250ml H20  sat. phenol 
10ml isoamyl alcoholImM EDTA 
0.2M NaCl
The suspension was mixed by rolling gently with a glass rod to minimise breakage of the 
DNA. An equal volume of PCI was added, gently mixed and centrifuged at 5K rpm for 
10 mins. The supernatant was collected with a wide mouth pipette, an equal volume of 
PCI added to it, centrifuged, and the supernatant further extracted with an equal volume 
of CHC13. The aqueous phase was transferred to a corex tube and two volumes of 100% 
ethanol added. DNA was pelleted at 2K rpm for 5 mins, washed twice with 80% ethanol 
and inverted to dry. The pellet was dissolved in 6ml of TE, and dialysed against 21 of TE 
for 2hrs. CsCl gradients were set up as described previously, adding only 40pxl EtBr to 
avoid breakage of the DNA. The centre prominent band was taken from the gradient and 
treated as in section 4.2.2.
5pil of the DNA solution was used as a test digest.
Southern Blotting
Total chromosomal DNA was digested with a restriction endonuclease and the digest run 
on a 1% agarose gel to produce a smear of DNA. The EtBr-stained gel was 
photographed and notched. The gel was gently shaken twice for 20 mins in 500ml of 
0.4N NaOH, 1.5M NaCl to denature, and neutralised for three periods of 10 mins in 
350ml of 1M Tris/Cl pH 8.0, 3M NaCl. The DNA was transferred overnight to 
nitrocellulose in 20x SSC.
The nitrocellulose was rinsed in 2x SSC for 5 mins and dried between Whatman #1 
papers. It was then baked for 2hrs at 80°C. The nitrocellulose was wetted in 6x SSC and 
sealed in a bag with 5ml of hybridisation mix. The heat-denatured probe was injected
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and the sealed bag incubated at 65°C overnight.
The nitrocellulose was washed twice for 15 mins in 200ml of 2x SSC, 0.1% SDS. then 
for four 5 min periods in 5mM Tris/Cl pH 8.0. Excess liquid was blotted off and the gel 
exposed overnight at -70°C.
4.3. RESULTS
Generation and Classification of pel M utants
The strategy employed by Prof. A. Tzagoloff and colleagues to produce and classify pet 
mutants is briefly described in this section, and is discussed in detail in Tzagoloff et al, 
1975a. Yeast strain D273-10B/A1 was mutated by treatment with N-methyl N-nitro 
nitrosoguanidine or ethyl methane sulphonate, which are mutagens shown to specifically 
affect nuclear DNA, and mutants selected for their inability to grow on glycerol 
containing medium. These respiratory-deficient mutants produced were screened for 
their ability to carry out mitochondrial protein synthesis by differential inhibition of 
nuclear protein synthesis with cyclohcximide. and m uants deficient in mitochondrial 
protein synthesis were stored for future analysis, but were not investigated in this study. 
This step eliminates the most probable mitochondrial muution, a mit mutation in the 
large rRNA-coding gene. It also eliminates nuclear muutions which cause deficiencies 
in mitochondrial protein synthesis. Nuclear-coded mutants were selected on their ability 
to complement a p° tester strain derived from S.carlsbergensis by ethidium bromide 
muagenesis (CB 11 p°). Crosses which gave rise to diploids showing no growth on EG 
after 2-3 days were classified as cytoplasmic.
Mutants were further characterised according to phenotype by preliminary enzymatic 
analysis. Assays for ATPase, cytochrome oxidase and cytochrome QH2 reductase were 
carried out and mutants grouped according to which enzyme activity, or combination of 
enzyme activities were affected (Tzagoloff et al, 1975a,b,c). Five general groups were
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defined, three of which describe specific deficiencies in the enzyme complexes assayed, 
one in which pleiotropic deficiency in more than one of the enzyme complexes was 
observed, and one in which none of the complexes in the assay were affected. These 
three enzymes are unique in that they are under dual genetic control and thus of much 
interest in terms of biosynthetic control, transport and assembly of the subunits of the 
complex.
Each mutant was crossed to CB11 and respiratory deficient spores were isolated to 
generate haploids of different mating type. These were crossed to the original mutants, 
and those producing diploids which did not grow on EG after 2-3 days were assigned the 
same complementation group. This experiment classifies mutants together that affect the 
same activity, thus one cannot compensate for the mutation in another.
Preliminary Genetic and Biochemical Analysis of Complementation Group G57
The genotypes of strains used in this study are show in Table 4.3.1. A complementation 
group, shown to have deficient ATP hydrolase activity in the initial selection carried out 
by Prof.Tzagoloff and colleagues, was chosen for analysis. Firstly experiments were 
carried out to confirm the nuclear location of the mutation, and the ATPase deficient 
phenotype that had been evident in preliminary enzymatic analysis. Complementation 
group G57 is comprised of 8 independent isolates which have recessive mutations 
producing a respiratory deficient phenotype. Mutants are complemented by crossing to 
the haploid p° strain CB11 p°, indicating that the defect is located in a nuclear gene as 
the p° strain has no mitochondrial genetic material and thus cannot complement any 
mitochondrial mutation. Mutants are not complemented by inter-group crosses, 
confirming that they are in the same linkage group. The mutation has a stable genotype 
having a low rate of conversion to cytoplasmic petites when grown under non-selective 
conditions.
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Strain Nuclear Genotype MitochondrialGenotype
CB11 a P*
C B llp0 a p °
D273/10B-A1 a  met~ P*
D273/10B-Alp° a  met~ p °
KL14p° a p °
W303 a/a  his ~ura ~trp ~ade ~ P*
B264 * pet SI P*
B264/U1-U4 pet„ ura P*
W150 * Pet n p *
C80 a  petn Pf
N540 apeti7 P*
E54 tit pet a P*
El 13 a p et„ P*
E394 et Pet si P*
E695 «  Pet si P*
E822 apetsi p *
T ab le  0 . 1  Nuclear and Mitochondrial genotype o f S.cerevisiae strains used in this chapter 
Mitochondria were prepared from all of the strains in the linkage group and assayed for 
ATPase activity according to the method outlined in the following chapter. The results 
are shown in Table 4.3.2, and from these it is evident that all members of the 
complementation group G57 show deficiency in mitochondrial ATPase activity, 
generally showing <10% of the activity of the wild-type.
Strain S.A. S.A. + rutamycin
D273/10B-A1 4.304 1.192
B264 0.198 0.167
N540 0.317 0.304
E54 0.315 0.213
El 13 1.610 0.476
E394 0.346 0.346
E695 0.565 0.377
E822 0.189 0.169
Table 4.3.2 Specific activity (in (i.Mmg_1min_1)of mitochondrial ATPase from members 
of the 057 complementation group. Mitochondria were prepared by the zymolase procedure 
(described in Chapter 5) from an overnight culture of each mutant strain and tested for AT­
Pase activity. Mitochondrial protein (0.1 mg per assay) was incubated with ATP and inor­
ganic phosphate generated was measured colourimetrically. Specific activity was calculated 
for each sample, with wild-type mitochondria assayed as a control. Rutamycin was added to 
a further incubation (5 pi of 1 rngml-1) to determine whether the residual ATPase activity 
was rutamycin-sensitive.
Isolation of the PET57 Gene by Complementation
One of the groups 8 members. B264, was crossed to W303 and a number of PETura~ 
spores were collected. The purpose of this is to generate spores with a requirement for 
uracil, as this is the marker used for the plasmid library, but also to produce a variety of 
spores for transformation, as different spores from the same cross show much variation in 
their efficiencies for transformation. Spores B264/U1-B264/U10 were generated from 
the B264 cross and were used for transformation. These spores were transformed with a 
wild type library constructed from a SauIUa partial digest inserted into the BamHI site of 
shuttle vector Yep24 (Figure 4.3.1). Transformants were selected on TGly plates, which 
provide selection both for the wild type copy of the PET gene and for the ura* plasmid 
marker. Transformant colonies were picked onto WO after 3 days, and subsequently 
replicated onto EG as a check on retention of their respiratory competent phenotype. 
After growing up overnight on non-selective medium (YPD) cells were spread for single 
colonies on YPD. These plates were grown up overnight, and then replicated onto WO
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p Pstl 
E EcoRI 
NNCOI 
HHnom 
B BamHI
S o S p h l 
Sa S a il 
X X b a l 
Sc S e a l 
K K p n l
ACC ATQ ATT ACG AAT TCP AQC TCP GT A CCC POP  PAT CCT CTA GAP TCP ACC TQC AQQCAT GCA AGC TTQ
EcoRI S i l l  K p n l___________ BamHI Xbal ____________  P a il Son I  H.nOID
Xm a lS m a l S a il Ace I
HmeH
Figure 43.1  Plasmid vectors used in this study. The plasmids Yep 331 and Yep 332 were constructed by 
Hill et at, 1986. All three plasmids are shuttle vectors containing the E.coii gene specifying ampkil- 
lin resistance. Yep 24 and Yep 332 have the Scerevtsiae ura gene, and Yep 331 carries the leu
marker.
and EG to check for co-retention/co-deletion o f the markers PET/ura*.
The purpose of this analysis is to check that the PET  gene is present on the transforming 
plasmid as there are several other possibilities that would allow the transformed yeast to 
grow on the selective medium:
1. The complete plasmid containing ura* and PET  markers could be stably integrated 
into the chromosomal material of the cell by a recombination event, as its sequence 
has homology with yeast chromosomal DNA. Any progeny would be PET ura* as 
the integrated DNA could not be lost from the cell.
2. The yeast can spontaneously mutate to PET  by either reversion of the original 
mutation or by a suppressor mutation because of the selective pressure imposed. 
After being transformed by ura* coding plasmids the resulting transformant 
colonies would have a PETura* phenotype. Plasmids are spontaneously lost by 
cells and need to be maintained by exerting selective pressure. Thus all progeny 
would be PET but would be either ura* or uraT depending on whether they contain 
the ura* plasmid.
3. When transfoiming yeast there is a high probability of more than one type of 
plasmid entering one cell. This gives a heterogeneous population o f plasmids. 
Progeny from such a transformant having a ura*PET plasmid allowing it to grow on 
selective medium, and also a ura* plasmid could have any one of the following 
phenotypes: ura*PET, ura*pet or uraTpet.
4. The transformant has only the ura*PET plasmid so the markers are either both 
retained or both lost in any progeny ie. coretained or codeleted.
The ura*PET plasmid could be prepared from a type 4 colony, or from a type 3 colony 
after several rounds of selection for a ura*PET/ura~pet segregating colony.
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A number of transformant colonies were examined in this way and four which showed 
good co-retention/co-deletion of markers were selected; B264/U1#1B, B264/U1#2A, 
B264/U4#l A and B264/U4#2B. The nomenclature used for these strains refers firstly to 
the spore used in that transformation (e.g. B264/U1), then to the number of the 
independent transformation (i.e. 1 or 2 as two independent transformations were 
performed on each spore), and finally to a letter which was sequentially assigned to each 
transformant taken from a particular plate. Plasmid DNA prepared from these four 
colonies by the method outlined in section 4.2.1 was used to independently transform 
E.coli RRI. DNA from mini-preps of these E.coli transformants was analysed by 
restriction enzyme digestion with EcoRI. In three of the transformants non-identical but 
overlapping plasmid inserts were present (Figure 4.3.2), each o f these having an identical 
0.8 Kbase piece excised from within the insert, and several non-identical fragments. This 
provides evidence that the correct insert had been isolated, and suggests that the coding 
region is adjacent to or within the 0.8 Kbase EcoRI fragment.
Subcloning of the PETS1 gene
The plasmid from B264/U4#2B was selected for further analysis as it was incorrectly 
thought to have the smallest insert (in fact it had an EcoRI doublet), and was mapped by 
restriction enzyme digestion (Figure 4.3.3). Using this map restriction sites were chosen 
to sub-clone smaller fragments of the insert into the shuttle vector Yep 352 which also 
uses the ura* gene as a selectable marker for the plasmid. Back-transforming plasmid 
constructs into the spore B264/U4 allowed determination of the region of DNA in which 
the gene lay.
Firstly pieces ST1 and ST2 were produced by digestion with Sst/Sph and Xba/Sst 
respectively and inserted into the plasmid Yep 352 to give the plasmid constructs 
pG57/STl and pG57/ST2 respectively. Together with the parent plasmid pG57/Tl these 
constructs were used to transform B264/U4. The transformant colonies were picked onto 
YPD plates after 3-4 days. After growing at 30^C for 1-2 days colonies were replicated
90

Xbal S Sst I
E EcoR I 
B  Bgin
H Hind m  
Xh X h o l
X E
-H -
B  E B S E
H ------ 1— H - f - H— I------------1
I— ! r — I 
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Figure 43 .3  Restriction map of the plasmid insert B264/U4#2B, together with fragments used for back 
transformation. Fragments ST, to ST« were excised from the parent plasmid pG57fTl and inserted 
into the plasmid vector Yep 352. These constructs were used to back-transform into B264/U4. Frag­
ments which transformed this strain to respiratory competence are marked (♦). those which failed to
do so (-).
onto YPG to determine whether the plasmid insert had transformed them to respiratory 
competence. On comparison, colonies from certain transformations grow at a faster rate, 
and these are usually found to be respiratory competent when replicated onto YPG, and 
thus contain a functional copy of the gene o f interest
In this transformation pG57/STl and pG57/Tl gave rise to respiratory competent yeast 
transformants. The plasmid pG57/STl was further digested with EcoRI to remove a 
0.2Kbase piece, and self-ligated (pG57/ST3). This procedure was repeated digesting 
pG57/STl with HinDin to remove a 1.2Kbase piece (pG57/ST4). Transformants 
produced from both of these plasmids grew up when replicated onto YPG, thus locating 
the gene between the EcoRI and HinDin sites as this is common to both plasmids. To 
verify this location a construct was made by digesting pG57/ST4 with EcoRI, self- 
ligating and transforming B264/U4 (pG57/ST6). As expected, respiratory competent 
colonies were produced. Thus the smallest fragment transforming B264/U4 to 
respiratory competence was a 1.2Kbase EcoRI HinDIII piece (Figure 4.3.3).
Sequencing Strategy
This fragment was completely sequenced by the Maxam and Gilbert chemical method. 
Firstly digestions were made with a number o f enzymes recognising sites 4 bases in 
length. The enzymes HinF and TaqI were chosen for this sequence as they gave well 
separated fragments of a reasonable size (preferably 100-600 bases). By sequencing 
DNA from these digestions the complete order of bases could be derived from overlaps. 
A further double digestion was needed with TaqI and BstN to derive the sequence o f the 
largest fragment. An open reading frame was found which extended farther than the 
EcoRI terminal site. The gene was being transcribed from an in frame start codon in the 
vector (Figure 4.3.4). The 5' end sequence of the open reading frame was determined by 
taking an SstI HinDIII fragment (ST4) 1.4 Kbases long and sequencing strands from a 
HinF digest, which gave the sequence of the complete reading frame. It was discovered 
that the 12 N-terminal codons had been deleted. The complete open reading frame was
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approximately lKbase long coding for a protein with 325 amino acids with a predicted 
molecular weight of 36 Kdal. The sequencing strategy is shown in Figure 4.3.5, and the 
complete sequence and its translation in Figure 4.3.6.
r * .
r f .
ATG AAC ATG ATT ACG AAT TCC ATA 
Vector Sequence
ATG CTG  CAA  TCA TTA AG G AAG G G A  TGC TTC  ATT GTG AAT TCC ATA
PG57/ST4
PG57/T1
Figure 43 .4  The gene for pel57 is transcribed from an in frame start codon in the vector Yep 352 in 
construct pG57/ST4.
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Figure 4.33  The experimental strategy used to determine the complete sequence of the PETjj gene. DNA 
was cut into fragments 100-600 bp in length using the restriction enzymes indicated, and the 5' phos­
phate of each strand labelled with 12P. Strands were separated by polyacrylamide gel electro­
phoresis. and preparatively isolated. The Mazam and Gilbert chemical method was used to deter­
mine the sequence of each strand. The complete DNA sequence was derived from overlapping 
sequences produced by cutting the DNA with different restriction enzymes.
1  TC A T C T  GAG A AA T T T  C T T  CAC TG T TA C T T T  T T A A T T GCT A TA T C T  T T A  AAC TC A T T C  A T T
1 0 2 0 30 40 50 60
1  T T C T T C  AGA GAA AAG A AA  AAA A T T AAG G TA  AAG GAA AAG GCT A AA  TA A  GAA CAA AAC ACT
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0
M a t L a u P r o  S a r  L a u A r g L y a  G ly
1  TGA AGG CAA ACG AAA CCC TA C  AAA AGA GAA TAC GGA ATG CTG CCA TC A  T T A AGG AAG GGA
1 3 0 1 4 0 IS O 1 6 0 1 7 0 1 8 0
1  C y a P h a  I l a  V a l A a n  S a r  l i a  A r g L a u L y a  L a u P r o  A r g  P h a T y r  S a r  L a u A a n A la  G in
1  TGC T T C  A T T  GTG A A T TCC A T A  AGA TT G A AA  CTG CCC CGA T T C TA C  TC A  T T A A A T GCC CAG
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0
1  P r o L a u  G l y  T h r A a p  A a n  T h r  l i a G lu A a n  A a n T h r P r o  T h r G lu  T h r  A a n A r g L a u  A sn
1  CCA CTG GGG ACA GAC AAC ACG A T T GAG A A T  AAC ACT CCT ACG GAA ACA A AT AGA T T G  AAC
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0
I  L y a T h r  S a r  G in L y a  P h a  T r p  G lu L y a V a l  S a r S a r A a n  A r g A a p  V a l  G lu L y a G l y  L y a
I  A  AA A C T TC A  CAG AAG T T T  TGG GAA AAG GTG TCA TCA A A T AGG GAT G T T  GAG AAA GGA AAG
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0
1  1 1 « A la  L a u  G in L a u  A a p  G l y  A r g  T h r I l a  L y a T h r P r o  L a u G l y  A a n  G ly I l a I l a  V a l
I  A T T GCT CTA  CAA T T A  GAT GGC AGG A C T A T A  AAA ACT C C T CTA GGA A A T  GGA A T T A TA  GTT
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0
1 A a p A a n  A la  L y a S a r  L a u  L a u  A la  T y r L a u  L a u L y a L a u  G lu  T r p  S a r  S a r L a u S a r  S a r
1 G A T A AT GCA AAG T C T  CTC T T A  GCA TA C C T A  TT A AAA CTG GAG TGG TCG TCC CTA TCC AGT
4 3 0 4 4 0 4 5 0 4 6 0 4 7 0 4 8 0
L a u S a r  l i a  L y a T h r  H la  S a r  L a u P r o L a u  T h r S a r L a u  V a l A l a  A r g  C y a l i a  A s p  L a u
1 C T T TCC A TC  AAA A C T CAC T C T  TT G CCA C TA  ACT TCA T T A  GTG GCA AGA TGC A TA GAT T T A
4 9 0 5 0 0 5 1 0 5 2 0 5 3 0 5 4 0
I  G in M a t T h r  A a n G lu  P r o  G l y  C y a A a p  P r o  G in L a u V a l  A la L y a  I l a  G ly  G l y A a n  S a r
1 CAA A TG  ACA A AT GAG CCT GGC TG T GAC C C T CAA T T A G T T  GCA AAG A T T  GGA GGC AAC AGT
5 5 0 5 6 0 5 7 0 5 8 0 5 9 0 6 0 0
1 A a p V a l  l i a  L y a A a n  G in  L a u  L a u A r g T y r  L a u A a p  T h r  A a p T h r  L a u  L a u V a l P h a  S a r
G A T G TT A T A  AAA A A T CAG T T G  T T A AGA T A T  T T A GAT ACC GAT A C T T T A  TT G GTC T T T  TCC
6 1 0 6 2 0 « 3 0 6 4 0 6 5 0 6 6 0
I P r o M a t A a n  G lu P h a  G lu  G l y  A r g L a u A r g  A a n A la G in  A a n G lu  L a u  T y r I l a P r o  I l a
CCT ATG A A T GAG T T T  GAA GGA AGA TT A CGC A AT GCG CAA A A T GAG T T A  T A T A TA CCC ATC
« 7 0 6 8 0 6 9 0 7 0 0 7 1 0 7 2 0
l i a L y a  G l y  M a t G lu  G lu  P h a  L a u A r g A a n  P h a S a r S a r  G lu S a r  A a n  I l a A r g L a u  G in
A TC AAA GGA A TG GAA GAG T T T  T T A CGC AAC T T T TCA TCC GAG T C T  A A T  A T T CGA CTA  CAA
7 3 0 7 4 0 7 5 0 7 6 0 7 7 0 7 8 0
Z i a L a u  A a p  A la A a p  I l a  H la  G ly L a u A r g  G l y  A an G in  G in S a r  A a p  I l a V a l L y a  A a n
A T T T T A  GAT GCC GAC A TC  C A T GGG T T A CGA GGC KAT CAG CAG TCG G A T ATC G TT AAG AAT
7 9 0 8 0 0 •  10 8 2 0 •  30 •  40
A la A la  L y a  L y a  T y r  M a t S a r  S a r L a u S a r  P r o T r p  A a p  L a u A l a  I l a  L a u G lu L y a  T h r
GCA GCA AAA AAA T A T  ATG AGC AGC T T A TC A  CCA TGG GAT C T T GCA A T T  C T T GAA AAA ACT
•  50 8 6 0 8 7 0 8 8 0 8 9 0 9 0 0
9 6
V a l  L e u  T h r  T h r  L y a  S a r  P h a  I I *  C y a  G ly
S T A  T T A  ACC ACA AAG TCC T T C  A T T  TGC GGC
9 1 0  9 2 0  9 3 0
A l a  A a n  L a u  I l a  P r o  A la  L a u  L y a  T h r  A a p
GCG AAC T T A  A T T  CCC GCC T T G  A AA  A C T GAT
9 7 0  9 9 0  9 9 0
G i u  T h r  I l a  P h a  G in  V a l  G iu  L y a  T r p  G l y
G A A  A C A  A TC  T T C  CAA G T T  GAA AAG TGG GGA
1 0 3 0  1 0 4 0  1 0 5 0
A r g  A a p  I l a  A r g  A r g  L y a  I l a  M ia  T h r  A la
A G A  GAC A TC  AGA AGA AAA A T T  C A T A C T GOT
1 0 9 0  1 1 0 0  1 1 1 0
V a l  L a u  L a u  L a u  G i u  A a n  L y a  L y a  A a p  T h r
GTG C T A  T T A  T T A  GAA A A T  AAA A A A  G A T A C T
9 4 0  9 5 0  9 6 0
M a t A a p  A a n  I l a  V a l  A r g  A la  A l a  T h r  L a u
A TG  G A T A A T  A T T  G TA  CGT GCC GCC ACC T T A
1000 1010 1020
G iù  V a l  G iu  A a p  T h r  H la  A a p  V a l  A a p  L y a
GAG G TT  GAA G A T A C T  C A T GAC G T T  GAC AAA
1 0 6 0  1 0 7 0  1 0 8 0
A l a  I l a  A l a  A l a  P h a  L y a  G i n ---------------- ---------
GCG A T T  GCT G CT T T T  AAG CAA T A A  T A T  GGT 
1 1 2 0  1 1 3 0  1 1 4 0
C T T  T T C  CCC T A T  GAA TG A  G T T  TG A  AGG AAG  A T T  ACG CAA TGC OCA A AA  TGA G T T  A T A  T A T  
1 5 1 0  1 5 2 0  1 5 3 0  1 5 4 0  IS S O  1 5 4 0
Figure 4 J .4  The complete sequence of fragment ST4, with the protein translation of the 
open reading frame.
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Computer analysis of the PETyj sequence
The Staden DNA and protein sequence analysis programs (ANALYSEQ and ANALYSEP 
respectively), available on the University of Warwick UNIX system ‘Daisy’, were used 
for manipulation of the DNA sequence. When direct comparison with predetermined 
sequences was required these were transferred from the EMBL DNA database stored on 
the IBM system ‘Sky’. An extensive search was made with the protein translation of 
PET„ on the system at Edinburgh University with the assistance of Dr M. Collins, the 
database probed being the most complete available at the time. This search looks for 
regions of amino acid homology within the sequences compared, so is preferable to the 
type of search which determines the overall degree of homology of two sequences as it 
also finds regions o f good homology in sequences which are dissimilar overall. The local 
searches did not show homology with any known ATPase subunit, and the more 
extensive search did not show any other significant homologies. The computer analysis 
is shown in detail in Appendix II.
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Phe TTT 6 Ser TCT 3 Cys TAT 3 Cys TGT 1
Phe TTC 4 Ser TCC 7 Cys TAC 2 Cys TGC 3
Leu TTA 22 Ser TCA 8 * TAA 1 * TGA 0
Leu TTG 6 Ser TCG 2 • TAG 0 Tip TGG 4
Leu CTT 3 Pro CCT 5 His CAT 3 Arg CGT 1
Leu CTC 1 Pro CCC 3 His CAC 1 Arg CGC 2
Leu CTA 7 Pro CCA 4 Gin CAA 7 Arg CGA 3
Leu CTG 4 Pro CCG 0 Gin CAG 5 Arg CGG 0
lie ATT 13 Thr ACT 12 Asn AAT 17 Ser GGT 0
lie ATC 7 Thr ACC 3 Asn AAC 6 Ser AGC 2
He ATA 6 Thr ACA 5 Ly> AAA 16 Arg AGA 8
Met ATG 6 Thr ACG 2 Ly. AAG 10 Arg AGG 3
Val GTT 8 Ala GCT 4 Asp GAT 14 Gly GGT 0
Val GTC 1 Ala GCC 5 Asp GAC 6 Gly GGC 5
Val GTA 2 Ala GCA 7 Glu GAA 9 Gly GGA 8
Val GTG 4 Ala GCG 3 Glu GAG 9 Gly GGG 2
Table 4 J J  Codon usage in the PET37 open reading frame 
The open reading frame has a possible signal sequence, having 5 basic residues and 4 
hydroxyl groups. Thus the N-terminus has a net positive charge, which is a common 
feature of leader sequences directing proteins to the mitochondrial inner membrane or 
matrix. This is discussed further in Appendix n. Codon usage of the PET57 protein 
translation is shown in Table 4.3.3.
Construction o f  a disrupted PETS1 Reading Frame
To determine whether this reading frame coded for the PET phenotype a disruption of the 
reading frame was constructed. This involves deleting a fragment of the gene of interest 
and inserting a piece of DNA containing a known marker gene into the reading frame 
thus inactivating the gene. The only usable restriction sites within the reading frame 
were 2 Ncol sites cutting out a fragment 73 bases in length. Because Yep 352 has 1 Ncol 
site the fragment ST4 was transferred to plasmid Yep 351, which is not cut by Ncol. 
This construct was digested with Ncol to remove the small fragment, treated with
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Klenow to make blunt ended, and then with CIP to prevent self-ligation.
The yeast /ujIII gene was cut out o f the plasmid Pucl8 by digesting with BamHI, treating 
with Klenow, and then redigesting with Smal to excise a 2.4 Kbase fragment containing 
the complete sequence for the hisIII. This gives a blunt ended piece because the 
overhang left by BamHI is filled in with Klenow and digestion with Smal leaves a blunt 
end. The Air III fragment was blunt-end ligated into Yep 351/ST4 and transformed into 
E.coli RR1. Colonies with the correct construct were identified by colony hybridisation 
using a AifIII probe because blunt end ligation has a very low efficiency. A control 
ligation was also carried out with vector but no insert to determine the amount of vector 
self-ligation. Colonies showing positive in the hybridisation were checked by restriction 
enzyme digestion of mini-preps, and one with the hislll insen was selected. A restriction 
map of the construct is shown in Figure 4.3.7.
DNA prepared from this positive clone was used to produce an integrating vector, in 
which the /drill insert is flanked by sequences of the disrupted G57 reading frame. The 
Yep 351/ST4//urin construct was digested with Seal and Hpal to produce a linear piece 
containing the disrupted gene. This was used to transform yeast strains aW303, oW303 
and a/oW303. Transformant colonies were selected on T plus ura/ade/thr amino acid 
additions and colonies produced were picked onto YPD. This plate was replicated onto 
EG to determine whether transformants had acquired a respiratory deficient phenotype. 
Over 50% of the transformant colonies did not grow on glycerol medium. On mating 
these colonies separately to p° tester strains C B llp0 and KL14p°, diploids produced 
grew on glycerol-containing medium showing that respiratory deficiency in these strains 
was not due to p- formation (Rayco and Goursot, 1985). The ATPase activity of 
mitochondria prepared from these deleted strains is shown in Table 4.3.4 together with 
the ATPase activity of strain B264/U4 transformed to respiratory competence with 
plasmids pG57Al and pG57/ST6. Chromosomal DNA was prepared from respiratory 
deficient colonies (judged from their inability to grow on glycerol), from transformed
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strains aW303 and aW303 called aW303VG57 and «W303VG57 respectively.
Strain S.A. -  Rutamycin S.A. + Rutamycin
aW303 5.24 0.96
aW303G57 0.255 0.221
OW303G57 0.211 0.190
B264/U4 0.310 0.255
B264/U4/pG57/Tl 5.14 0.68
B264/U4/pG57/ST6 4.97 0.91
Table 0 4  Specific activity (in |XMmg- I m in - I > of mitochondrial ATPase from strains 
transformed to respiratory competence and respiratory deficiency. Strain B264/U4 was 
transformed to respiratory competence by the plasmids pG57/Tl and pG37/S76. Strain 
W303 (both a and a  mating types) was transformed to respiratory deficiency by the 
integration of P E T 37 disrupted with his III. Methods for preparation o f mitochondria by the 
zymolase procedure and for assay of ATPase activity are described in detail in Chapter 3.
T his DNA was digested with restriction enzymes EcoRI, HinDIII and SstI, and this gel 
blotted onto nitrocellulose. Nick translation labelled ST4 was used as a probe. If 
aW303VG57 and aW303VG57 have been transformed to respiratory deficiency because 
the disrupted gene has integrated into their chromosomal DNA thus destroying the wild- 
type gene, the restriction map of the region will have altered. Fragments produced by 
enzymes which do not cut his III will be shifted to a higher molecular weight because of 
the disruption, for example EcoRI and Sstl. Enzymes which cut within his III will also 
produce fragments of anomalous molecular weight, for example HinDIII. By examining 
the restriction maps of wild-type and disrupted genes, we can determine whether 
transformation to respiratory deficiency is due to incorporation of the disrupted gene. 
The autoradiograph produced from the Southern blot of wild type and disrupted DNA is 
shown in Figure 4.3.8, together with the expected restriction map with and without the 
gene disruption. From this it can be seen that the bands from the restriction digests in 
both aW303VG57 and aW303VG57 are identical, and that this is consistent with the 
restriction map proposed for the disrupted gene.
102

4.4. DISCUSSION
The gene causing respiratory deficiency in the pet mutant B264 has been cloned by 
complementation with a wild-type library, and its DNA sequence determined. Analysis 
of the sequence revealed an open reading frame 1 Kbase in length. A disrupted copy of 
this reading frame provided evidence that it encoded the gene responsible for the 
respiratory deficient phenotype as wild-type cells could be made respiratory deficient by 
replacing the wild type copy o f  this reading frame with a copy disrupted by insertion of 
the hislll gene. The predicted protein sequence coded for by this gene is a 36 Kdal 
species which has no homology with the protein sequence of any of the subunits of the 
mitochondrial ATPase previously sequenced in other species, and is not thought to be a 
subunit of the enzyme.
The N-terminus of this protein has a net positive charge and also a number of hydroxyl 
groups, but no acidic amino acid side chains. Analysis of the N-terminal region of 
nuclear-coded mitochondrial proteins targeted to the inner membrane or matrix has 
shown that most mitochondrial targeting sequences are significantly enriched in the 
amino acids Arg, Leu and Ser (but not Lys), but have few Asp, Glu, Val and He residues 
(von Heijne, 1986). This amino acid bias is evident in the N-terminal region of the 
PETy/ predicted protein sequence so it could be a protein destined for the inner 
membrane of the mitochondrion, or the mitochondrial matrix. A hydrophobicity plot of 
the protein shows that it does not contain the high percentage of hydrophobic sequences 
common to the mitochondrially-coded F0 polypeptides so the protein is not an integral 
membrane protein.
However the 12 N-terminal residues of the protein do not affect its function as they can 
be completely deleted. The attenuated protein produced can still compensate for the 
respiratory defficiency in mutant strains, thus is transcribed, translated and transponed to 
its correct site in fully functional form.
104
CHAPTER 5
IMMUNOLOGICAL CHARACTERISATION OF 
COMPLEMENTATION GROUP G57
5.1. INTRODUCTION
This chapter describes some phenotypic characteristics of the mutant group G57 which 
were obtained by a combination of biochemical and immunological analysis. The 
immune replica technique (Cabral et al, 1978, Todd et al, 1979) was used, which 
involves antisera recognising antigenic determinants already resolved by polyacrylamide 
gel electrophoresis, without the need for immune precipitation. The major subunits of 
ATPase F, are dissociated and separated by electrophoresis, and detected by their 
reaction with anti-F, antibody (which is labelled by binding 125I-Protein A to the Fc 
portion of the antibody). This immunological technique can be used to detect a specific 
protein, or group of associated proteins, in a complex mixture of protein, for example F, 
subunits in a mitochondrial preparation.
5.2. MATERIALS AND METHODS
Zymolase 20000 was purchased from Miles.
Preparation of S.cerevisiae Mitochondria 
All procedures were at 0-4°C unless stated.
Enzymatic Method
A 1% (vol/vol) inocculum into 500ml of YPGal was grown up overnight at 30°C (usually 
16-17 hrs). Cells were harvested in an International centrifuge at 2K rpm for 7 mins, and 
washed with 100ml 1.2M sorbitol. The pellet was weighed and suspended in 3ml
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zymolase mix per gram wet weight of cells.
Zymolase mix 
30ml of 2M sorbitol 
3.75ml of 1M KP04 pH 7.5 
O.ltnl of 0.5M EDTA 
0.5ml of P-mercaptoethanol 
25mg zymolase 20000 
H20  to 50ml
After incubating at 37°C for one hour spheroplast formation was monitored under the 
microscope, and the zymolase digestion continued if incomplete.
If spheroplast formation was satisfactory, 1.2M sorbitol (150ml) was added and the 
spheroplasts spun down in a Sorvall GSA rotor at 5K rpm for 10 mins. After washing 
with an additional 150ml 1.2M sorbitol, spheroplasts were re-suspended in 40ml 0.5M 
sorbitol, 20mM Tris/Cl pH 7.5,0.1 mM EDTA (isolation buffer) and blended in a Waring 
blender for 30 secs. The suspension was spun at 2K rpm for 10 mins and the supernatant 
taken and re-centrifuged. The supernatant was collected and centrifuged at 15K rpm for 
15 mins in a Sorvall SS34 rotor. The mitochondrial pellet thus produced was washed 
three times with 30ml of isolation buffer, re-suspended in a minimal volume of isolation 
buffer or TE, and stored at -70°C.
Mechanical Method
Cells were harvested as before, washed and re-suspended in MTE buffer so that each 
30ml of cell suspension contained 5 grams wet weight o f cells. An equal volume (30ml 
each) of cells and glass beads were poured into a shaker bottle, which was shaken for one 
minute in a Bronwill shaker. The broken cells were decanted and the cell debris pelleted 
twice at 2.5K rpm for 10 mins in a Sorvall GSA rotor. Mitochondria were isolated by 
centrifuging the supernatant at 15K rpm for 15 mins in a Sorvall SS34 rotor, washed 
three times with MTE buffer and re-suspended in MTE or TE buffer.
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Preparation of Submitochondrial Particles (smps)
Mitochondria were sonicated for a single 5 sec burst in a Braunsonic 1510 sonicator at 
full power. The suspension was centrifuged in a Beckman 50Ti rotor at 40K rpm for 20 
mins at 4°C. The smps appeared as a translucent pellet, and were re-suspended in TE 
buffer. The supernatant from this spin was saved and is referred to as sonic supernatant.
Preparation of S.cerevisiae Fi
By Sonication (Tzagoloff, 1969)
Submitochondrial panicles were subjected to sonication. up to 3 mins in 30 sec bursts at 
room temperature, with one minute intervals at room temperature to prevent overheating. 
The suspension was centrifuged in a Beckman 50Ti rotor at 40K rpm for 20 mins at 
25°C. The supernatant from this spin contained F( in wild type strains
By Extraction with Chloroform (Beechey et al, 1975)
Submitochondrial particles were suspended in 250mM sucrose, lOmM T ris/S04 pH 7.6, 
ImM EDTA. 1 vol of AR chloroform was added and the tube was vortexed for 30 secs, 
centrifuged in a microfuge for one minute and the aqueous layer removed to a fresh 
Eppendorf. This was centrifuged for a further 10 mins in a microfuge and the 
supernatant taken as the F, fraction.
Preparation of the F(Ft  Complex (TzagolofT and Meagher, 1971)
Submitochondrial particles were suspended in 250mM sucrose, lOmM Tris/Ac pH 7.5 at 
25m gm TI. 4mM Tris/Ac pH 7.5 (2.9 vols) and O.lvol 10%(w/v) solution of Triton 
X-100 (to 0.25% final) was added to 1 vol of smp suspension, and ATP was added to a 
concentration of 2mM and EDTA to ImM. The suspension was centrifuged at 40K rpm 
in a Beckman 50Ti rotor for 30 mins at 4°C. The supernatant was collected and 0.4ml 
layered on a 5ml linear gradient of sucrose (7-20% w/v) containing 5mM Tris/Ac pH 7.5,
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0.1% Triton X-100, 2mM ATP, ImM EDTA and centrifuged at 60K rpm in a Beckman 
65Ti rotor for three hrs at 4°C. Fractions were collected by puncturing the bottom of the 
tube.
Protein Estimation
Protein concentrations were determined by the method of Lowiy (1951).
Determination of ATPase Activity
ATPase activity was assayed in a 1ml reaction containing 50mM Tris/S04 pH 8.0, 4mM 
MgS04, O.lmg mitochondrial protein and lOmM ATP. The reaction was timed after 
addition of ATP and stopped with 0.2ml 50% TCA after 12 mins. Inorganic phosphate 
produced was determined by adding 0.2ml of assay solution to 5ml 0.5% TCA. 5% 
ammonium molybdate (0.5ml) and ANS reagent (0.15ml) were added, mixing well after 
each addition. After incubating for 10 mins at room temperature tubes were read 
spectroscopically at 660nm. The phosphate liberated was determined by comparison 
with a standard curve constructed under similar conditions.
Protein Analysis
Proteins were separated on 12% polyacrylamide gels by the method of Laemmli 
(Laemmli, 1970). Gels to be subjected to immunological analysis were 
electrophoretically transferred to nitrocellulose sheets in a vertical tank at 100V for one 
hour or 50V for four hrs. The lanes on which protein standards were run were cut away 
before transferring, and stained with bromophenol blue by standard methods. The gel to 
be transferred was notched at one comer for orientation, and plug gel removed with a 
sharp scalpel. The gel and nitrocellulose were sandwiched between 2 sheets of Whatman 
#3 and 4 Scotch-britc pads ensuring that no air bubbles were trapped between gel and 
nitrocellulose. This was placed in a plastic holder which was slotted into a tank 
containing western transfer buffer. Care was taken to ensure the nitrocellulose was
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positive of the gel when a voltage was applied.
Transfer Buffer
192mM glycine 
25mM Tris/Cl 
20% MeOH
Rinse Buffer Rinse Buffer + NaCl
lOmM T ris /a  pH 8.0 
ImM EDTA 
150mM NaCl 
0.1% Triton X -100
lOmM T ris/a pH 8.0 
ImM EDTA 
1M NaQ
0.1% Triton X-100
The nitrocellulose was sealed in a seal-and-save bag and vibrated for 45 mins in 10-15ml 
of rinse buffer plus 1% whole milk powder. Antibody was added at a 100-400 dilution 
depending on its strength, injected into the bag together with 0.5ml of rinse buffer plus 
milk. After incubation at room temperature for a minimum o f one hour with agitation, 
the nitrocellulose was removed and rinsed three times for 15 mins in 250ml of rinse 
buffer. After re-bagging with 10-15ml o f  RB and milk, 10-15^11 of 125I-labelled protein 
A in 0.5ml of RB and milk was added, and the sealed bag incubated at room temperature 
for a minimum of one hour with agitation. The nitrocellulose was removed and washed 
three times with 250ml RB plus 1M NaCl, blotted dry, and exposed overnight at -70°C.
Total RNA preparation from S.cerevisiae
All solutions used were made RNase free by autoclaving and gloves were worn 
throughout. A 50ml overnight culture o f the yeast strain in YPD was centrifuged at 5K 
rpm for 10 mins in a Sorvall GSA rotor and the pellet re-suspended in 5ml LETS 
solution.
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LETS PCI
lOOmMLiCl 
lOmM EDTA 
lOmM Tris/CI pH 7.4 
1% SDS
250ml CHC13 
250ml H20  sat. phenol 
10ml isoamyl alcohol
To this Vi vol of glass beads was added, followed by 1 vol of PCI. After vortexing for 
one minute, tubes were centrifuged at 5K rpm for 5 mins (Sorvall SS34 rotor), the 
aqueous layer removed and the PCI extraction repeated until there was no interface 
between the two layers. The aqueous fraction was then extracted once with CHCI3, LiCl 
added to a final concentration of 0.2M, and finally 2 vols ethanol were added. After 
leaving at -20°C for 4 hrs the RNA was centrifuged out at 10K rpm for 10 mins, ethanol 
washed and then dried under vacuum. RNA was dissolved in 300p.l H20  and the debris 
removed by centrifugation. The RNA was stored at -70°C.
Northern Blotting
All steps prior to transfer were RNase free. An RNase free 1% agarose gel (TBE buffer) 
was prepared using autoclaved agarose and gel plates. RNA samples were loaded and 
the gel run. stained and photographed as for a DNA gel. After notching for orientation 
the gel was soaked twice for 20 mins in 200ml 200mM NaAc buffer pH 4.0.
Meanwhile NBM paper was treated for blotting by floating in 100ml of 20%(w/v) 
sodium dithionite at 65°C for 30 mins. After pouring off the dithionite the paper was 
washed thoroughly with dH20  (rinsed 10 times). The paper was rinsed in 100ml 30% 
acetic acid, then washed thoroughly with dH20 . 100ml o f cold 10% HC1 was used to 
float the paper, to which 3ml of a 3% solution of sodium nitrite was added. The paper 
was left to soak at a temperature between 0-4°C for a minimum of 30 mins.
Paper was then rinsed twice with dH20 , twice with 200mM NaAc, and put immediately 
onto the gel to transfer by the same method as that used in Southern blotting described in
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the previous chapter. The RNA was transferred overnight to NBM paper.
After tracing the outline of the gel in pencil the paper was sealed into a bag with 7ml of 
blocking buffer.
Blocking buffer Hybridisation buffer
50% formamide 30-50% formamide
5x SSC 5x SSC
5x Denharts solution 5x Denharts solution
50mM NaP04 pH 6.5 25mM NaP04 pH 6.5
l%(w/v) glycine 0. ItngmT1 cDNA (heat denatured)
0. lrngml-1 cDNA (heat denatured) probe (heat denatured)
After leaving at 45°C overnight the paper was removed, rinsed in 5x SSC and rebagged. 
Hybridisation mix was added at 1ml per lane on the gel, and the sealed bag was left at 
45°C overnight. The paper was pre-washed three times for 10 mins in 2x SSC, 0.1% 
SDS, washed twice for 15 mins in 0.5x SSC, 0.1% SDS and air dried for 10 mins. It was 
then exposed at -70°C.
If DBM paper was to be re-used it was washed for one hour at 45°C in 95% formamide, 
0.1% SDS, lOmM EDTA, 50mM tris/Cl pH 7.5. Then paper was washed at 45°C twice 
for 15 mins in 2x SSC, 0.1%SDS, and twice for 15 mins in 0.1% SSC, 0.1% SDS before 
rehybridising.
Fusion Protein preparation
Protein Production
The E.coli expression vectors pATH 3 and pATH 22 were used for the production of a 
chimeric protein. The 313 carboxy terminal residues of PETS1 was ligated into the two 
vectors so that it was in frame with the trp E gene. This construct was used to transform 
E.coli, and cells were selected on LB/Amp/Trp plates. The amino acid tryptophan was 
added to prevent the transformants from expressing the hybrid protein, as this would
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exert selective pressure to eliminate the hybrid gene. Cells were taken from an 
LB/Amp/Trp plate and used to inocculate 10 ml of M9+CA+W+Amp (omitting the Amp 
for the RR1 control).
lOx M9+CA
Na2HP04.H20 6g
k h 2p o 4 3g
NaCl 0.5g
NH4C1 lg
Casamino acids 5g
h 2o to 100ml
After growing to mid-log phase (2-4 hours) cultures were dumped into 21 flasks 
containing 100ml M9+CA+Amp (no Amp in RR1 control) and shaken well for l-2hrs. 
3P-indoleacrylic acid was added to 20pgml_1 (from a 2mgmTI stock in ethanol) and 
cells grown for a further 4hrs. The flasks were left at between 0-4°C overnight After 
pelleting the cells at 5Krpm for 10 mins and washing in 20mM Tris/Cl pH 7.5, they were 
re-suspended in cell lysis solution (20ml per 100ml culture).
Cell Lysis solution 
50mM tris/Cl pH 7.5 
5mM EDTA 
3mgml-1 lysozyme
After allowing to lyse on ice for one hour, 5M NaCl was added (1.4ml), and the 
suspension mixed. The detergent NP-40 (1.5ml of a 10% solution) was added, and the 
viscous suspension allowed to stand on ice for 30 mins. To shear the DNA the 
suspension was sonicated for 10 secs, taking care that lipids were not allowed to foam 
due to excessive sonication. The protein was then pelleted in a Sorvall SS34 rotor at 
lOKrpm for 10 mins, washed once in 20ml 1M NaCl, lOmM Tris/Cl pH 7.5, and once in 
lOmM Tris/Cl pH 7.5. The pellets were re-suspended in lOmM Tris/Cl pH 7.5 and 
checked for the presence of a high molecular weight protein species on an analytical 
Laemmli gel.
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Protein purification
Proteins produced in this way were purified by separation on a Bio-Gel A-0.5 column 
equilibrated in wash buffer. Firstly the column was washed through overnight with fresh 
wash buffer.
Wash Buffer 
lOmM Trii/C l pH 7.5 
0.1% SDS
5mM (3-mercaptoethanol
The fusion protein was pooled from all preparations which showed a large amount of a 
protein species at the estimated molecular weight of the fusion product. It was 
solubilised in 1% SDS, 5mM (3-mercaptoethanol with heating at 90°C for 1-2 mins. 
After allowing to cool, glycerol was added to 20%(v/v) and the sample loaded onto the 
column. Fractions were collected over a period of 18hrs, and their protein content 
estimated by reading at 280nm in quartz cuvettes against a buffer blank. Larger proteins 
elute from the column first, and as the fusion product is generally the largest protein 
present the first samples in which protein was detected were run on an analytical gel. 
Samples with high proportions of the fusion protein were pooled. To this l/20th volume 
of 5M NaCl was added, followed by four volumes of ice-cold acetone to precipitate the 
protein. The suspension was either allowed to stand on ice for one hour, or left overnight 
at -20°C. The protein precipitate was centrifuged out at 8Krpm for 10 mins in a Sorvall 
SS34 rotor, washed with H20 , and redissolved in a minimum volume of 1% SDS. This 
solution was checked on an analytical gel and its protein concentration determined.
Raising Antibodies
Antibodies were raised in rabbits, using two rabbits for the trpEIPETi7 antigen. A test 
bleed was taken before injection of the antigen to give a zero time control. The initial 
injection was o f 1-1.5ml (2-3mg protein), mixed with Freund’s adjuvent. A second test 
bleed was taken 3 weeks later, immediately prior to a booster injection of 0.5- lml (1-
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2mg) o f antigen. Plasma from these bleeds was used as antibody in western blotting.
5.3. RESULTS AND DISCUSSION
As sequence analysis did not prove effective in identifying the source of the respiratory 
deficiency in the complementation group G57, a course of biochemical analysis in 
conjunction with immunological characterisation was embarked upon. Two different 
antibodies were used as probes. The first section describes western blots in which an 
anti-F, antibody was used. This antibody had been prepared by injecting a preparation of 
Fi into rabbits, and was kindly provided by Dr S. H. Ackerman. The second section 
describes in detail the raising of antibodies to a fusion protein made by ligadng the 
C-terminal end of the PETS1 reading frame into a bacterial expression vector and results 
derived from use of that antibody in western blotting.
Anti F , antibody
Mitochondria prepared from each independent isolate in the complementation group had 
already shown that most had less than 10% ATPase activity. To check that these mutants 
had all the major subunits of mitochondrial ATPase F,. 10pg of total mitochondrial 
protein was prepared from each strain by Zymolase digestion and was run on a Laemmli 
gel followed by western blotting onto nitrocellulose paper. This paper was probed with 
anti-F] antibody as described in section 5.2. From the autoradiograph shown in Figure
5.3.1 it can be seen that all of the mutants have the major subunits a ,  P and y, which are 
the same size as the wild type.
Strain B264, the parent strain of the spores used in the gene cloning, was examined in 
detail.
Firstly experiments were carried out to determine whether the mutants F, was bound to 
the inner mitochondrial membrane. In p~ mitochondria, which are lacking the
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mitochondrially-coded F0 subunits 6, 8 and 9, Fi subunits are still synthesised and 
imported into the mitochondrion. However, because of the F0 subunit deficiencies the 
assembled F, is not bound to the mitochondrial membrane. By determining whether the 
mutant F, was membrane-bound it is possible to examine whether any F,F„ interactions 
were affected by the mutation in group G57.
The method used to determine whether Fj is membrane-bound depends on the method 
used for preparation of the mitochondria. Preparation of mitochondria by breaking cells 
with glass beads will damage the mitochondrion such that the integrity of the 
mitochondrial membrane is lost, and its matrix contents released. Thus matrix enzymes 
will be lost into the supernatant when the mitochondria are pelleted. Preparation of 
mitochondria by the enzymatic method using zymolase leaves mitochondria intact, 
although the yield of mitochondria per gram wet weight of cells is smaller. Thus if the 
Fj subunits are imported into the mitochondrion but not bound to the membrane they will 
appear in the post-mitochondrial supernatant in glass bead prepared mitochondria. 
However in zymolase prepared mitochondria the Ft subunits will be present in the 
mitochondrial preparation and will only be released into the supernatant when the 
mitochondria are disrupted by short sonication and the submitochondrial particles thus 
produced spun down.
All mitochondria used for this experiment were produced by the enzymatic method. 
Sonication was carried out at 0-4°C for 5 sec and submitochondrial particles resuspended 
to their original volume in TE buffer. Equal volumes o f mitochondria, sub-mitochondrial 
particles and sonic supernatant were loaded onto a Laemmli gel (based on a volume 
containing 10 pg of mitochondrial protein), western blotted and probed with anti-F,. The 
results are shown in Figure 5.3.2a. The mutant’s F, appears in the submitochondrial 
particle fraction and thus is still associated with the membrane, as is the wild-type 
control.
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However a number of differences can be observed when comparing the equivalent 
mutant and wild-type lanes on the autoradiogram produced from this experiment, and 
these differences are consistent throughout all other preparations. In the sonic 
supernatant from the mutant strain a clear band is present at a molecular weight of 42 
Kdal, which is much less evident in the wild-type sonic supernatant. Additionally, other 
bands are missing in the mutant fractions. However, an equivalent band occurs in the 
lane in which a preparation of Fj is run. In addition a 33 Kdal species is released on 
sonication of the mutant strain, but not released from the wild-type D273/10B-A1. These 
bands are also evident in the sonic supernatant from disruption mitochondria (Figure 
5.3.2b).
Prolonged sonication will remove wild-type F, from the inner mitochondrial membrane, 
and free F, can be detected in the sonic supernatant. Fj is cold-labile and thus all steps 
were carried out at room temperature to preserve its activity. To determine whether 
mutant F, could be activated when removed from the membrane, mutant and wild-type 
zymolase mitochondrial preparations were sonicated for a total of 3 mins each with 
intervals to prevent overheating. The suspensions were seen to clarify and become more 
translucent during sonication. Pelleted submitochondrial particles were resuspended in 
the starting volume of TE buffer, and mitochondria, smp’s and sonic supernatant were 
assayed for ATPase activity (Table 5.3.1). When removed from the mitochondrial 
membrane F! is insensitive to oligomycin and rutamycin.
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Fraction S.A S.A.+ Rutamycin
D273/10B-A1 mitochondria 3.44 0.314
D273/10B-A1 smp 2.28 0.56
D273/10B-A1 3 min sonic pellet 0.772 0.456
D273/10B-A1 3 min sonic sup. 16.67 15.0
B264 mitochondria 0.738 0.676
B264 smp 0.173 0.224
B264 3 min sonic pellet 0.738 0.676
B264 3 min sonic sup. 1.778 1.50
Tabic 5.3.1 ATPasc activity of fractions from a prolonged sonication of mutant and wild 
type submitochondrial panicles. Submitochondrial particles prepared from a five second 
sonication o f  mitochondria as described in section 5.2 were subjected to a  further sonication 
for a total o f  three minutes at room temperature (with intervals for cooling). After centrifu­
gation a t 100000g for 30 minutes at 20°C  the supernatant and pellet produced were tested 
for ATPase activity, and for sensitivity of ATPase activity to Rutamycin. Specific activity is 
given in j lM m g -1m in -1 .
Thus active F, ATPase activity is present in the sonic supernatant from the wild-type, but 
no significant ATPase activity is seen with the mutant. The wild type F, is also more 
active when released from the mitochondrial membrane as it is freed from regulating 
factors, and this accounts for the high specific activity shown. Fractions were analysed 
immunologically to determine whether mutant F, was released from the membrane, 
volumes loaded based on that containing lOjig mitochondrial protein. Figure 5.3.3 
shows that no Fi subunits are detectable in the sonic supernatant from the mutant 
mitochondria.
Wild-type F, can be released specifically by extraction of the membranes with 
chloroform according to the method of Beechey et a l (1975). A small-scale preparation 
of F, from mutant and wild type was assayed for ATPase activity. In the wild-type the 
expected high specific ATPase activity was present, which was insensitive to oligomycin. 
The mutant Fj ATPase activity was not detectable, and mutant Ft was only detectable in 
low quantity compared to wild-type in a western blot (Figure 5.3.4).
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Fiiurr 3.J.4 F, U not 4
Fraction S.A. -  Oligomycin S.A. + Oligomycin
D273 mitochondria 3.46 0.61
B264 mitochondria 0.812 0.75
D273 chloroform extract 14.1 14.3
B264 chloroform extract 1.9 1.95
Tabic 5 J .2  Chloroform extraction of wild-type and mutant submitochondrial panicles by 
the method of Beechey (Bcechey el al, 1975). Submitochondrial panicles were extracted 
with AR chloroform at room temperature. After centrifugation the aqueous layer (chloro­
form extract) was tested for ATPase activity.
To attempt to assign the mutant to Ft or F0 a reconstitution experiment was performed, 
which involved treating submitochondrial particles with urea to degrade Fj. After 
washing, an F, preparation was added which would bind to wild-type F0 still present in 
the membranes. The ATPase activities of the reconstituted complex are shown in Table
5.3.3, together with ATPase activity of the submitochondrial particles before treatment 
with urea. The bound activity on the mutant membranes is significant, especially when 
compared to the unbound activity (i.e. the mutant membranes can bind F, such that it 
remains active). This activity is also sensitive to oligomycin and is comparable to that of 
the reconstituted complex using wild-type membranes. This provides evidence that the 
mutants o f group G57 have a defective F, moiety. The previous experiment showed that 
the mutant's F, is only detectable when associated with mitochondrial membrane 
fractions. Investigations were now made to find out whether the mutant’s F( is 
assembled into a complex with F0, and if so, whether this complex shows any gross 
differences to the wild type complex. The detergent Triton disrupts the mitochondrial 
membrane and will release the wild-type F,F0 complex in tac t The complex will be 
present in the supernatant fraction after spinning the Triton extraction at lOOKg for 
30 mins.
123
S.A.-Oligomycin S.A.+Oligomycin
D273 submitochondrial particles 9.17 3.33
B264 submitochondrial particles 1.1 0.76
D273 reconstituted complex 3.02 1.6
B264 reconstituted complex 2.57 1.48
Table 5-3.3 Reconstitution o f wild type and mutant membranes with wild type F , .  Submi- 
lochondrial particles were treated with urea and then washed thoroughly with buffer. Wild 
type F ] was added to the stripped membranes and incubated at room temperature for 30 
minutes before re-cooling to 4°C and washing to remove unbound F , .  ATPase activity of 
samples was estimated by the method outlined in section 5.2. Activity was not observed in 
any other samples, including the stripped membrane samples.
The Triton extract thus produced was loaded onto a continuous gradient of 7-20% 
sucrose to determine whether the mutant and wild type complex run to the same level in 
the gradient. A total of 30 fractions (0.2ml) were drawn off from the bottom of the 
gradient, fractions being labelled 1-30 in order of decreasing density. Alternate fractions 
were treated with 4x Laemmli loading buffer and 20pl loaded on a Laemmli gel. The 
two gradient cross sections are compared in Figure 5.3.5. The wild-type FiF0 ATPase 
peaks in fractions 16-20 whereas the mutant’s F, is not detectable in the Triton extract.
This experiment was repeated using the detergents Triton, deoxycholic acid and cholic 
acid, with varying concentrations of KC1 (to 1M). This should result in the release of all 
F, from the wild-type membrane. Supernatant from each of these reactions was 
compared with an equal volume of pelleted material resuspended to its original volume. 
As can be seen from Figure 5.3.6 the major subunits of F, in the mutant preparation are 
barely detectable in the pelleted material and undetectable in the supernatant in all 
detergent plus salt preparations. In the wild-type F, is clearly present in the supernatant 
from the detergent extracts.
This exposes the possibility that the mutant F] may be more susceptible to protease 
digestion than the wild-type when removed from the membrane. To investigate this a
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protease inhibitor PTFB was added at 20pgm T1 (1:100 dilution of stock solution in 
ethanol) to the mitochondrial preparation, and its concentration kept constant throughout 
preparation of submitochondrial particles and further Triton extraction. Figure 5.3.7 
shows that the majority of Fj is still in the pellet fraction in the mutant, with small but 
detectable amounts, especially of the a  subunit in the supernatant. In the wild-type 
control, F, has been released into the supernatant as expected.
Also there is consistently less F, detectable in mutant fractions of mitochondria per unit 
protein when compared with wild-type fractions. This could be due to gradual 
degradation of the enzyme on the membrane, if it is indeed more susceptible to protease 
digestion than wild type, but it could also be explained by differing rates o f transcription 
or instability of the mutant RNAs. Thus a northern blot was used to compare quantities 
of wild type and mutant Fj RNA. Firstly total RNA was prepared from mutant and wild 
type strains by the method outlined in section 5.2. This RNA was run on a normal 
agarose gel together with size standards (Figure 5.3.8) and two lanes of each sample 
blotted onto NBM paper.
Two different DNA probes were used, both cut from plasmid vectors provided by Dr
S. H. Ackerman. Sequences used were from the F, a  and (3 subunits as these are the only 
F] subunits that have yet been cloned (Saltzgaber-Muller et al, 1983). The complete a  
gene was used as probe (with short vector sequences at either end), and in addition an 
830 bp region of the gene for the (3 subunit was used in a second hybridisation. These 
fragments were labeled by nick translation and used in separate hybridisations, each 
being used to probe both mutant and wild-type RNA.
Unfortunately any signal produced with the a  DNA hybridisation was indistinguishable 
from the background signal resulting from hybridisation to rRNA, which is abundant in 
total RNA preparations. An attempt was made to wash off the probe, and to re-hybridise 
under more stringent conditions (i.e. a higher concentration of formamide) but with no
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greater success. However a clear band is distinguishable with the (3 DNA probe which, 
when read against the molecular weight markers run on the original gel, corresponds in 
size to |3 mRNA.
On comparing the quantities of (3 mRNA from wild-type and mutant no significant 
difference can be detected. The wild-type mRNA is slightly more abundant than the 
mutant mRNA but this difference can be explained when referring back to the UV 
photograph of the gel, because the mutant lane used in this hybridisation has been subject 
to a small amount of degradation. Differences between the mutant and wild-type at 
transcriptional level are not thought to be the cause of differences in the level of the F1 
subunits.
Preparation and use o f fusion protein antibody
To gain more information concerning the nature o f the protein for which the cloned gene 
codes, a fusion between this gene and trp E  was constructed using the bacterial 
expression vectors pATH 3 and pATH 22. The fragment ST6, encoding the 313 
carboxy-terminal residues of PET37, was inserted into these vectors in frame with the trp 
E gene (Figure 3.3.9a). The calculated molecular weight of the fusion product was 65K 
daltons. After making the initial construct, transformation into E.coli RR1 was 
conducted under conditions in which the fusion product would not be expressed. The 
gene is repressed by tryptophan, so this amino acid was added to media until the final 
growth stage. The fusion gene product was prepared as in section 3.2, and Figure 3.3.9b 
shows a comparison between pellet and supernatant in the clones expressing the fusion 
product, compared with the wild-type RR1 pellet
The pellets in the expressing clones show a high molecular weight species at 65K 
daltons, that expected for the fusion protein. This protein is over-expressed and. in 
addition, there are lower molecular weight species which are probably degradation 
products. The high molecular weight protein was purified by passing through a Bio-gel
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Figure 5.3.10 Protein profile of fusion product in Bio-gel eluate. The fragment ST4 was 
cloned into the EcoRI site o f bacterial expression vectors pATH 3 and 22 in frame with the 
irpE gene. The protein product from this construct was prepared from RR1 cells transformed 
with this plasmid. It was further purified by sepcration on a  Bio-Gel A-0.5 column, fractions 
were collected over an 18 hour period and their protein content estimated from optical 
density at 280 nm.
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column, the elution profile obtained is shown in Figure 5.3.10. Fractions 68 to 78 were 
pooled and precipitated as described in section 5.2.
Antibodies raised in rabbits to this fusion protein were used to identify the per57 gene 
product. Mitochondria from a transformant strain, a disrupted strain and wild-type were 
compared by western blotting and probing with this antibody at a 1:100 dilution in rinse 
buffer and milk. Varying concentrations of mitochondrial protein were loaded, up to 
lOOpg per lane. The major species present in the wild-type is of an apparent molecular 
weight of 34K daltons (Figure 5.3.11). This species is also present in the deleted strain 
and the transformant (in reduced amounts). This is not the translation product of the 
reading frame for the PET57 protein as it is detectable in the deleted strain.
A second protein can be seen in the wild-type at an apparent molecular weight of 32K 
daltons. This protein is not detectable in the disrupted strain, but is expressed in the 
transformant over 10 times more than in the wild-type as would be expected from a 
multicopy plasmid. This is thought to be the G57 translation product, and its molecular 
weight of 32K daltons is consistent with the gene having a cleavable leader sequence. 
This indicates that G57 expresses a protein which is imported into mitochondria. It is 
unlikely to be a structural protein as it is not present in significant quantity in 
mitochondrial fractions.
5.4. CONCLUSIONS
A mutant phenotype has been described, which shows a number of unusual features 
which differ from any previously analysed mutants. The selectable phenotype used to 
clone the gene was its respiratory deficiency, thus allowing selection of transformants on 
the non-fermentable substrate glycerol. This was found to be due to a mutant ATPase 
activity. Thus investigation focused on this enzyme, which was identified by its reaction 
with anti-F, antibody.
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Firstly the major subunits of Fr ATPase were present in all the members of the 
complementation group. No differences could be observed in size of these subunits in 
mitochondrial protein samples. If the mutation was located in one of the genes coding 
for an F( subunit, the pattern expected when analysing its complementation group in this 
way would show a number of group members which had premature stop signals causing 
an attenuated transcript. This would be either degraded, and hence not observed on 
blotting, or the shortened protein would be detectable at a lower molecular weight than 
its wild-type equivalent. This is not the case for complementation group G57 so we must 
conclude that the cloned gene does encode an F, subunit.
The subunits of F] were membrane associated in the mutant, but inactive with respect to 
their ATPase activity. This highlights the question as to whether the F, domain is itself 
inactive, or whether it is incorrectly coupled to the membrane, either due to some factor 
in F0 or because it is binding to something other than F0 (i.e. a different membrane 
component). Mutants of E.coli with proton permeable membranes and low ATPase 
activity have been investigated, where Ft shows abnormal binding characteristics. In 
contrast, this resulted in an F, which was easier to remove from the membrane, and when 
stripped from the membrane F, had normal ATPase activity (Maggio et al, 1988). This 
was found to result from a point mutation in the a  subunit.
When considering the lack of ATPase activity shown in the mutant strain, it is useful to 
know that when reconstituted from its constituent subunits only a ,  P and y  are needed to 
produce a functional ATP hydrolysing unit. These subunits are present in the 
mitochondrial fractions of the mutant strains. The other subunits 5 and e are needed for 
integration into the membrane to produce a functional enzyme capable of ATP synthetic 
activity.
The fact that F, subunits cannot be detected when attempts have been made to displace 
them from the membrane could be attributed to two differing phenomena
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1. The F, domain of the enzyme could be exhibiting abnormal membrane binding 
characteristics as discussed previously. This would explain why displacement from 
the membrane was not detectable after using a variety of methods which released 
the wild-type F! (or even the complete wild-type complex F,Fo). These include 
prolonged sonication, extraction with choloroform and extraction with a number of 
detergents which normally isolate the complex. Detergent extraction with KC1 was 
also attempted, which will remove all F1 from the wild type membrane.
2. The Fj subunits could be degraded as soon as they were removed from the 
membrane, which would explain why no a  and |3 subunits could be detected in 
either the pellet or supernatant in the detergent and salt extracts. This would also 
explain certain discrepancies when comparing the quantities of wild-type and 
mutant subunit in further preparations. The major protease mitochondrial and 
submitochondrial particle activity present in mitochondria is that of a serine 
protease. A protease inhibitor PTFB was used to investigate this possibility, in all 
steps from production of mitochondria through sonication and isolation of smps to 
the final extraction with triton and KC1. However, this experiment did not provide 
any evidence to support the theory of degradation, and any protection from protease 
digestion (not a significant amount) only affected the membrane bound subunits.
Thus neither of these possibilities provides a satisfactory explanation of the mutant Fj.
Although it appeared from examining all mutant strains that a  and (3 subunits were 
present in approximately equal quantities, when comparing later preparations of B264 
and D273/10B-A1 mitochondrial and submitochondrial particle preparations the mutant 
strain was found to have consistently less a  and (3 subunit. This was not found to be due 
to transcriptional factors, as analysed by preparation of total RNA from mutant and wild 
type and Northern blotting with a  and (3 probes. The quantities of RNA in the mutant 
and wild-type strains was almost identical, and any difference was not sufficient to
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explain the different subunit stoichiometries observed on western blotting.
The mutant FjFo complex could not be isolated by the usual method of detergent 
extraction, so no information could be derived about the size or gradient migration 
properties of the complex. However, the reconstitution experiment shows that the F0 of 
the mutant strain is capable of binding wild-type F, and integrating it into a functionally 
active complex. This experiment adds to the evidence that the Fj domain of the ATPase 
enzyme is mutant and causes the respiratory deficiency in B264.
The protein coded for by the gene that is mutated in B264 is not one of the structural 
units of ATPase F ,, as although it is a similar size to the y  subunit it had little homology 
with the sequence o f  the y  protein in other species. Therefore the mutation must be in a 
component which controls synthesis or assembly of F,.
Analysis of mitochondrial protein samples with fusion protein antibody shows that the 
protein coded for by PETS1 is present in mitochondria, but not in the quantities expected 
for a structural protein.
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CHAPTER 6
GENERAL CONCLUSIONS AND DISCUSSION 
6.1. Antibiotic Resistance
The nuclear-coded genes for the a  and (3 subunits o f F, (genes ATP 1 and ATP 2 
respectively) and the gene for ATPase subunit 4 (ATP 4) have been isolated in 
S.cerevisiae by other laboratories (Saltzgaber-Muller et al, 1983, Velours et al, 1988). 
The genes ATP 1 and ATP 2 were cloned by genetic complementation o f pet mutants 
specifically lacking the a  and (J subunits respectively with a wild-type plasmid library. 
The gene ATP 4 was isolated from a  S.cerevisiae genomic library by hybridisation with 
an oligonucleotide probe, constructed by back-translation of the amino-terminal 
sequence of the isolated protein. The genes for the a  and (3 subunits o f  mitochondrial 
ATPase in the fission yeast S.pombe were also cloned by genetic complementation of 
mutants lacking either the a  or P subunits (Boutry et al, 1984). Thus the method of 
choice for cloning nuclear subunits of mitochondrial ATPase is not by expression of 
antibiotic resistance, even though antibiotics binding the F, moiety of the enzyme are 
available (for example aurovertin).
In this study the majority of mutants isolated showed cross-resistance to other antibiotics 
affecting mitochondrial function (Groups I and II), including the antibiotics 
chloramphenicol and erythromycin. This indicates that the site of resistance is not 
located on ATPase F0 as chloramphenicol and erythromycin inhibit mitochondrial 
protein synthesis, but suggests resistance at the mitochondrial membrane or plasma 
membrane level resulting in lowered permeability to a variety of antibiotics. This type of 
cross-resistance is a feature of nuclear-coded mutants isolated in previous studies (Avner 
and Griffiths, 1973a, b, Griffiths e t al, 1973, Lancashire and Griffiths. 1975a, b). Some 
of these cross-resistant mutations were ambiguous in their mode of inheritance, showing 
both nuclear and cytoplasmic factors (Cohen, 1977, Cohen and Eaton, 1979), which led
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to the proposal of an additional cytoplasmic element with which expression of resistance 
is associated (Guerineau et al, 1974). However, most sources believe that the 
cytoplasmic loci involved are located on the mitochondrial genome (Cohen and Eaton, 
1979, Simmons and Breen, 1983).
Group I mutants isolated in this study are thought to be alleles of the pdr  linkage group 
on S.cerevisiae chromosome VII described by Saunders and Rank (1982), based on 
linkage to leux and phenotypic properties. As well as multiple antibiotic resistance, 
diploid crosses of haploids from this group with the sensitive strain D22 give isolates 
with a semi-dominant background but having resistant papillae identical to the pdr allele 
anti characterised by Cohen and Eaton (1979). Group II mutants (VenRCapR) are 
probably controlled by a different pleiotropic chromosomal gene. Mutants of similar 
phenotype, non-allelic to pdr (Saunders and Rank, 1982), have been described by 
Guerineau et al (1974).
Crosses between all venturicidin mutants isolated and a sensitive wild-type strain gave 
rise to diploids of intermediate resistance. Complementation tests were of little use in 
defining associated groups of mutants because o f  ambiguity of resistance in diploids. 
Mutations of this phenotype would be extremely difficult to clone, and if  this was ever 
attempted it would be on the assumption that a gene dosage effect would mean that a 
partially dominant gene could appear dominant i f  expressed in sufficient quantity. This 
would be achieved by transformation of a sensitive strain with a high copy number 
plasmid containing a genomic library prepared from a resistant strain.
None o f the mutants generated in this study showed increased resistance to the selective 
antibiotic at mitochondrial ATPase level. In comparison, the mitochondrial ATPase of 
S.cerevisiae strains having mitochondrially-coded antibiotic resistance invariably shows 
an increase in Ijq for that antibiotic (Connerton, 1986, Ray et al, 1988). Unless this could 
be demonstrated in a nuclear mutant it would be uneconomic to attempt to identify the
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mutant gene by cloning because of the problems associated, as it is unlikely to be a 
structural component of the complex. As the nuclear components of F0 have already 
been identified in S.cerevisiae (Velours et al, 1988) a more direct method of cloning the 
genes is now available, and has been used successfully to clone ATP4, the structural gene 
for ATP subunit 4 (Velours et al, 1988). This would involve limited protein sequencing 
and probing a wild-type genomic library with an oligonucleotide probe derived from this 
sequence, thus identifying the gene for a known ATPase F0 subunit.
From sequence analysis of mitochondrial DNA from oligomycin and venturicidin 
resistant mutants having mutations in oli! and old! the amino acids responsible for 
resistance in subunits 9 and 6 respectively have been defined (Ooi et al, 1985, Nagley et 
al, 1986, John et al, 1986, Ray et al, 1988). From this domains involved in antibiotic 
binding and, by inference, domains important in proton translocation have been 
identified. This type of analysis may prove difficult with the nuclear-coded subunits, as 
by far the most frequent mutation to antibiotic resistance appears to be in a non-specific 
membrane factor (this study, Avner and Griffiths, 1973a,b, Guerineau et al, 1974, 
Griffiths et al, 1975, Lancashire and Griffiths, 1975a,b). The only nuclear-coded 
antibiotic resistant mutation resulting in an alteration of a structural component of 
ATPase was isolated by Willson and Nagley (1987) when they identified a nuclear 
suppressor to a mit~ mutation which also conferred venturicidin resistance to the 
complex.
6.2. Organotin/Hydroxyflavone Complexes
At present studies are at a very early stage, and experiments are in progress with other 3- 
hydroxyflavone derivatives to determine which have the most desirable characteristics, 
and to further identify their binding site. However, the potential o f these compounds as 
fluorescent probes of mitochondrial ATPase F0 is already evident. A number of possible 
applications can be envisaged. Trialkyl tin compounds are known to bind F©, but no
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resistant loci have been mapped to the mitochondrial genome, suggesting that the binding 
site is composed of nuclear-coded subunits only, in contrast to oligomycin and 
venturicidin. The fluorescent compounds could conceivably be used as a simple method 
of screening groups of pet mutants for the presence of this binding site. Unknown 
compounds could be screened for F0 binding at this site, and known ATPase inhibitors 
investigated to determine whether they share the organotin binding site. It may also be 
possible to monitor F0 in biochemical preparations. All are potentially interesting 
directions for future research.
6.3. The PETS7 mutant
This thesis describes a S.cerevisiae PET mutant which lacks functional F |F0 ATPase 
activity. The DNA encoding the PET57 gene has been completely sequenced, and was 
found to encode a putative protein product 36 Kdal in size. This protein has a region at 
its N-terminus which shows a number of features evident in known mitochondrial signal 
sequences which are post-translationally cleaved. Antibodies to a trpE/PET37 fusion 
protein detect a protein species of molecular weight 31 Kdal in mitochondrial 
preparations, which is not observed in mitochondria from a strain where PET57 was 
disrupted with his III, but is overexpressed (in comparison with wild-type) in 
mitochondria prepared from strains transformed with a complete copy of PET57 in a 
plasmid vector. So from this evidence it would appear that the PETJ7 protein product is 
transported into mitochondria.
The mutant mitochondrial FjF0 ATPase from the mutant parent strain (B264) shows 
many abnormal characteristics. The level of the Ft a  and f) subunits in mitochondrial 
preparations appears significantly lower in the mutant that in the wild-type. The F | or the 
F,F0 complex has not been successfully isolated from B264, but whether this is due to 
abnormal membrane binding characteristics or to increased susceptibility to protease 
digestion is unclear at present. It is also evident that the complex can be reconstituted
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into functional, oligomycin-sensitive form by adding back wild-type Fj to stripped 
mutant membranes. The protein product of PET57 would appear to exert its effects post- 
transcripdonally, as comparison of RNA levels for the (3 subunit of F1 ATPase between 
mutant and wild-type does not show a significant reduction in the mutant strain which 
could account for the lowered level of the (3 subunit in the mutant mitochondria.
The biochemistry of the pet57 mutant phenotype shows a number of similarities with the 
mutant per936 isolated by Todd (Todd et al, 1979). The author describes a mutant which 
lacks functional F,F0 ATPase activity and shows a similar repression of the 
mitochondrial enzyme complex cytochrome oxidase. Investigations were focused on the 
mitochondrial ATPase. On immunoprecipitation of this complex with antisera to a 
Triton extract (i.e. to the complete FiF0 complex) only 18% of the wild-type level of 
ATPase determinants were precipitated in the mutant. The amount of translatable 
mRNA was compatible in mutant and wild type, although this was not quantified in terms 
of Fj a  and (3 mRNA as the respective genes ATP1 and ATP2 had not been cloned at that 
time. The author also identifies two additional protein species present in 
immunoprecipitates from the mutant strain, and changes in the relative stoichiometry of 
other ATPase subunits. The conclusions drawn to explain the phenotype of this mutant 
suggests that the nuclear gene product from /*£T936 enhances translation of mRNA 
encoding nuclear ATPase and cytochrome oxidase subunits, and by this common 
translation mechanism the biogenesis of the two complexes are coordinated at the 
molecular level. Thus the PET936 gene product is expected to exert its effect outside the 
mitochondrion, so mitochondrial import would not be necessary. A similar mutant has 
been observed in the fission yeast S.pombe (Goffeau et al, 1974) in which a single 
nuclear mutation results in deficiencies in mitochondrial ATPase and cytochrome 
oxidase. However, mitochondrial ATPase activity is present in this mutant, although 
sensitivity to oligomycin is lost, and there is evidence that the mutation is in a structural 
subunit, so this mutant group may be unrelated to that described previously (current
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study, Todd e t a l, 1979).
Cheng and collègues (1989) describe a conditional recessive pet mutant, mi/4, which is 
essential in conferring a conformation on imported mitochondrial proteins making them 
competent for further assembly or sorting. The mtf4 gene encodes heat shock protein 
hsp60, which is one of a group of proteins termed “ chaperonins”  as they chaperone 
oligomeric protein assembly. No mature F, ATPase subunit could be detected in the 
supernatant after extraction of mutant mitochondria with chloroform, and the authors 
conclude that the f) subunit fails to assemble into the ATPase complex. The mutant also 
fails to assemble cytochrome l>2 and the Rieske Fe/S protein of complex ID, and these 
proteins accumulate in the mitochondrial matrix as incompletely processed 
intermediates. Therefore the phenotype of this mutant also has similarities to the PETs7 
mutant phenotype.
However, when the PET57 DNA and protein translation were used in DNA and protein 
database searches, no homology with chaperonin proteins was discovered. The EMBL 
nucleotide sequence library was searched (release 19. May 1989) which contains the 
E.coli and wheat chaperonin sequences. The Genebank DNA sequences (March, 1989) 
and the PIR and Swiss-Prot protein sequence databases (both March, 1989) were also 
searched. A more specific analysis, comparing the PET57 protein translation with the ten 
known chaperonin proteins including that investigated by Cheng (Cheng et al, 1989), did 
not show significant homology with alignments of the chaperonin sequences. In addition 
there was no apparent ATP binding site, and chaperonin proteins are thought to have 
some ATPase activity. So the PETj7 protein is not a member of the group of chaperonins 
reported to date.
Many PET genes have been isolated and for some their protein products identified. A 
specific function can be attributed to some protein products, others have been identified 
tentatively. PET genes and their function are summarised in Table 6.1. The known PET
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products fulfill the following requirements; in addition to structural proteins and tRNA 
synthases, factors exist which process mitochondrial mRNA and enhance its translation.
Predicted Product Gene Name Reference
a  subunit of Fj ATPI
P subunit of F) ATP2 Saltzgaber-Muller et al, 1983
ATPase subunit 4 ATP4 Velours et al, 1988
Subunit 4 of cytox COX4 Maarse étal, 1984
Subunit 5 of cytox COX5 Koemer étal, 1985
Subunit 6 of cytox COX6 Wright et al, 1984
A DP/ATP translocator OP1 O’Malley et al, 1982
Ribosomal protein MRP1
tRNA synthetases MSY, M STI, MSD Pape é ta l, 1985
MSF1MSW Myers and Tzagoloff, 1985
Cyt.b matura sc CBP2 McGraw and Tzagoloff, 1983
Cyt.b 5’end processing CBPl Dieckmann étal, 1984
Cyt.b translation factor CBP1.CBP6 Dieckmann and Tzagoloff, 1985
MK2 Roedel eia/,1985
Cyt.ox sub 1 pre-mRNA splicing MSS1I6, MSS51 Faye and Simon, 1983a, b
Cytox sub 2 translation factor PETI 11 Poutre and Fox, 1987
Cytox sub 3 translation factor PET494, PET54 Mueller et al, 1984
Mitochondrial protein assembly mi/4 Chcng et al, 1989
Cytoplasmic RNA translation PET936 Todd et al, 1979
Table 6.1 PET genes and their predicted protein products 
The protein encoded by PETS7 does not fall under any of these categories as it appears to 
affect the products of nuclear genes. Evidence has been presented in this thesis that this 
protein is transported into mitochondria, and this argues against it exerting its effects on 
the mitochondrial F, ATPase subunits at the level of mRNA. The requirement of nuclear 
proteins to enhance the translation of mitochondrial mRNA appears a common 
mechanism in the nuclear control of mitochondrial biogenesis, and it is not unreasonable 
to propose a similar mechanism for the control of cytoplasmically-derived mitochondrial 
subunits, ft is possible (but unlikely) that the PETj7 protein product could enhance the
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translation of both nuclear and mitochondrial mRNA in their respective cellular 
compartments, which would allow for transport of the protein into mitochondria. 
However, the simplest explanation is that the PETS7 protein product is involved in 
processing or assembly of subunits imported from the cytoplasm, such that its absence 
causes aberrant integration into the ATPase complex.
Future investigations into the petsl mutation are initially directed at determining whether 
the mutation is allelic to the pet936 mutation described by Todd (Todd et al, 1979). The 
first step will be to determine whether per57 and pet936 are in the same complementation 
group by mating the two strains and observing whether respiratory competent progeny 
result. The biochemistry of the mutant parent strain B264 can also be further 
investigated which would give an indication as to whether the two mutations had 
identical phenotypes. Firstly B264 mitochondria could be assayed for cytochrome 
oxidase, as Todd reports a pleiotropic deficiency in this enzyme in pet936 mitochondria. 
Use of the antibody to trpEIPETi7 should be able to answer questions about the location 
of the PET57 protein; whether the protein is membrane-bound or soluble, and whether it 
is detectable in any significant quantity in the cytosol. The PET57 protein is an essential 
factor in the biogenesis of mitochondrial F]F0 ATPase, an enzyme of dual biosynthetic 
origin, and further investigations may clarify factors coordinating nuclear and 
mitochondrial protein synthesis systems.
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APPENDIX I
Preliminary Analysis of S.cerevisiae Resistance to other ATPase Inhibitors
This appendix covers results generated from the use of other antibiotics known to inhibit 
mitochondrial ATPase by binding to the F0 domain of the enzyme complex. Each 
antibiotic was used in preliminary studies to determine whether it inhibited oxidative 
growth of S.cerevisiae, and if it could be used to generate resistant mutants.
Materials and Methods
All methods used in this chapter have been covered previously in Chapter 2, in which 
suppliers of chemicals for S.cerevisiae media and antibiotics have also been identified.
Results
Initially antibiotics were added to solid media to give plates containing increasing 
concentrations of antibiotic. The sensitive strain D273/10B-A1 was then streaked on 
each concentration and its growth scored after 3 days incubation at 30°C. Antibiotic 
plates were used within 24 hours of their preparation. Table la shows the extent of 
growth on antibiotic-containing media using four different antibiotics. The 
3-hydroxyflavone derivative and the morin derivative were described in this study, 
leucinostatin was investigated by Lardy (Lardy et al, 1975) and diethylstilbesterol by 
McEnery and Pederson (1986).
The fluorescent Sn compounds did not inhibit S.cerevisiae growth in either solid or liquid 
media (results not shown), which was thought to be due to either a permeability barrier at 
plasma membrane level or to reaction with the media chemicals. Diethylstilbesterol 
inhibited S.cerevisiae growth at high concentration, but was unstable in the medium -  
plates containing this antibiotic had to be used immediately so it was difficult to achieve
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Antibiotic Antibiotic Concentration in Media (pgmT1)0.3 1 2 4 3 10 13 20
Diethylstilbesterol
Leucinostatin
Bu3Sn(of)Br
Bu3Sn(morin)Br
+-M- + + +  + + +  -M-+ + *  -  -  
-H-f + +  -  -  -  
+ + +  + + +  + + +  + + +
+ + +  + + +  + + +  + + +
Table la  Resistance o f D273/10B-A! to the antibiotics diethylslilbesterol. leucinostatin and 
organotin compounds. The sensitive strain D273/10B-A1 was replicated onto N3 (buffered 
glycerol) medium with antibiotic additions. Growth was scored after three days incubation at 
30°C with (♦+♦) representing uninhibited growth and ( - )  used for concentrations which inhi­
bited growth completely.
good levels of inhibition. Leucinostatin inhibited growth at a lower concentration, there 
was good definition between inhibition and growth, and plates could be kept for more 
than two weeks without the antibiotic losing its effectiveness. Therefore this antibiotic 
was selected for further study.
Leucinostatin resistance
This antibiotic has a mode of action similar to that of the tri-alkyl tin compounds which 
have been previously investigated in this laboratory. At low concentrations leucinostatin 
causes a loss of ATPase activity, but when the concentration is increased the compound 
causes dissipation of the mitochondrial membrane potential. This can be observed easily 
in rat liver mitochondria (Figure la) where addition of the compound causes a fall in 
fluorescence of the extrinsic fluorescent probe DSMP* (this experiment is described in 
detail in section 3.2). S.cerevisiae mitochondria are poorly coupled and thus this 
experiment cannot be applied.
The effect of this compound on mitochondrial ATPase is of interest because the 
leucinostatin and venturicidin binding sites are thought to overlap (Lardy et al, 1973). Its 
dual mode of action also suggests comparison with the tin compounds may be of interest.
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Figure la  Turbidity of D273/10B-A1 in liquid N3 with addition of (a) 5 u g m l'1 leucinostatin and 
(b) 3 u * m r‘ venturicidin. Turbidity was measured on an EEL colourimeter using a 607nm filter as 
described in Chapter 2.
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Figure lb  Mitochondrial ATPase resistance to the antibiotic leucinostatin from wild-type (D273/10B-A1) 
and leucinostatin resistant (LUV4) strains. Methods for ATPase assay, phosphate determination and 
protein assay are described in section 2.2. Concentration of inhibitor is given in ¿lg per mg o f  mito­
chondrial protein.
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Firstly strain D273/10B-A1 was grown in liquid culture, with or without leucinostatin, to 
determine whether this antibiotic solely affected the aerobic growth. Four cultures were 
inoculated, NO with 5 (igml-1 leucinostatin, N3 with 5 pgml-1 leucinostatin and controls 
without the antibiotic. Turbidity of these cultures was measured at varying time intervals 
and is shown in Figure lb, together with a similar experiment using venturicidin as 
inhibitor. From this it can be seen that leucinostatin has similar effects on D273/10B-A1 
growth as the previously characterised antibiotic venturicidin. Leucinostatin inhibited 
aerobic growth in the culture medium (at 30°C for 50 hours.
Leucinostatin was added to solid medium from an ethanolic stock solution, using a 
variety of concentrations to determine over which limits the antibiotic was effective. A 
small amount of growth of the wild-type (sensitive) strain D273/10B-A1 was observed 
on solid N3 medium containing 1 pgml-1 leucinostatin, but 2 ( ig m l1 was completely 
effective in inhibiting growth.
D273/10B-A1 was mutated using UV irradiation by the method described in Chapter 2 
and resistant mutants were selected on N3 medium containing 2 and 5 pgmT1 
leucinostatin. LR mutants were isolated at 2 pgm T1. but not at the higher concentration. 
Further UV mutation of these LR mutants could generate resistance to 5 pgml-1, but this 
level of resistance was never achieved in a single step mutation. Cross resistance of the 
mutants isolated is shown in Table lb.
To determine whether any of the LR mutations were mitochondrially-coded, the selection 
procedure described by Lancashire and Mattoon (1979) was employed. This is based on 
the fact that a mitochondrial mutation will show dominant resistance in diploid if mated 
to a p° tester strain, but the diploids produced from converting mitochondrial resistant 
mutations to p° with EtBr and mating with a p* tester strain will be sensitive. To convert 
mutant strains to p°, colonies were grown on EtBr-  containing medium for three days 
and then replicated once on to a fresh EtBr plate. It was discovered that a proportion of
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Strain N3L N301 N3V N3CAP N3ERY Mating
LUV4 2 <0.5 1 1 4 -
LUV42 2 <0.5 1 1 4 -
LUV7 2 <0.5 1 1 4 +
LUV85 2 <0.5 1 1 4 +
DLUV4a 5 <0.5 0.5 1 4 _
DLUV42a 5 >5 1 4 10 -
DLUV7a 5 >5 1 4 10 +
DLUV85a 5 <0.5 1 1 4 +
D273-10B 1 <0.5 0.25 1 4
Table lb  Cross-resistance of leucinostatin-resistant mutants. Strains with the prefix D have 
been mutated twice and their singly-mutated parent strains are also shown. Growth on anti­
biotic containing media was scored after three days at 30°C. Concentrations of the inhibitors 
leucinostatin (L). oligomycin (Ol) and venturicidin (V) are given in p g m l-1 . Concentrations 
of chloramphenicol (CAP) and erythromycin (ERY) are given in m g m T 1. Antibiotic plates 
were made up in buffered glycerol medium (N3).
the Lr mutants were sensitive to ethidium bromide, and also that they would not mate to 
tester strains. This was retained in doubly-mutated strains originating from the deficient 
mutants.
Mutant mitochondria were tested for ATPase activity and degree of resistance to 
leucinostatin compared to the parent strain. Methods used are described in chapter 2.
Mutant mitochondria showed no observable increase in Ijq for leucinostatin. and from 
this we must conclude that a structural change in an ATPase subunit is unlikely. 
Inhibition curves are shown in Figure lb, and I30 for D273-10B/A1 was 0.12 pg/mg 
protein.
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APPENDIX II
Guidelines on the Use of Computers in DNA Sequencing Projects
This appendix describes programs available on the UNIX system at Warwick for the 
analysis of DNA and protein sequence data. In addition it covers programs available at 
other U.K. universities, specifically Cambridge and Edinburgh. All programs described 
should be readily available to researchers at Warwick in the near future if they obtain 
user codes on the SERC machine at Daresbury. Where analyses have been performed on 
the DNA sequence resulting from this project, or its protein translation, the output has 
been included for illustration. Programs not used in this project have been described in 
outline.
Input o f Data from Gels
Information can be taken directly from photographs or autoradiograms of gels by using a 
digitiser, a lightpen and a lightbox. This method is used for
1. Restriction mapping of DNA
2. Generation of a consensus sequence from a number of sequencing gels.
Firstly the computer can be used to estimate the lengths of fragments produced by 
restriction enzyme digests by comparison with size standards of known length run on the 
same gel (FRAGS IZE). The most probable restriction maps of the restriction sites for 
the enzymes used can then be generated (RESTRICT), together with an associated error 
value. The error value is used to differentiate between a “ good”  map and a “ poor” 
map. These programs are not yet available at Warwick, and their accuracy is 
questionable at present as they are in a basic form, with problems known to occur when 
analysing enzymes producing small fragments.
IS2
DNA sequence data can be analysed on the UNIX system at Warwick. The method 
available, termed the “ DB System" is normally applied to fragments generated by the 
Sanger dideoxy sequencing method, but is probably transferable to Maxam and Gilbert 
gels. The user defines the four areas containing the sequencing lanes using pen and 
digitiser, and then inputs the sequence into the computer by touching the pen to 
successive bands on the gel (GELIN). The data from each gel is stored in a separate file. 
Vector sequences can be identified by the SCREENV program, and subsequendy 
removed from the contaminated files. The program DBAUTO is then implemented to 
compare each gel with all others in the sequence project database, and to arrange gels 
which overlap into contigs. A consensus sequence is calculated from each contig and 
used as a  basis for further analysis (comparison with a DNA database, determination of 
putative open reading frames etc.).
DNA Analysis by Computer
The restriction map and sequence of PET57 were determined without the use of a 
computer, but the DNA and protein sequence analysis programs were used extensively. 
ANALYSEQ is R. Staden's collection of sequence analysis programs, which have 
programs subdivided into groups performing similar functions, and accessible through 
different menus. The menu number and the instruction number to implement the 
program discussed is shown in brackets.
Identification o f  Coding regions
To determine the most likely reading frame o f a sequence a variety of methods are 
available in ANALYSEQ, which can be accessed by entering the "gene search by 
content m enu”  (-3). It is usually necessary to analyse all 6 reading frames of a DNA 
sequence so the complement of the DNA as stored must be generated. To reverse and 
complement a sequence in ANALYSEQ the general menu (-1) must be accessed, and the 
reverse and complement option selected (13). Two methods are discussed in detail as
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This region is reached by 
16% of coding regions 
0% of non-coding regions
Figure Ha Interpretation o f graphical display produced using the method o f uneven positional base fre­
quencies (Staden, 1984a).
Figure lib  Output generated by  applying the method of uneven positional base frequencies to the coding 
strand of PETyj.
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Figure lie  Interpretation of the graphical display using the method o f Fickett (1982).
Figure lid  Output generated by applying F ickea's method to the coding strand of PETJ7.
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illustration. The first, uneven positional base frequencies (54), relies on the assumptions 
that
1. A non coding region of DNA has a random distribution of nucleotides in all three 
codon positions, for all three reading frames.
2. A coding region of DNA has some nucleotides overrepresented in certain codon 
positions, for all three reading frames (Staden, 1984a).
The output generated by this program is graphical, and is interpreted as shown in Figure 
Ila. Computer analysis of the PETyj by this method does not identify it as likely to 
encode a protein (Figure lib).
The method of Fickett (21, 1982) was developed from  this basic strategy. This method 
differs from the uneven positional base frequency method as it weights the parameters 
generated according to their ability to differentiate between coding and non-coding 
regions of DNA (the weightings were generated by analysis of a library of known 
proteins). The output from this program classifies windows into three categories as 
shown in Figure lie.
The output generated by the PET57 protein is shown in Figure lid.
The second method discussed relies on the uneven use of amino acids by proteins. The 
positional base preference method (58, Staden, 1984a) determines the frequency of each 
base in each of the 3 codon positions. In a coding region G is frequently found in 
position 1 and A in position 2. This analysis is repeated for each reading frame, and the 
method is probably most useful in determining the coding frame of a protein-coding 
DNA. The results are presented in the form of three graphs per strand, each representing 
one reading frame (Figure lie).
Of the two types of option available in ANALYSEQ to determine the probability of a
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DNA sequence coding, the gene search by content menu (-3) contains the m ost powerful 
methods available to date. The alternatives, in the gene search by signals menu (-4), 
include programs to identify start (24) and stop (25) codons, mapping the longest open 
reading frames (16), and options to mark possible ribosome binding sites (3, 38) or 
polyadenylation sites (39). These options are self-explanatory so will not be covered in 
this appendix (see Staden, 1984b).
DNA Database Searching
The initial step towards identifying the gene under investigation is to compare the DNA 
sequence with sequences of known function stored in a database (such as EMBL, stored 
on the IBM system SKY at Warwick). The sequences in the database most closely 
related to the probe sequence can be identified and extracted. For the gene PET57 a 
search of this nature was carried out on the Cambridge University Molecular Biology 
VAX 8350. The EMBL database was searched with the complete 1.6 Kb sequence of the 
coding strand PETS7 using the program FASTN. The best scores were saved and listed 
with an initial score and an optimised score. The former gives an indication of the 
degree of homology o f the first significant alignment found in a particular sequence, the 
latter refers to the score when considering the two sequences as a whole. The PETS7 
DNA did not produce any good alignments with any of the entries of the database (Figure 
IIO. Of the best scores produced, 25% of the database entries were located on yeast 
mitochondrial DNA. This may be significant, as current theories propose that 
mitochondrial genes have been gradually transferred to the nucleus, and synthesis of the 
PET57 protein is a requirement for biogenesis of functional mitochondria. However, this 
was not helpful in directly identifying the PETj7 gene.
From the analysis of PET57 DNA the function of the open reading frame could not be 
identified. Now we will discuss what information can be generated from  computer 
analysis of the putative protein product of the open reading frame. Again, programs not
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Figure I l f  Sample output from a database search, comparing the coding strand o f PET„  with the EMBL 
DNA database by use of the program FASTN. The best scores are displayed in order, and part of a 
sequence alignment is included.
available at Warwick are described in outline, and, where appropriate, the results 
generated from the protein translation of PET57 will be included.
Analysis o f Protein Sequences (reviewed by Hodgeman, 1986)
Protein Database Searching
R. Staden's collection of protein sequence analysis programs available at Warwick are 
accessed by selecting ANALYSEP. The simplest options can be used to calculate the 
molecular weight of the protein product and its amino acid composition (menu -5, option 
19) and its net charge (-5, 20). However, the most successful method currently available 
to ascribe a function to an unknown open reading frame is by demonstrating substantial 
homology to a protein of known function. By scanning a protein database such as 
SWISSPROT (available on SKY), the PROTSEQ database (available at Cambridge 
University), or the CLAVCUT database (available at Edinburgh University), the proteins 
giving the best scores in search and alignment programs are selected and listed. Searches 
for homologous sequences to the PET57 protein product were conducted on the latter two 
databases, and the results generated from each will be considered in turn.
The search conducted by the Biocomputing Research Unit in Molecular Biology at 
Edinburgh University (E-mail: ‘ebmo02@uk.ac.edinburgh.emas-a’) was carried out by 
Dr M. Collins. The output of this search is included in Figure Ilg and can be interpreted 
as follows; although biological significance does not always correlate with the score of 
alignments, the output lists alignments in order of decreasing score. The most significant 
information is presented as two different parameters
Expected-, the expected score is the number of times a collection of unrelated proteins the 
size of this database would generate this score. Therefore scores less than 1 are of 
interest.
Loc.Exp.: the local expected score refers to the number o f times a collection of unrelated
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7 9  D D F R T K F E T E Q S L R M S V  E A D IN G L R  1 0 3
.9 3  E E F L R  N F S S E S N IR L Q IL D A D IH G L R  2 1 8
> E C O H S D S B P l ECO B EN ZYM E S P E C I F I C I T Y  S U B U N IT  ( H S D S )  E S C H E R IC H IA  C O L I B ( S T R A IN  
1 3 . 9 6 9  0 . 2 2 4  - 0 . 1 5 1  0 . 0 0 4  0 . 4 8 9  7 2  6 8 1 0  98
N o . 3  S c o r e -  98  Q u a l i t y  8 . 6 1 2  L o c .  E x p .  0 .4 2 0 1 E + 0 0  SD 3 . 8 7 4  
H I T S -  7 3  M IS M A T C H E S -  5 3  IN D E L S -  1 7  E X P E C T E D  N O . 0 . 9 1 2 5 E + 0 0  SD 0 . 8 1 8
1 3 3  L S A  IN A N T S S V T V K H L S S R T L Q  D T L L P L P P L A E  Q K I IA E K L D T L  LA Q VD STK A R LE  1 8 f
1 4 0  L V A K IG G N  S D V IK N Q L L  R Y L D T D T L L V F S P M N E F E G R L R N A Q N 1 L Y IP IIK G M E E F L R  19*.
1 8 9  Q IP Q IL K R F R Q A V L A A A V T G  R L T K E D K D F IT K K V E L D N Y K I L IP E D W S E T IL N N IIN T  24«
1 9 8  N F S S E  S N IR L Q IL D A D IH G L R  GNQQSD IV K N A A  K K Y M S S L S P  W D L A IL E K T V L T  2 5 1
2 4 7  Q R P  L C Y G V V Q P G D D IK D G IE L I 2 6 8
2 5 2  T K S F IC  G V L L L  E N K K D T A N L I 2 7 2
> P P A 1 1 P 1  E l  P E P T ID E  (A A  A T  1 )  F P V - 1  D N A  FR O M  C H A F F IN C H  E P IT H E L I A L  W A R TS .
1 5 . 3 3 4  0 . 8 5 6  - 0 . 2 0 5  0 . 0 1 5  3 . 8 8 0  6 8  1 5 5 8  9 8
N o . 4 S c o r e -  97  Q u a l i t y  2 4 . 7 4 5  L o c .  E x p .  0 . 1 0 3 8 E - 0 1  SD 5 . 3 3 5
H I T S -  3 2  M IS M A T C H E S -  1 5  IN D E L S -  4 E X P E C T E D  N O . 0 .1 0 6 3 E + 0 1
3 6  L K G R P K K S C IT IA G V P D S G K S M F A Y S L IK F L N G S V L S F A N S K S H F W L Q P L T  86
7 3  L D G R T IK T P  LG N G 11VD N A K S L L A  Y  L L K  L E W S S L S S L S IK T H  S L  P L T  1 1 9
> P lK R B O V I K E R A T IN .  5 4 K  T Y P E  I  C Y T O S K E L E T A L  -  B O V IN E C Y T O K E R A T IN  V I B \  5 4 -K D A  7 
1 3 . 7 7 9  0 . 6 6 3  - 0 . 1 7 1  0 . 0 1 1  3 . 7 1 9  7 1  2 1 6 5  9 8
N o . 5 S c o r e -  9 6  Q u a l i t y  2 0 .4 6 9  L o e . E x p .  0 . 7 4 5 4 E - 0 1  SD 3 . 9 1 7
H I T S -  3 4  M IS M A T C H E S -  18  IN D E L S -  5 E X P E C T E D  N O . 0 . 1 2 3 9 E * 0 1
2 1 3  D D F R L K  Y E N E V T L R  Q S V E A D IN G L R R V L D E L T L T K T D L E M Q IE S L T E  E LA Y L K K  2 6 6
1 9 3  E E F  L R N F S S E S N IR L Q IL D A D IH G L R  G N Q Q S D IV K N A A K K Y M S S L S P W D L A IL E K  2 4 7
>S V G E N S T O B E V  GENOM E P O L Y P R O T E IN  (C O N T A IN S : P R O B A B L E  R N A -D EPEN D EN T RNA 
1 4 . 6 5 8  0 . 6 2 7  - 0 . 1 8 4  0 . 0 1 1  2 . 4 4 9  6 9  2 2 9 8  9 8
N o . 6 S c o r e -  9 6  Q u a l i t y  2 1 . 7 1 9  L o c .  E x p .  0 . 4 7 6 1 E - 0 1  SD 4 . 8 5 9
H I T S -  3 0  M IS M A T C H E S -  1 7  I N D E L S -  4 E X P E C T E D  N O . 0 . 1 2 3 9 E * 0 1
1 1 4 1  V F K IL N K F K G IL S S T E R E I  I  Y TQ S L D D Y V T T F D D N M T IN L E L N M D  ELH  1 1 8 8
1 6 6  V F S P M N E F E G R L R N A Q N E L Y IP I IK G M E E F L R N F S S E S N IR L Q I LOAD IH  2 1 5
Figure IIg Sample output from a database search comparing the protein translation of PET,-, with the
CLAVCUT database
proteins the size of this database would produce an alignment with the specific piece of 
test sequence shown in the alignment. This is also o f  interest if less than 1.
The CLAVCUT database used contains 8216 proteins giving a total of 2168041 
residues, and the maximum score possible (by comparing the protein sequence with 
itself) is calculated at 2783.
The PROTSEQ library was also searched on the Cambridge University Digital 
Equipment Corporation VAX/VMS (V 4.7). This database contains 2 224 790 residues in 
7724 protein sequences. The results are interpreted as follows; the initial score describes 
the degree of homology in the first significant alignment and the optimised score the 
degree of homology considering both sequences in their entirety (Figure Ilh).
The results generated arc different as the two methods of searching rely on different 
criteria, but neither search could pinpoint a protein sequence with substantial homology 
to the PETj7 protein product. At present database searching and alignment programs are 
under investigation to attempt to identify more subtle and distant relationships between 
sequences without generating false positives.
The dot matrix graphics program DI AGON is available at Warwick, and is used to 
identify regions o f conserved sequence for both DNA and protein sequences. It is most 
widely used for the latter; for nucleic acid sequences chance matches occur for 25% of 
the plot so it is difficult to identify significant homologies from background. The two 
sequences to be compared are arranged as the two sides of a 2-dimensional plot, one 
reading horizontally (x axis) and one reading vertically (y axis). The 2-dimensional plot 
is generated by assigning a score to each coordinate and joining points over a certain 
value. Thus regions of homology appear as diagonal lines, and parallel diagonal lines 
show homologous sequences interrupted by introns. For protein sequences two options 
are available: perfect (identity) matching and proportional matching. For perfect 
matching the score at a particular point is the sum o f the identities found when looking
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PROTSEQ database.
back along the diagonal, and when a mismatch is found the score is reset to zero. The 
method o f proportional matching is generally more useful, as many significant protein 
sequence alignments result from comparison of chemically and structurally similar 
amino acids and contain few identities. The program calculates a score from comparison 
of a window (or span) of residues along one diagonal. The resultant score is attributed to 
the central residue of the span (thus the span is always set to an odd no. of residues), for 
every region of the sequence, and scores over a certain cut-off value are show on the plot.
Once the graphics plot is displayed a number o f options are available to help 
interpretation. Probably the most useful command for orienting oneself within the 
sequence is the cross hair option (6); the user can align the cross hair on a specific point 
using directional keys, read the coordinates of that point (in residues) from the display, 
and convert the graphical information to a textual display of the sequences at the cross 
hair (11). Regions of homology can be enlarged on the display by redefining the length 
of sequence analysed for the plot (14, 15), and a scale added by selecting the “ draw ruler 
or scale”  option. The matrix of scores can also be displayed (20). Figure Ili shows a 
Diagon plot o f the PET37 protein compared with itself using proportional matching.
Motif Analysis
Regions which have been conserved in related sequences generally serve a particular 
structural or functional purpose. Such conserved regions are termed motifs and can give 
some indication of the function of an unknown protein. However, the use of motifs in 
analysing protein function is at a very early stage of development, and is at present a last 
resort in protein analysis. A motif is often so complex that it cannot be described as a 
simple consensus because the characteristic distribution of amino acids in the length of 
sequence is so diverse. If a number of separate motifs are present within one protein a 
“ pattern”  results, and there may be rules governing the motif separation or allowing the 
substitution of alternative motifs. The highest level o f analysis by this method defines 
“ templates”  which describe patterns produced by known protein structures.
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Figure HI A DIAGON plot produced by comparing the PET„  protein with iueif (hence complete identity) 
uiing proportional matching. This comparison is useful as it will detect repeated amino acid motifs
Improvements to motif analysis are continuing, and in future it may become a very 
powerful technique for identification o f protein functional domains.
By far the most common type of motif used is based on sequence similarity between 
regions of associated function. To search for the characteristic sequence associated with 
a particular motif a weight matrix must be generated by programs such as WEIGHTS 
available on the Cambridge University CSBS VAX 8350. This takes sequence 
alignments of known motifs and calculates the amino acid frequencies in each position as 
well as giving some measure of the sequence variability. This method is demonstrated in 
Von Heijne (1986a) when attempting to identify signal sequence cleavage sites. Many 
examples of a particular motif are required to give a statistically convincing result. 
W hen comparing an unknown sequence with a motif scores are generated whose 
magnitude is related to the degree of homology of a particular sequence window with the 
characteristic motif sequence.
Prediction o f Protein Structure
Information in the primary sequence of a protein can be used to determine its manner of 
folding. Each amino acid residue is thought to bear information which determined the 
favoured conformation of that and surrounding residues. These methods rely on data 
from  known crystal structures or from stereochemical and biophysical considerations. 
The statistical methods of Chou and Fasman (1978) and Robson (Gamier et al, 1978) 
assign probability values to windows o f residues, but to date only 50-60% of residues are 
assigned to their correct structure. However, meaningful results can still be obtained, as 
this overall figure arises because some regions are more difficult to predict than others.
The Robson algorithm, available in the "Staden Plus" program package, produces output 
which shows the probability of four different structures; alpha helix, beta sheet, beta turn 
and “ random” coil. However, this type of output should not be overinterpreted as 
several factors must be taken into account. Firstly, the parameters incorporated into the
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Robson program were derived from soluble proteins. Ray (1985) attempted to adapt the 
Chou and Fasman method to enable analysis of membrane proteins, specifically the 
ATPase F0 subunits 6 and 9. The prediction is also based on summed values of 
surrounding residues and, without thoughtful analysis of output, it is possible to overlook 
obvious mistakes, such as the inclusion o f proline residues in a-helical regions. Short 
helices and sheets have low predictive values and are difficult to identify. Finally, the 
effects of post-translational modification on the secondary structure of a protein has not 
been incorporated into either of these structure prediction programs.
Amino acid hydrophobicity is a useful parameter with which to predict whether a protein 
is integral to a membrane, anchored to the membrane, or free within the cytosol. On 
analysis of subunits 6 and 9 of mitochondrial ATPase. a hydrophobicity plot indicates 
that both polypeptides are highly hydrophobic, and membrane-spanning helices can be 
distinguished, with extra-membrane loops shown as areas of relative hydrophilicity (Ray, 
1985). Analysis of PET51 gives a hydrophobicity plot which indicates that it is not an 
integral membrane protein as it does not have long regions of hydrophobicity (Figure Ilj).
The program used to generate hydrophobicity plots again uses a sliding window having 
an odd number o f residues with the mean hydrophobicity of the window being positioned 
at the central residue of that window. Different information about a protein can be 
obtained by varying the window length as described by Eisenberg (1984). Evidence 
exists that a high percentage of mitochondrial targeting sequences may form ampiphilic 
helices with a  high hydrophobic moment (Von Heijne, 1986b). Hydrophilicity 
(-1 x hydrophobicity) plots can be used in conjunction with secondary structure 
predictions to determine likely antigenic sites, with a view to raising antibodies to 
synthetic oligopeptides to aid identification o f the parent protein.
Analysis of DNA by computer is presently in a developmental stage, but can still be used 
productively in DNA and protein sequencing projects. With the rapid pace of nucleotide
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sequence analysis resulting in putative protein products of unknown function, computing 
methods are likely to become increasingly necessary, especially in projects generating a 
large amount of sequence data. The field o f  computer analysis will therefore be of 
increasing importance to molecular biologists, however the limitations of present and 
future programs must be considered seriously by the researcher when interpreting their 
output.
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